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This thesis concerns the design and preparation of compounds which are 
relevant to a new strategy for the selective chemotherapeutic treatment of tumour cells. 
These bridged polycyclic compounds are prepared by Diels-Alder chemistry involving 
cyclic dienes. The bridge is to be cleaved at the cancer site by tumour-selective 
chemistry acting on an appropriate trigger. This activation of a low toxicity 'prodrug' 
results in the formation of a planar, aromatic structure which is a characteristic of 
known anti-cancer drugs (intercalating agents). 
The crucial step in the organic synthesis of these potential prodrugs is a Diels-
Alder reaction involving two classes of diene, l-(methylthio )isobenzofurans and 
pyranones, with various dienophiles. Examination of this step started with the reaction 
of 1, 1-bis(methylthio )ethene with various pyranones. Stable adducts were isolated from 
its reaction with methyl coumalate and a benzopyranone; but only substituted 
carbazoles were observed from the reaction with pyrano[3,4-bJindol-3-ones. An 
investigation into the thermal stability of the isolated adducts resulted in the 
observation of an unusual [1,5J-methylthio migration. In comparison to 
1, 1-bis(methylthio)ethene, l-(methylthio)-l-(p-tolylsulfonyl)ethene was observed to 
have lower reactivity and regioselectivity upon reaction with electron-deficient 
pyranones. The resulting adducts were unstable due to the facile elimination of 
p-toluenesulfinic acid and only aromatic products were isolated. Diels-Alder adducts 
were isolated from the reaction of l-(methylthio)-l-(p-tolylsulfonyl)ethene with 
l-(methylthio)isobenzofurans, but they were of low stability and of mixed regio- and 
stereo- chemistries. The reaction of arynes with l-(methylthio)isobenzofurans was also 
investigated. The Diels-Alder reaction between 3,4-didehydropyridine and a protected 
l-(methylthio)isobenzofuran resulted in the preparation of a precursor of a tricyclic 
hetero-aromatic compound, namely the known biologically active compound, 
2-azaanthraquinone. 
ABBREVIATIONS: 
Ar ...................................... arolnatic 
r'\ 
18-Crown-6 ...................... 1,4,7,10,13, 16-hexaoxacyclooctadecane, (0 0'") 
'-tG°5 
COSY 2D-NMR ............... conelation spectroscopy, 2-dimensional NMR, 1 H by IH 
DNA ................................. deoxyribonucleic acid 
ESR ................................... electron-spin resonance 
Et ...................................... ethyl, ~CH2CHa 
HOMO .............................. highest occupied molecular orbital 
Lawesson's Reagent ......... 2,4-bis( 4-methoxypheny 1 )-1,3 -dithia-2 ,4-diphosphetane-
2,4-disulfide, (p-CHaOC6H4-PS2)2 
LDA .................................. lithium diisopropylamide, [(CHa)2CH]2NLi 
LUMO .............................. lowest unoccupied molecular orbital 
.MTT .................................. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
2H-tetrazolium bromide, 
NBS Nb ... "d o~o 
. .................................. - romOSUCClnlml e, ~r 
NMR ................................. nuclear magnetic resonance 
nOe ................................... nuclear Overhauser effect 
Nu ..................................... nucleophile 
Ph ...................................... phenyl, -C6H5 
RNA .................................. ribonucleic acid 
TBAF ................................ tetrabutylammonium fluoride, [CH3(CH2b]4N+~ 
TFA .................................. trifluoroacetic acid, CFaCOOH 
Tol .................................... tolyl, -C6H4CH3 




This thesis concerns the design and synthesis of molecules which may be 
relevant to the treatment of cancer. This introduction will start with a description of 
cancer and some of the conventional methods for the treatment of this disease and their 
shortcomings. New approaches of selectivel)! targeting drugs at tumours will be 
described. This will lead on to a proposed design of a class of potential anti-cancer 
drugs and a description of how such molecules can be synthesised using Diels-Alder 
cycloaddition chemistry. 
1.1. Cancer -A description of the disease and its treatment 
1.1.1. The disease 1 
The replication of mammalian cells is normally carefully regulated by growth 
control mechanisms. Cancer arises when mutations in the cell's DNA cause this 
mechanism to break down, allowing the cell to replicate uncontrollably. Eventually a 
mass of cells, called a tumour, can form. Most tumours provide little risk to the host 
animal because they are localised and contained. These are termed benign. However, 
tumours can be malignant. These tumours begin to invade surrounding tissue, 
eventually allowing cells to separate from the tumour and spread around the body via 
the blood stream and lymphatic system. These cells can set up other sites of cancerous 
growth. This spread of tumour cells and establishment of sites of secondary growth is 
called metastasis and is often fatal. 
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1.1.2. Conventional treatment of cancer 2,3 
There are several accepted methods for the treatment of cancer. If a tumour is 
benign or yet to metastasise, it can be removed by surgical methods; that is, physically 
cutting out the cancerous growth. Another possible treatment is radiotherapy which 
involves bombarding the tumour with a focused beam of ionising radiation. The 
resulting formation of radicals is cytotoxic to the cells because of the eventual 
formation of lethal double strand breaks in the DNA. Both of these. forms of treatment 
involve a localised attack on the tumour. The other major area of the treatment of 
cancer is the use of chemotherapy. Often these approaches are combined in the battle 
against this disease. 
Chemotherapy is the treatment of a disease by a chemical substance that has 
detrimental effects to the component that causes the disease. Cancer chemotherapy 
involves the application of a chemical or mixture of chemicals to tumour cells, with the 
aim of killing, or aiding the body in killing those cells. These chemicals, or drugs are 
usually administered orally or intravenously and therefore much of the victim is 
potentially exposed to the drug. These drugs therefore require several properties to be 
successful: 
• they must be amenable to successful transport around the body, that is, from 
the point of administration through to the tumour or cancerous cells 
• the active form of the drug must be stable to degradation by the body's 
metabolic processes 
• the drug must be of maximal toxicity to the tumour cells but of minimal 
toxicity to normal cells, in other words, the side effects of the drug must be 
inconsequential or, preferably, non-existent. 
The last point of selective toxicity to cancerous cells is a major challenge in 
cancer chemotherapy. The only major characteristic that differentiates most tumour 
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cells from normal cells is that they divide more often due to the loss of growth control 
mechanisms. Rapid cell replication is therefore a main target in cancer 
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Most of these drugs target processes involving deoxyribonucleic acid (DNA), 
the information carrying molecule in the cell. The structure of DNA is outlined in 
Figure 1.1. Disruption in the biochemistry of this molecule is often sufficient to induce 
death of the cell. Most cancer chemotherapeutic regimes today involve a combination 
of drugs. This combination usually contains an antimetabolite4 and an agent that 
directly interacts with the DNA5 The mode of action of these drugs is as follows: 
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• Antime tabo lites: 
These inhibit enzymes involved in the synthesis of DNA. They are 
therefore only lethal to cells which are in the DNA synthesis stage of their 
cycle, resulting in a fairly selective toxicity to rapidly dividing cells. 
• Agents that interact directly with DNA: 
Molecules that interact directly with DNA and affect its biochemistry 
may be cytotoxic. 
Some anti-tumour agents act by covalently binding to the DNA. The 
N-7 position of guanine (indicated in Figure 1.1) is one of the more 
nucleophilic sites and hence is susceptible to electrophilic attack. However, the 
reactivity of sites on DNA is strongly controlled by steric, electronic and 
hydrogen-bonding interactions between the drug and the DNA. 
Some anti-tumour agents do not covalently bind with DNA but are 
shaped such that they fit snugly into a specific part of the DNA molecule. 
They are held in place by various interactions such as van der Waals' forces 
and hydrogen-bonding. Some are thought to bind in the major or minor 
grooves of the double helix (see Figure 1.1). Others are planar, aromatic 
molecules that slot (intercalate) between the base pairs of the DNA, distorting 
the helical backbone (see Section 1.1.7). 
If any of the above modifications are drastic enough, the biochemistry 
of the DNA is disrupted, leading to cell death. 
1.1.3. Limitations of conventional cancer chemotherapy 
A limitation of anti-proliferatives is that they do not target one of the basic 
changes which define cancer cells, but a later consequence of these changes. Thus they 
are not 'cancer-cell specific' so much as 'dividing-cell specific'. Rapid cell replication 
is also a characteristic of the normal cells in bone marrow, the gut, skin epithelium, and 
mucosa of the mouth. Therefore, common side-effects involved in cancer 
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chemotherapy are nausea, vomiting, irritation to skin and mucous membranes, and the 
long term delayed side-effect of bone marrow depression. In some forms of cancer 
(those associated with solid tumours) there is a population of slow growing cells which 
are not affected by conventional chemotherapeutic drugs. In these cases, treatment is 
not curative and regrowth can occur. 
Regrowth can also occur if a certain population of the mutant tumour cells is 
unaffected by a particular drug. After the rest of the tumour is killed off, this resistant 
strain of cells remains to replicate. The resulting secondary tumour will be immune to 
treatment by this drug. Hence a combination of drugs and treatments is often used. If 
this combination involves treatments with different mechanisms of action then there is 
an increased chance of killing all the cells and preventing the development of drug 
resistance. 
1.1.4. Hypoxic cells as a target for chemotherapy 6,7,8 
Some of the above short-comings of conventional cancer chemotherapy could 
be overcome if a property that is more selectively characteristic of tumours is found. 
This should limit drug side-effects and increase drug toxicity. One such characteristic 
found in solid tumours is chronic hypoxia. The majority of human cancers are slow 
growing solid tumours9. For a tumour to reach a diameter of a few millimetres, it must 
induce development of additional blood supply. This cancer cell vasculature is not 
efficient and cells in the tumour can end up a long way from the nearest blood vessel. 
In the body, the oxygen needed by the cells for respiration is carried over long distances 
in the blood stream complexed with haemoglobin. However, the oxygen has to get from 
the blood stream to the cells by diffusion.]t is consumed by living cells so its 
concentration drops as a function of distance from the nearest blood vessel. At about 
150 ~m (about ten cells) from a vessel, the oxygen concentration falls essentially to 
zero. Cells further than this from a blood vessel suffer oxygen deprivation and are 
termed hypoxic. Such hypoxia has been termed diffusion limited and often surrounds a 
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zone of necrosis where the oxygen starved cells have died (Figure 1.2). Another 
transient type of hypoxia has been observed in animal tumours caused by the 
spasmodic closing off of a blood vessel, possibly because of the high fluid pressure in a 
tumour. This is termed perfusion hypoxia. A combination of these factors means that 










Figure 1.2: Hypoxic cells and the zone of necrosis in a solid tumour 
Hypoxic cells only replicate occasionally because they are starved of nutrients 
and hence they are not susceptible to conventional anti-proliferative drugs. In fact, once 
the rapidly replicating cells around the hypoxic cells have been killed off, the hypoxic 
cell's blood supply is replenished, allowing them to start rapidly proliferating. These 
cells have already been exposed to the drug and so may have mutated to resist that 
treatment. Hypoxic cells also have an increased resistance to the lethal effects of 
ionising radiation. The DN A radical, produced by the encounter of this radiation with 
normal cells, reacts with molecular oxygen to form the peroxy-DNA radical, 
DNA-OO-. This relatively stable radical can ultimately result in lethal DNA strand 
breaks. Tn hypoxic cells, this stabilisation cannot occur. Species such as thiols, acting as 
free radical scavengers, chemically restore the DNA radical to undamaged DNA, 
making hypoxic cells more resistant to radiotherapy. A few drugs, such as the radical 
generator bleomycin rely on a reaction with oxygen to cause DNA breaks and so this 
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treatment is al so of lower toxicity to hypoxic cells. The very distance of these cells 
from blood vessels makes it difficult to get a reasonable concentration of the drug into 
these cells; especially if it has a high binding efficiency and so gets 'caught up' on the 
way. 
Hypoxic cells therefore present a maj or challenge in cancer chemotherapy and 
much effort has been put into overcoming these problems; for example drugs called 
sensitisers can be administered before radiotherapy; these take place of the oxygen in 
the formation of stabilised DNA radicals. The hypoxic property of solid tumours can 
however be used to the advantage of cancer chemotherapy. Here is a unique and 
consistent characteristic of a portion of tumour cells that differentiates them from 
normal cells. This property can be used by drugs to selectively target tumours, 
potentially decreasing side-effects and allowing an increase in toxicity. 
1.1.5. Drugs for the treatment of hypoxic cells 6,8,10 
One way to target hypoxic cells selectively is by the use of prodrug 
methodology. A prodrug is a precursor of a drug molecule that is of lower toxicity and 
may have improved delivery properties when compared to the active drug. The prodrug 
must undergo spontaneous or enzymatic transformation within the body near, or at, the 
required site in order to release the active drug. As prodrugs are converted to an active 
form at the targeted site, the prodrug has the added advantage that it is always moving 
down a concentration gradient. The requirements of a hypoxic cell prodrug are as 
follows: 
• Effective distribution: 
The prodrug form must be of low toxicity, or preferably non-toxic, 
and stable to normal metabolic processes. It must be able to efficiently migrate 
from the blood vessel to the isolated hypoxic cells. Solid tumours, because of 
their poor blood supply, have difficulty in removing cell waste products and 
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the mutant cells can often be 'leaky'. Both of these factors result in a large 
amount of extracellular fluid in tumoursll. Nutrients and drugs often rely on 
pressure gradients to allow them to migrate out of the blood vessel. In tumours 
this gradient can be close to non-existent meaning that the only mode of 
distribution available is diffusion. Efficient diffusion is favoured for 'small' 
molecules with low binding affinities. 
Activation in hypoxic conditions: 
The prodrug must undergo rapid and selective metabolism to the 
active drug in hypoxic environments. Hypoxic cells, being oxygen deficient, 
encourage irreversible reductive chemistry. Bioreductive activation is possible 
in all cells, but is readily reversed by molecular oxygen in well-oxygenated 
cells. Therefore a prodrug would ideally be activated by a reduction process 
with a reversible component, preferably occurring with a reduction potential in 
the 'window' of -450 to -300 mY. A reduction potential less than this means 
that cellular reduction is not sufficiently rapid; a potential greater than this 
means that the scavenging reaction by molecular oxygen in normal cells is too 
slow allowing premature activation. An example of a type of bioreductive 
trigger that fulfils these criteria is nitro-aromatics. The reduction of the nitro 
group to an amine involves several steps (Figure 1.3). The first step can be 
reversed by molecular oxygen. The change from an electron-withdrawing nitro 
group (Hammett 0' value = +0.78) to an electron-donating amine group (0' = 
-0.66) can be utilised in the activation of a prodrug. 
nitro nitro radical anion nitroso hydroxylamine amine 
1e- 2e- 2e-
------- [ArN=O 1 -- ArNHOH -- ArNH2 
Figure 1.3: The reduction of nitro-aromatics 
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• Suitable properties of the active fonn: 
The non-replicating property of hypoxic cells requires that the active 
form of the drug must be toxic to all phases of a cell's cycle. A high 
differential between the toxicity of the prodrug and the active form allows the 
use of larger doses. Another preferable property of the active form is a long 
half life and the ability to diffuse to neighbouring cells. The high interstitial 
pressure of tumours compared to normal cells is thought to encourage the flow 
of the activated drug from the hypoxic core to the surrounding oxygenated 
tumour cells. This allows the drug to be toxic to a greater portion of the 
tumour than just the hypoxic region. 
1.1.6. Some examples of hypoxia-selective cytotoxins 6,12 
A few selected examples of hypoxia-selective cytotoxins that fulfil some of the 
above criteria are as follows: 
• Mitomycin e l3 
Mitomycin C, la, is one of a series of hypoxia-selective cytotoxins 
that is activated by the reduction of a quinone functionality. A nitrogen in 
mitomycin C (coloured red in Figure 1.4) is amide-like in that its lone pair is 
conjugated, through the quinone double bond, to a carbonyl group. Reduction 
converts this nitrogen to a nucleophilic tertiary amine which promotes the El 
elimination of methanol. This causes activation of the drug, as shown, 
encouraging DNA alkylation. Subsequent reaction with the DNA produces 
lethal cross-links. Mitomycin C is the only drug currently used clinically that 
is thought to be a hypoxia-selective cytotoxin. Porfiromycin, lb, has superior 
selectivity in vitro and in vivo and is now in clinical trial. 
Quinones are reduced in a two step process, firstly to the semiquinone 
radical anion and then to the hydroquinone. The first step is reversible which 
was a postulated requirement for successful prodrugs. However, many 
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0 OCONH2 OCONH2 
H2N 2e- H2N 
H3C NR 2H' H3C NR 
0 OH 
1a (R = H) mitomycin C J - CH30H 1 b (R = CH3) porfiromycin 
( OCONH2 H, OCONH2 OH 
H2N H2N 
I '" ONA -
H3 
h H3C H3C 
OH NHR OH NHR OH 
OH NHR 
Figure 1.4: The bioreductive activation of mitomycin C, 1 a, and porfiromycin, 1 b, and 
subsequent cross-linking of DNA 
quinones, including mitomycin C, are good substrates for enzymes that are 
capable of reducing them in a single two-electron transfer, a step that is not 
reversible by molecular oxygen. Thus, mitomycin C can be tox.ic to 
oxygenated cells. 
• Nitrobenzyl quaternary mustards l4,15 
SN 25246, 2, is one of a series of nitro benzyl quaternary mustards 
designed specifically to be hypoxia-selecrive cytotoxins. In hypoxic cells the 
nitro radical anion produced (see Figure l.3) fragments to generare a benzyl 
radical and a nitrogen mustard, 3 (the clinical drug mechlorethamine) (Figure 
loS). In vitro, 2 is several thousand-fold more toxic towards hypoxic tumour 
cells than normal oxygenated ones. Mechlorethamine shows activity against 
non-replicating cells and shows results suggesting that it is capable of 
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-
2 SN 25246 3 
Figure 1.5: The bioreductive activation of SN 25246 
migrating from the hypoxic site of formation and killing surrounding 
oxygenated cells. The reduction potential of SN 25246 is -350 mV. These 
results fulfil the criteria laid down in Section 1.1.5 for hypoxia-selective 
cytotoxins. 
• Nitracrine l6 
The I-nitroacridine derivative 
nitracrine, 4 (R = N02), has been used 
clinically as an anti-cancer drug and has been 
shown to have potent hypoxia-selective 4 nitracrine 
cytotoxicity against tumour cells in culture. 
Toxicity maybe caused by reduction to give 4 (R = NHOH or NH2) which 
could subsequently intercalate DNA and form cross-links via nucleophilic 
attack of the hydroxylamine or amine group. However, 4 did not show 
significant activity against hypoxic cells in vivo, probably because of its rapid 
metabolism and relatively high level of DNA-binding which would be 
expected to markedly slow its rate of diffusion into areas of hypoxia. 
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1.1.7. Intercalating agents 12,17,18,19 
An intercalating agent (such as nitracrine, 4) is a non-covalently binding drug 
which reversibly slots (intercalates) in between the base pairs of helical DNA. The 
intercalating components of such compounds are planar and usually polycyclic and 
aromatic in nature. For optimal intercalation, this planar component must possess a 
minimum surface area of 28 A2, that is, three or four appropriately arranged 5- to 6-
membered rings. Intercalation of the chromophore forces the base pairs apart vertically, 
from an original distance of 3.4 A to a separation of 7-8 A. This causes puckering and 
unwinding of the sugar-phosphate backbone to accommodate the intercalating agent. 
This is shown diagrammatically for B-DNA in Figure 1.6. The principal driving forces 
for intercalation of an intercalating agent are: 
• favourable van der Waals forces between the base pairs and the intercalated 
molecule 
• a decrease in hydrophobic interactions by the removal of an aromatic molecule 
from an aqueous medium 
• favourable electrostatic and hydrogen bonding interactions between 
substituents on the intercalating agent and the DNA. 
Many intercalating agents show potent anti-tumour activity and hence have 
been used in cancer chemotherapy. n was thought that the presence of the intercalating 
agent directly interfered with DNA or RNA synthesis; however, the anti-tumour 
activity of an intercalating agent does not necessarily correspond to its DNA-binding 
strength. Ethidium bromide, for example, is a strong intercalator, but is only weakly 
cytotoxic. Also, the concentration of intercalating drug required to block replication 
and transcription of DNA is many times greater than that necessary for clinical activity. 
It is now known that many intercalating agents cause cell death by stimulating strand 
breaks in the DNA. It is thought, and in some cases has been shown, that this is due to 
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Figure 1.6: Intercalalion of a planar aromalic molecule into B-DNA causing unwinding and 
elongation of the helix 
an interaction involving topoisomerase II. Topoisomerase II is a homodimeric protein 
Ihat helps regulate the torsional strain and controls the conformation of super-coiled 
DNA. This enzyme cuts both strands of the DNA. with a four base pair stagger between 
Ihe nicks, and then allows another DNA duplex to pass through the break before 
resealing the strands, changing the amount of super-coiling in the DNA. This is shown 
diagrammatically in Figure 1.7. 
Many potent intercalating agents form a stable ternary complex with the 










Figure 1.7: The breaking and resealing of a segment of circular DNA by topoisomerase II 
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DNA complex and hence interferes with the resealing step, keeping the DNA in the 
broken state. Topoisomerase II is in greater concentrations in replicating cells 
explaining the selective toxicity of intercalating agents towards tumour cells. Cytotoxic 
intercalating agents therefore seem to require two components, a planar aromatic 
system and a substituent that can affect the biochemistry of DNA. 
1.1.8. Some examples of intercalating agents17 
A few selective examples of intercalating agents are as follows: 
• Amsacrine 16 
5 amsacrine 6 proflavine 
The phenomenon of intercalation was first used to describe the 
interaction of proflavine, 6, with DNA. The first acridine to reach clinical use 
was amsacrine, 5. It is postulated that the acridine ring system intercalates the 
DNA with the anilino substituent lying at an angle to the acridine plane in the 
minor groove (see Figure 1.1) with the NHS02CH3 substituent pointing 
tangentially away from the helix in a position to interact with a second 
macromolecule. The mode of action was found to involve an enzyme mediated 
cleavage of DNA and subsequently the topoisomerase II-intercalator-DNA 
complex was first described for amsacrine. Amsacrine however has poor drug 
distribution properties and so analogues are being investigated with improved 
aqueous solubility and lower pKa. 
Chapter 1 INTRODUCTION 17 
• Ellipticine20 
R 
7 eliipticine (R = H) 8 NMHE 
Ellipticine,7 (R = R), and 9-methoxyellipticine, 7 (R = OCR3), were 
originally isolated from the leaves of Ochrosia elliptica Labill. A derivative, 7 
(R = OR), was found to have improved anti-cancer activity, but low solubility 
, . 
was still a problem which led to the preparation of NMRE (or elliptinium), 8. 
Ellipticine and NMHE are strong intercalating DNA-binders and cause double 
DNA strand breaks as expected for a DNA-topoisomerase II targeting agent. 
Ellipticine and its derivatives have not been used widely as anti-tumour drugs 
because of toxicity problems. They decrease heart rate and can cause 
irreversible respiratory depression. 
• Anthracyclines21 
9 (R = H) daunorubicin (Daunomycin) 
10 (R = OH) doxorubicin (Adriamycin) 
Daunorubicin, 9, and doxorubicin, 10, were the first anthracycline 
drugs introduced into clinical use for the treatment of malignant tumours. 
Their success caused the production of several hundred analogues. At present, 
doxorubicin has the widest spectrum of anti-tumour activity of all such anti-
cancer drugs and is the most used anti-tumour drug worldwide. These 
intercalating agents differ from others in that they intercalate 'head first'. A 
crystal structure of the daunorubicin/d(CGTACGh complex shows the planar 
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chromophore to be at right angles to the base pair's axis rather than parallel to 
it, with the amino-sugar lying in the minor groove. Strong evidence exists that 
both daunorubicin and doxorubicin can generate protein-associated strand 
breaks in DNA that correlate well with the anti-tumour activity of the drugs, 
suggesting that these intercalating agents are able to form a complex with 
topoisomerase II and DNA. Doxorubicin is also an effective iron-chelator and 
the resulting complex is very reactive in catalysing free radical reactions, 
notably the conversion of hydrogen peroxide to the lethal hydroxyl radical. 
This property, as well as providing an al'ternative mode of action against some 
forms of human cancer cells, also causes the cardiac toxicity observed for 
doxorubicin. 
• Actinomycin D 18,22 
L-Pro L-Pro 
/' '-.. /'" ~ 
Sar D-Val D-Val Sar 
I I I I 
L_MeV~o/L_Th~r 0 ~o L-Th~o~eval 
~ I N" ~ NH2 
~ 0:::::"" 0 
CH3 CH3 11 actinomycin 0 
An X-ray crystal structure of a deoxyguanosine/actinomycin D 
complex confirms that the planar chromophore of actinomycin D, 11, 
intercalates DNA, with the two identical cyclo-peptides binding along the 
minor groove, holding the chromophore in place. The resulting slow 
dissociation of actinomycin D is thought to account for its superior biological 
activity. The ability of actinomycin D to intercalate DNA and to inhibit DNA-
dependent RNA synthesis is widely accepted as its major mode of action. 
Actinomycin D has been used clinically, but only against a narrow range of 
tumours and toxicity is a problem. 
Chapler 1 INTRODUCTION 19 
1.2. The proposed design of an anti-cancer prod rug 
The aim of this research is to investigate the preparation of a prodrug precursor 
of an intercalating agent. Placing a bridge over one of the aromatic rings of a potential 
intercalating agent will block intercalation, not only because of the steric interactions of 
the bridge, but also because of the resulting loss of planarity. This prodrug will be 
selecti vely acti va ted in the vicini ty of the cancer si te to release, upon bridge removal, 
the planar intercalating drug (shown diagrammatically in Figure 1.8). A bioreductive 
trigger attached to the bridged area could encourage bridge opening upon its activation, 
allowing selective production of a cytotoxic intercalating agent in hypoxic cells. The 
active form of the hypoxia-selective cytotoxin, nitracrine (Section 1.1.6), is an 
intercalating agent, but the prod rug form still has the planar chromophore moiety intact. 
This inactivated form therefore still has reasonable DNA-binding affinity, affecting the 
delivery of the drug. A 'small', bridged molecule should have low or no DNA-binding 
properties allowing ease of diffusion throughout the body, including into the isolated 
hypoxic core of a solid tumour. 
Activation ~ 
• 
Figure 1.8: The activation of the proposed bridged prod rug to form an intercalating agent 
Because the intercalating form is only produced at the target site, there is no 
need to limit its DNA-binding affinity. This drug, with high DNA-binding affinity, may 
therefore have very limited diffusion properties, preventing ejection of the compound 
from the hypoxic cell; a common defence mechanism of tumour cells. Interactions 
between the DNA and substituents on the intercalating component will disrupt the 
DNA function, leading to cell death. The cytotoxicity of these substituents can be 
comparatively low, allowing the prodrug to be of low toxicity. However, upon 
activation of the prodrug and intercalation of the active form, the cytotoxic substituent 
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will be held in prolonged proximity to the DNA, encouraging interaction with the 
strand or associated molecules. This cytotoxic interactlon, upon intercalation, 
effectively becomes an intramolecular reaction rather than a less favoured bimolecular 
one. 
The cytotoxic substituent could, for example, be a mild alkylating agent. Upon 
intercalation, subsequent pseudo-intramolecular alkylation will covalently bind the 
active drug to the DNA strand, resulting in superior biological activity, comparable to 
the strong DNA-binding actinomycin D (Sectiop 1.1.8). Another possible substituent 
could interact with one of the many enzymes associated with DNA, such as 
topoisomerase II (Section 1.1.7). This disruption in the biochemistry of DNA could 
lead to cell death. 
To summarise: the postulated prodrug will be selectively activated at the 
centre of a solid tumour by bioreductively triggered bridge opening. The high DNA-
binding affinity of the resulting intercalating agent will target it to the hypoxic cell's 
DNA and selectively hold the DNA destructive component for a prolonged time in the 
immediate vicinity of this cell's DNA, where it can undergo its cytotoxic mode of 
action. This high selectivity should keep any side effects to a minimum. This prodrug 
will be a small, metabolically stable, organic molecule that will therefore be able to 
diffuse through solid tumours to the isolated hypoxic core. This envisaged prodrug 
could be used in Eonjunction with conventional anti-proliferative drugs to totally 
eradicate solid tumours. 
1.3. The strategy for the synthesis of a prodrug precursor of 
an intercalating agent 
A direct method for the preparation of bridged polycyclic systems is a Diels-
Alder reaction involving a cyclic diene. The following sections will introduce the 
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Diels-Alder reaction and outline the requirements of the resulting bridged adducts. The 
bridge must be chosen such that stable adducts can be easily synthesised. It must also 
be possible to attach an appropriate trigger to the prodrug form which, upon activation, 
causes cleavage of the bridge and formation of a planar polycyclic system. 
1.3.1. The Diels-Alder reaction23 
The Diels-Alder reaction is a [n4s+rc2sJ cycloaddition. It is a very useful 
reaction in synthetic organic chemistry and its discovery earned Otto Diels and Kurt 
Alder the 1950 Nobel Prize in Chemistry. 
( + II - [(:J 1 - 0 
diene dienophile cyclohexene ring 
a: A concerted, synchronous mechanism 
b: A two-step mechanism 
Figure 1.9: The Diels-Alder reaction 
Most Diels-Alder reactions can be described by a bimolecular, one-step 
mechanism. Support for this concerted mechanism can be seen in the syn 
stereospecificity of the reaction and in the rate acceleration that occurs when pressure is 
applied to the reaction; the latter observation resulting from the large negative (-30 to 
-40 cm3 mor1)24 volume of activation required to achieve the transition state. In the 
case of a synchronous mechanism, where the bond-forming and bond-breaking 
processes occur simultaneously, this transition state can be represented as shown in 
Figure 1.9a. Substituents on the diene and dienophile can cause the rate of formation 
of one a-bond to exceed the second one. The reaction mechanism is now termed non-
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synchronous, the extreme case being a two-step mechanism involving a biradical or 
zwitterion intermediate (l~'igure 1.9b). 
EDG EDG 
( + ~EWG _ aEWG 
Normal electron-demand Inverse electron-demand 
Figure 1.10: The Diels-Alder reaction 
(EDG = electron-donating group, EWG = electron-withdrawing group) 
For a Diels-Alder reaction to be facile, the reagents require substituents with 
complementary electronic properties. By convention, a normal electron-demand Diels-
Alder reaction is characterised by the reaction of an electron-deficient dienophile with 
an electron-rich diene. This is the most commonly observed situation in efficient Diels-
Alder reactions. Consequently, a Diels-Alder reaction with the opposite electronic 
demands is termed an inverse electron-demand reaction (l<'igure 1.10). The reaction is 
reversible and the reverse process is termed a retro-Diels-Alder reaction. Frontier 
molecular orbital theory describes the Diels-Alder reaction as the interaction of the 
highest occupied molecular orbital (HOMO) of one component with the lowest 
unoccupied molecular orbital (LUMO) of the other one. The dominating orbital 
interaction is between the two orbitals closest in energy. Electron-donating (alkyl, 
alkoxy or amine) groups raise the energy of molecular orbitals; whereas electron-
withdrawing (nitrile, nitro, carbonyl or sulfone) groups lower their energy. Therefore 
the dominating orbital interaction in a normal electron-demand reaction is the diene 
HOMO with the dienophile LUMO (l<'igure 1.11). 
1.3.2. The bridge of the adduct 
The bridge of the polycyclic compound could realistically be either one or two 
atoms long. Some possible two-membered bridges include -CH2-CH2-, -CO-O-, 















Figure 1.11: HOMO-LUMO arrangements for various types of Diels-Alder reactions 
or amide- bridges are relatively stable, making subsequent drug activation difficult. 
Some possible one-membered bridges include -CH2-. -0-, and -NH-. Again, the 
alkyl- and amine- bridges would probably be too stable for our purposes. Carboxy- and 
oxygen- bridged compounds are isolable and the Diels-Alder chemistry of the 
associated cyclic dienes is well documented. These bridges also have the potential to be 
selectively cleaved upon activation of the prodrug and so will form the basis of the 
work in this thesis. 
1.3.3. Attachment of the trigger 
The trigger requires an appropriate linkage for ease of attachment and 
successful action. Attachment of the trigger to the prodrug using a sulfide unit has 
several advantages. A thiolate anion is a good nucleophile that can be alkylated with a 
wide variety of substituents, allowing attachment of a great range of triggers with 
synthetic ease. Thiols are reasonable leaving groups allowing cleavage of the trigger-
sulfur bond upon activation. Delocalisation of the sulfur electrons can then initiate 
cleavage of the prodrug's bridge. There are several well-documented benzyl-based 
protecting groups of thiols that can be cleaved by reduction25 (for example, see Figure 
1.12). The activation of such a prodrug in hypoxic conditions would be similar to the 
activation of hypoxia-selective cytotoxin, 2 (Figure 1.5). 
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A sulfide linkage has also been reported for a cancer prodrug that is activated 
by an enzyme attached to the tumour cell by way of an antibody-enzyme conjugate26 
The antibody selectively binds to an antigen on the tumour cell surface and the attached 
enzyme metaboJises the prodrug in direct vicinity of the tumour ce.ll, releasing the thiol 
substituted active drug (Figure 1.13). 




Figure 1.12: An example of selective cleavage of a trigger-sulfur bond in the reducing 
conditions of a hypOXiC cell to produce a thiol substituted drug 
......,  __ -A-tt-ac-k-s-t-um-o-u-r c_e-II---- HS-rUg 
Antibody 
Antigen 
- Tumour cell Prod rug 
Figure 1.13: An example of antibody-directed enzymatic cleavage of a trigger-sulfur bond in 
the vicinity of a tumour cell to produce a thiol subslituted drug 
1.4. Synthetic work in this thesis 
1.4.1. Carboxy-bridge 
Carboxy-bridged compounds can be prepared by the reaction of pyranones 
with alkenes. Diets-Alder reactions of this type have been known to give stable bridged 
adducts24 However, the reactions of alkynes with pyranones give highly strained, and 
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pyranone 






Cleavage of R*-S j 
and loss of RS-
25 
Figure 1.14: The preparation of a carboxy-bridged polycyclic compound and the subsequent 
transformation to a planar, aromatic compound 
hence unstable, bridged cyclohexadienes. These adducts spontaneously lose carbon 
dioxide to give the aromatic product. This, therefore, is a way of triggering the 
transformation of a non-planar, polycyclic compound to a planar aromatic one. If a 
thiol protecting group (R *) is cleaved from a Diels-Alder adduct such as 12 (Figure 
1.14) then subsequent loss of a thiolate anion followed by tautomerisation will produce 
a carboxy-bridged cyclohexadiene which will spontaneously aromatise to give 13. 
The adduct, 12, can be prepared from the Diels-Alder reaction of a pyranone 
with an appropriately substituted dienophile (Figure 1.14). Chapter 2 of this thesis 
describes an investigation into the preparation of such adducts by the reaction of a 
model dienophile, l,l-bis(methylthio)ethene, with various pyranones. Chapter 3 deals 
with the thermally induced deem'boxy lation of two of the adducts prepared in Chapter 2 
and an unusual rearrangement observed during this decomposition. Chapter 4 describes 
an attempt to improve the reactivity of the dienophile by replacing one of the sulfides 
with a sulfonyl group. The reaction of this new dienophile with various pyranones is 
repOlted. 
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1.4.2. Oxygen-bridge 
Oxygen-bridged polycyclic compounds can be prepared from Diels-Alder 
reactions involving the well-known isobenzofuran diene system27 . These dienes have 
been used in the synthesis of several polycyclic aromatic compounds28 , such as a 
derivative of daunorubicin (Section 1.1.8)29. The oxygen-bridge in the initial Diels-
Alder adduct is cleaved to reveal an aromatic ring. This provides another strategy for 
the preparation of prodrugs of intercalating agents. If a thiol protecting group (R *) is 
cleaved from adducts such as 14 or 16 (Figure, 1.15) then this should induce bridge 
cleavage (and in the case of 14, elimination of water) to give the planar aromatics, 15 





{:cO R CODR Cleavage +~ Diels-Alder of R*-S {m R • Reaction 
-H2O ~ ~ I 





Cleavage (Co +10 Diels-Alder oto of R*-S c¢o .. ~ :;,....... Reaction ~ ,--::; ~ ~ ,--::; 
OH 
isobenzofuran aryne 16 17 
Figure 1.15: Two possible preparations of oxygen-bridged polycyclic compounds and the 
subsequent transformation to planar, aromatic compounds 
The preparation of 14 and 16 involves the Diels-Alder reactions of 
isobenzofurans with alkenes and arynes respectively (Figure 1.15). Chapter 5 of this 
thesis describes the preparation of models of 14 by the reaction of 
l-(methylthio)isobenzofurans with the sulfonyl substituted dienophile (mentioned in 
Section 1.4.1). Chapter 6 describes the reaction of these same dienes with arynes with 
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the aim of isolating adducts comparable to 16. The formation of planar compounds 
from these adducts is also investigated. 
1.5. Conclusion 
Cancer accounts for about 20% of deaths in Western countries15 . Despite 
substantial research, there is still much to be learned about the successful treatment of 
the disease. The major difficulty facing cancer chemotherapy is the similarity of 
cancerous cells to normal cells. The structure and suggested mode of action of some 
conventional anti-proliferative drugs have been described. A majority of human cancers 
are solid tumours with hypoxic cores. The development of drug resistance and the side 
effects observed for the above drugs have lead to the investigation of hypoxia-selective 
cytotoxins. The aim of this project is to investigate the preparation of bridged 
polycyclic compounds with the impetus of preparing prodrugs of intercalating agents. 
These pro drugs could be activated by hypoxic conditions or by antibody-directed 
enzyme catalysis. This could provide a method for the selective delivery of a DNA 
damaging component to the desired target, namely the DNA in tumour cells. 
This thesis describes the synthesis of such compounds which involves the 
Diels-Alder reactions of pyranones and isobenzofurans with various dienophiles. The 
inclusion of an appropriately positioned sulfide moiety is required for the later addition 
of a trigger functionality. The ability of these bridged adducts to form planar aromatic 
compounds, a characteristic of intercalating agents, is also investigated. 
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There have been only a few, specialised reports ofbis(alkylthio)ethenes acting 
as dienophilesin Diels-Alder reactions1,2. Bis(alkylthio)ethenes, with conjugated 
substituents, have however occasionally been used as successful dienes1.3. 1,1-
Bis(methylthio)ethene, 19, could be considered to be a moderately electron-rich 
dienophile and therefore it was proposed that it could participate in inverse electron-
demand Diels-Alder reactions. The few reports of 19 participating in [4+2J 
cycloaddition reactions involve hetero-atom dienes as shown in Figure 2.1. 
R1 0 R1 0 SCH3 R~ H3 ClrSCH3 a- b: room temp. )\fSCH3 + .. c: 5 kbar, 70°C R2 
R3 R3 
18a-c 19 20a-c 
Ar Ar 
N~N + H3 CSirSCH3 room temp. ::rSCH3 • ~ I I II (- N2) N~N N~ 
21 19 22 
Figure 2.1: The reaction of 1, 1-bis(methylthio)ethene with hetero-atom dienes 
a: R1 = H R2 = CHO R3 = 2-thienyl; 
b: R1 = H R2 = CHO 3 R = 4-C1C6H4; 
c: 1 R = CH3 R2 = SPh 3 R = (CH2bC02CH3 
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The reaction of 19 with 18a and b occurred at room temperature to give 20a 
and b in 84% and 67% yield respectively4,5. The reaction of 19 with 18e was carried 
out at 5 kbar pressure and gave 20e in 72% yield6. The diene, 21, was reacted with 
various dienophiles; 19 was the least reactive example given. The Diels-Alder reaction, 
followed by extrusion of nitrogen, gave exclusively the ortho aromatic product, 227. 
We are unaware of any reports of Diels-Alder reactions between simple 1,1-
bis(alkylthio)ethenes and all-carbon dienes. The dienes of interest in this work are 
pyran-2-ones (23, see Figure 2.2), a class of all-carbon dienes. Because of their partial 
aromatic character, pyranones undergo Diels-Alder reactions less easily than most 
cyclic conjugated dienes. Nevertheless, many successful cycloadditions have been 
reported8,9. Pyranones can participate in normal or inverse electron-demand Diels-
Alder reactions providing that the electronic properties of their substituents are 
complementary to those of the dienophile. 
The possible products from a cycloaddition between a pyranone and 1,1-
bis(metllylthio)ethene, 19, are outlined in Figure 2.2. Two regioisomeric adducts are 
possible, A and B. Isolation of these adducts may be complicated by subsequent 
decomposition. The adducts could extrude carbon dioxide to give the corresponding, 
unstable dihydrobenzene. This retro-Diels-Alder will be encouraged by tIle gain in 
entropy obtained by the production of a gas. It is expected that the dihydrobenzene 
formed would immediately eliminate methanethiol to give the corresponding stable 
aromatic compounds (C or D). It is possible that the elimination of methanethiol could 
occur first, resulting in the formation of a bridged diene. This product is equivalent to 
the adduct expected from the reaction of an alkyne with a pyranone. There have been 
no reported isolations of such adducts8 . Therefore the bridged diene would be expected 
to spontaneously lose carbon dioxide to give a substituted benzene. 
A study was initiated to ascertain whether l,l-bis(methylthio)ethene reacts 















Figure 2.2: The Diels-Alder reaction between a pyran-2-one and 1,1-bis(methylthio)ethene 
resulting Diels-Alder adducts were stable enough to be isolated, or whether they 
spontaneously eliminated methanethiol or carbon dioxide. The bridged products A or n 
are of interest in this research because of their potential use as prodrugs for cancer 
chemotherapy. 
This chapter starts with the preparation of the dienophlle, 19. It then describes 
the preparation of simple mono cyclic pyranones through to hetero-polycyclic 
examples. Each preparation is followed by a discussion of the Diels-Alder reaction of 
the diene with 19 and the products observed. 
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2.2. The preparation of 1, 1-bis(methylthio)ethene 
1) Mglether 
2)CS2 ~ 
CH31 ----~ CH3-C, 
4) (CH30)2S02 I~ 5) LDA pCH3 
----..... CH3- C, .. CH2= G. 
3) NH40H S- NH4+ SCH3 6) CH31 SCH3 
24 19 
Figure 2.3: The preparation of 1, 1-bis(methylthio)ethene 
There are many methods for the synthesis of 1,1-bis(alkylthio)alkenes1,1O. The 
method chosen for the preparation of l,l-bis(methylthio)ethene, 19, was the 
methylation of methyl dithioacetate, 24 Wigure 2.3). This has the advantage that one of 
the sulfide linkages is formed by an alkylation in the last step allowing a late 
introduction of a possible functionalised trigger. Methy lmagnesium iodide, prepared in 
the usual way from iodomethane, was reacted with carbon disulfide, which, after the 
addition of aqueous ammonia, gave the dithioacetate saltl1 . This salt was methylated 
with dimethyl sulfate to give 24. This is a low yielding reaction, but the availability and 
low cost of the reagents make it the most convenient method. (A more etIicient method 
utilises methylmagnesium chloride12, but this reagent is technically more difficult to 
prepare.) 24 was deprotonated with lithium diisopropylamide and alkylated with 
iodomethane to give the required alkene, 19. 
2.3. The reaction of 1, 1-bis(methylthio)ethene with two 
simple pyran .. 2 .. ones 
The preparations of two simple pyran-2-ones are shown in Figure 2.4. Methyl 
coumalate, 25, was prepared via dimerisation of malic acid in fuming sulfuric acid 13. 
The 4,6-dimethyl substituted analogue, 26, was similarly prepared from methyl 
acetoacetate l4. 
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25 
26 
Figure 2.4: Preparation of methyl coumalate and methyl 4,6-dimethylcoumalate 
The Diels-Alder reaction of 25 with l,l-bis(methoxy)ethene, 27, has been 
reported by Behringer and Heckmaier15 . The only product they observed was 29a 
(Figure 2.5). The other regioisomer was not observed; neither was the loss of methanol 
nor carbon dioxide. When I carried out the corresponding reaction of the sulfur 
analogue (19 with 25), the only product observed was the bridged adduct, 28. The 
regiochemistry was confimled by comparing the coupling constants in the proton NMR 
spectrum with those reported for a similar compound, 29b (R:::: Et)15 (Figure 2.6). This 
data is also consistent with the generalisations made by Afarinkia et al. 8 for the Diels-
25 19X=S,27X==O 28 X ;: S, 29a X == 0 (R == CH3) 
CH::y':Y 0 XCH3 
CH 0 :::::.... 0 + CH2=< 
3 2 XCH 
CH3 3 
--
26 19 X == S, 27 X == 0 30X==O 31 X == S, 32 X :::: 0 
Figure 2.5: The reaction of 1, 1-bis(methylthio)ethene, 19, and 1, 1-bis(methoxy)ethene, 27, with 
methyl coumalates 
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29b 28 
Figure 2.6: A comparison of the proton NMR chemical shifts (ppm) and coupling conSlanlS (Hz) 
obseNed for 29b 15 and for 28 
Alder adducts of pyran-2-ones and pyrid-2-ones. Exo protons appear down-field of 
endo ones and have a larger coupling constant with the bridge-head hydrogen. 
Regiochemistry was also confirmed by the analysis of subsequent thermal 
decomposition products (described in Section 3.2). 
The reaction of 27 with the dimethyl substituted coumalate, 26, was examined 
by Jung and Hagenahl4. They found that the reaction gave mostly the aromatic product, 
32, in refluxing benzene, but that the conditions could be optimised to favour the 










ve slow reaclion 
Table 2.1 
The reaction of 26 with the sulfur analogue, 19, in refluxing toluene gave only 
the substituted benzene, 31. The bridged adduct was not isolated and no attempt was 
made to optimise the conditions to favour the isolation of this adduct. 
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In both cases the dimethyl substituted coumalate is less reactive than the non-
substituted analogue. This difference could be due to steric demands and/or the slight 
electron-donating ability of the methyl groups; the latter causing 26 to be a less suitable 
diene for inverse electron-demand Diels-Alder reactions. This property would also 
make 30 more reactive towards a normal electron-demand retro-Diels-Alder reaction. 
That is, the loss of carbon dioxide, triggering aromatisation, as observed. This 
observation suggests that the loss of carbon dioxide is the rate determining step towards 
aromatisation rather than the loss of methanol/methanethiol. lung and Hagenah 
attribute the low thermal stability of 30 to the alkyl substituent at the bridge-head 
position. 
Behringer et al. l5 and lung et al. 14 suggest that the above examples are not 
concerted cycloadditions, but rather a nucleophilic addition of the electron-rich 
dienophile to the pyran-2-one to give a zwitterionic intermediate 33, followed by 
carbon-carbon bond formation to produce the observed bridged product. They support 
this notion by isolating 35 (in 92% yield) from the reaction of 25 with the very 
electron-rich dienophile, 34. 
~o CH302 e 0 ffi XR 
XR 
33 34 35 
A similar dienophile to 19, ethylthioethene, has since been reported by Mark6 
and Evans to be unreactive with 3-carbomethoxypyran-2-one under thermal 
conditions16. Lewis acids are often used to catalyse Diels-Alder reactions 17 but it was 
stated that this type of catalyst, ego TiCI4, AlCI3, ZnBrz, SnX4, BF3.EtzO and EtzAlCl 
proved unsuitable for the reaction of alkyl vinyl ethers with electron-deficient pyran-2-
ones16 . They led to either polymerisation of the enol ether or decarboxylation of the 
adducts formed. It has been found that reactions of alkoxy and alkylthio ethenes with 
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3-carbomethoxypyran-2-one can occur at room temperature when catalysed by 
lanthanide complexes to give the Diels-Alder adduct in excellent yields16,18,19. 
2.4. The reaction of 1, 1 ~bis(methylthio)ethene with a 
benzopyranone 
The above Diels-Alder chemistry must be applied to the synthesis of bridged 
polycyclic compounds if it is to be of use in the preparation of potential prodrugs (as 
described in Section 1.2). Removal of the bridge must give a planar, aromatic 
compound. As a step towards this type of system, the reaction of 1,1-
bis(methylthio)ethene with a benzopyranone was examined. 
0+ C02H a ~H3 b ~H3 / I - -H3C 
0 Ph OH 
36 37 j c 
c¢t0 CH3 ~H3 e C¢C02H d 
- -::::..... ::::..... 0 ~ 0 
Ph Ph Ph 
40 39 38 
Figure 2.7: Preparation of 4-methyl-1-phenyl-3H-2-benzopyran-3-one, 40 
Reagents and conditions: (a) AICI3, benzene, reflux; (b) (i) PhMgBr, ether, reflux, (ii) 10% 
(e) cone. H2S04, gentle warming 
The benzopyranone, 40, was prepared as previously described20 (Figure 2.7). 
The indanone, 36, was prepared by a Friedel-Crafts acylation involving crotonic acid 
and benzene followed by ring closure. Reaction of 36 with the phenylmagnesium 
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bromide gave 37. Dehydration by phosphorus pentoxide gave the indene, 38, which 
underwent a ruthenium tetraoxide catalysed oxidative cleavage21 to give the keto acid, 
39. (The catalyst was prepared in situ from ruthenium trichloride and sodium 
metaperiodate.) Treatment of 39 with concentrated sulfuric acid gave the bright red 
benzopyranone, 40. This diene is relatively unstable due to the loss of benzenoid 
aromaticity and so was immediately trapped with the dienophile of interest. 
Verification of diene formation involved the reaction of the dehydration product with 
maleic anhydride20 (Figure 2.8); the disappearance of the red colour serving as an 
indicator of the end-point of the reaction. The single adduct isolated, 41, is expected to 
be the endo stereoisomer due to stabilising secondary orbital interactions in the 






Figure 2.8: The reaction of maleic anhydride with 4-methyl-1-phenylbenzopyran-3-one 
Benzopyranones are very reactive dienes because of the gain of benzenoid 
aromaticity when they undergo Diels-Alder reactions. The reaction of 19 and 27 with 4-
methyl-l-phenylbenzopyran-3-one, 40, has been reported to occur at similar rates in 
refluxing toluene2o . Both dienophiles gave a single bridged adduct, 42 and 43 
40 19 X = 8, 27 X == 0 42 X = 8, 43 X == 0 
Figure 2.9: The reaction of 1,1-bis(methylthio)ethene and 1,1-bis(methoxy)ethene with 
4-methyl·1-phenylbenzopyran-3-one 
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respectively (Figure 2.9). The cyc1oaddition of 40 and 19 was also carried out under 
high pressure conditions, 19 kbar at 20°C. The activation of this reaction by increasing 
the pressure strongly suggests a concerted mechanism. The sole product from these 
reactions was incompletely characterised and so the thermal cyc1oaddition of 40 with 
19 was repeated. A X-ray crystal structure of this regioisomer was obtained, confirming 
its identity (Figure 2.10). The regiochernistry of this reaction is the same as that 
observed for the coumalate case. 
C5' 
C4' 
Figure 2.10: The X-ray crystal structure of 42 
(For tables of structural data see Appendix A.1) 
c¢t0 OEt 0 0 I CH2=CH ct;~Et ~H3 + ~ ~ 0 fj~ r; ~-...;;; OEt 
Ph Ph Ph 
40 44a 44b 
Figure 2.11: The reaction of ethyl vinyl ether with 4-methyl-1-phenylbenzopyran-3-one 
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The reaction of 40 with ethyl vinyl ether (Figure 2.11) gave a pair of 
stereoisomers in the ratio of 78:22. Formation of the other pair of isomers with the 
alternate regiochemistry was not observed. The isomers formed were separated by 
fractional crystallisation. The regio- and stereo- chemistry of the major isomer, 44b, 
was determined by X-ray crystallography to be the endo isomer (Figure 2.12). These 
crystals had the unusual property of cracking when cooled to low temperatures and so 
the X-ray data collection was carried out at room temperature. The methyl group of the 
ethoxy side chain was disordered over two positions, CllA and Cll", As described 
Figure 2.12: The X-ray crystal structure of 44b 
(For tables of structural data see Appendix A.2) 
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earlier, the predominance of the endo isomer is to be expected due to secondary orbital 
effects. This is also consistent with other examples of Diels-Alder reactions of alkoxy 
ethenes with pyran-2-ones8,23. 
The high regioselectivity of the reaction of 19 and ethyl vinyl ether with 40 
can be attributed to steric and/or electronic factors. The methylthio/ethoxy substituents 
would probably prefer sterically to be oriented towards the methyl rather than the 
phenyl substituent. The favourable electronic interactions between these electron-
donating substituents and the electron-withdrav:ing carbonyl of the diene could also 
influence the regiochemistry. 
2.5. The attempted preparation of pyrano[3,4-b]quinol-3-ones 
The success of the Diels-Alder reactions involving the benzopyranone led us 
to extend this work to polycyclic heterocycles. These systems are expected to be more 
suited as successful prodrugs. The addition of the nitrogen and an extra ring will 
produce a tricycle which, after drug activation, is similar in structure to some 
conventional intercalating agents (see Section 1.1.8). The proposed synthesis for 
pyrano[3,4-b ]quinol-3-ones, 50, is outlined in Figure 2.13. It is based on a previously 
described preparation by Gray et al. of 2-carboxy-3-quinolineacetic acid (49a, Ph = 
OH)24. However, results from the benzopyranone work2o show that a methyl 
substituted pyrone is more stable and hence more amenable to synthetic study. The 
preparation of SOb was therefore investigated in parallel with a repetition of the known 
R = H series. 
The initial quinoline, 45, was prepared by a Friedlander synthesis between 2-
aminobenzaldehyde25 and the appropriate 2-oxocarboxylic acid26. The bromination of 
45 gave 46. Gray et al. used dibenzoyl peroxide as the radical initiator and achieved a 
yield of 22%. Lehn et alP used a 100 W tungsten light bulb as a radical initiator for 
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48 Ph 47 46 
R 
-H2O -:;/' -:;/' 0 
----- ..... 
::::-... :-... N 
Ph 
49 50 
Figure 2.13: The proposed synthesis of pyrano[3,4-b]quinol-3-ones (a: R =: H; b: R ::: CH3) 
Reagents and conditions: (a) NaOEt, ether, room temperature; (b) 10% H2S04, reflux; 
added, reflux; (e) N-bromosuccinimide, hv, CCI4, reflux; (f) R ::: H: KCN, CH30H, reflux; 
R::: CH3: KCN, 18-crown-6, CH3CN; (g) PhMgBr 
the bromination of a similar heterocycle and thereby avoided poly-bromination which 
plagued the dibenzoyl peroxide-method. The latter method, but using a 200 W bulb, 
was applied to 45. A yield of 80% was achieved in the preparation of 46b. 
The cyanide substitution reaction of 46a proceeded readily using potassium 
cyanide in refluxing methanol as previously described24. When these conditions where 
applied to the more sterically hindered 46b, the major product was 51. The weakly 
basic conditions have resulted in methoxide ions acting as the nuc1eophile. The reaction 
was repeated using acetonitrile as the solvent with a catalytic amount of a macrocyc1ic 
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polyether (18-crown-6) present. 18-Crown-6 chelates the cation of potassium cyanide, 
causing it to dissolve in acetonitrile, resulting in a "naked" cyanide ion that is a potent 
nucleophile28 . These reaction conditions were examined at a range of temperatures. 
Under reflux, intramolecular nUcleophilic substitution occurred to give the lactone, 52, 
as the major product. At room temperature, the required nitrile, 47b, was formed. It was 
found that intramolecular substitution was still competitive if the suggested 0.08 molar 
equivalents28 of 18-crown-6 were used. To achieve an acceptable yield of product 0.25 
molar equivalents of 18-crown-6 were required. 
51 52 
The reaction of the ester functionality of 47 with an aryl Grignard reagent 
required caution to avoid the fonnation of the disubstituted tertiary alcohoL One molar 
equivalent of phenyl magnesium bromide added to 47a and b at low temperatures 
(-78°C) gave the required product, 48a and b, without complications in both cases. 
Hydrolysis of the nitrile substituent involved refluxing 48a in 6 mol L- 1 HCF9. The 
product had a proton NMR spectrum consistent with the expected product 49a. The 
small amount of product obtained was lost in the attempt to purify it. The R = H series 
had by this stage served its purpose as a model synthesis and so preparation of 49a was 
not investigated any further. 
When 48b was refIuxed in 6 mol L-1 HCl, the product obtained in over 50% 
yield was 53. This benzo[b] [1,7]naphthyridine showed moderate activity in the in vitro 
P388 anti-tumour assay, corresponding to an 1Dso of 3400 ng/mL (see Section A.5). 
The formation of 53 corresponds to protonation of the carbonyl oxygen followed by 
internal attack of the nitrile on the resulting electrophilic centre and interception of an 
intermediate cation by a chloride ion. Dehydration, promoted by the gain in 




aromaticity, would result in the formation of 53. To alleviate this problem, the reaction 
was repeated using an acid with a relatively non-nucleophilic counter-ion. Refluxing 
40% sulfuric acid was used. The only product isolated was the lac tam, 54, 
corresponding to cyc1ization as described above, but where the cation has been 
intercepted by an oxygen containing nucleophile. Using refluxing 10% sulfuric acid, a 
different product was obtained and purified. This product had infra-red, proton and 
carbon-13 NMR and mass spectra consistent with the desired product, 49b, with one 
exception. The mass spectrum contained an extra peak at m/z = 336.1. This 
corresponds to a molecular formula of C20H20N203 (Compound 49b has m/z = 305.1 
and a molecular formula of C19H15N03). The 305.1 ion has been shown not to be a 
'daughter' of the 336.1 ion. Several unsuccessful attempts were made to obtain crystals 
of this product suitable for X-ray crystallographic analysis. An attempt was also made 
to dehydrate the product using the conditions described for the preparation of 
benzopyranones2o. If 49b had been prepared, then the formation of the pyrano[3,4-
b]quinol-3-one, SOb, was expected. This should undergo a Diels-Alder reaction with 
maleic anhydride to give a bridged adduct. This was not observed. Basic catalysed 
hydrolysis of the nitrile was attempted, without success, and so this route was 
abandoned. 
A further, more direct, synthesis was attempted with the aim of preparing a 
possible pyrano[3,4-b]guinol-3-one precursor, 55 (Figure 2.14). This involved the 
reaction of 2-oxopentane-l,5-dioic acid30 or its dimethyl ester with 2-
aminobenzaldehyde25 . Both reactions gave a complicated mixture of products that were 
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examined with proton NMR, UV and mass spectrometry. The required product, 55, was 




Figure 2.14: The attempted Friedlander synthesis to prepare 55 (R = H or CH3) 
2.6. The reaction of 1, 1-bis(me'thylthio )ethene with 
pyrano[3,4-b]indol-3-ones 
Pyrano[3,4-b Jindol-3-ones were first used as 
Diels-Alder dienes by Plieninger et at. in 196431 . It was 
not until 1985 that they where again used in synthesis, by 
Moody32. However, this class of compounds has now 7 
been extensively investigated and their Diels-Alder reactivity reviewed33 . They have 
been reacted with many electron-deficient dienophiles33 , but show little or no reactivity 
with electron-rich alkynes34. Van Broeck et al. 35 report that the reaction of various 
electron-rich alkenes with pyrano[3,4-bJindol-3-ones required heating at 80-120 °C in a 
sealed tube for several days. In this and other reports the bridged Diels-Alder adducts 
have not been isolated. The loss of bridging carbon dioxide is too facile in the 
conditions required for reaction. The product formed, after decarboxylation, is a 
carbazole, derivatives of which are known to show anti-tumour activity. For example, 
ellipticine, 7, is a potent intercalating agent36•37,38 (see Section 1.1.8). Pyrano[3,4-
b Jindol-3-ones are easily prepared, stable pyranones and therefore have the potential of 
providing a quick, simple route to a cancer chemotherapeutic prodrug; providing a 
stable bridged adduct can be isolated. 
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56 57 
Figure 2.15: Preparation of 1-methylpyrano[3,4-bJindol-3-one and 
9-acetyl-1-methylpyrano[3,4-bJindol-3-one 
Reagents and conditions: (a) acetic anhydride, BF3.Et20, room temperature; (b) NaH, acetic 
anhydride, dimethylformamide, 0 °C 
The pyrano[3,4-bJindol-3-one32 , 56, was prepared from commercially 
available indole-3-acetic acid by treatment of an acetic anhydride solution with boron 
trifluoride ether ate (Figure 2.15). This is analogous to the preparation of the 1-ethyl 
substituted analogue34. 56 was then treated with sodium hydride followed by addition 
of acetic anhydride to give the N-acylated pyrano[3,4-b Jindol-3-one, 5739. This last step 
uses N,N-dimethylformarnide (DMF) as a solvent because of the low solubility of 56 in 
more volatile solvents. This made the work up difficult due to the high boiling point 
and water solubility of DNIF, contributing to a low yielding reaction. 
The reaction of 56 with 19 was carried out in bromobenzene because of the 
low solubility of 56 in toluene. The isolated product was identified as the substituted 
carbazole, 58 (Figure 2.16). The other regioisomer was not observed. It is intriguing 
that this is the same regiochemistry as -observed for electron-deficient 
dienophiles39,40,41,42. Retro-Diels-Alder loss of carbon dioxide to form the aromatic 
product will be encouraged by the electron-donating nitrogen attached to the pyranone 
ring. It was therefore postulated that attaching an acyl group to the nitrogen should 
decrease its electron-donating properties, and hence make the bridged adduct more 
stable. This should also cause the diene to be more reactive towards inverse electron-
demand Diels-Alder reactions. (Acylation of 56 has been observed to cause a drop of 





56, R = H 19 
57, R = COCH 3 
58 R = H, 59, R = COCH3 
Figure 2.16: The reaction at 1, 1-bis(methylthio}ethene with pyrano[3,4-blindol-3-ones 
reactivity and change in regiochemistry for normal electron-demand reactions; the 
electron-deficient dienophiles involved were HC=C02Et34 and CH2=CHC02CH339). 
The N-acylated pyrano[3,4-h ]indol-3-one, 57, was therefore reacted with 19. 
The reaction was much slower than the non-N-acylated case and still gave the 
corresponding aromatic product, 59. The less electron-rich diene was not as reactive, 
which was counter to expectation. There was also no change in the regiochemistry of 
the reaction. The lone pair on the nitrogen makes 56 a rather electron-rich pyranone and 
these results suggest that 19 may be reacting in a normal electron-demand sense with 
this diene. This electron donation will be decreased by N-acylation, making 57 less 
reactive. To see if it was possible for 19 to undergo normal electron-demand Diels-
Alder reactions; it was mixed with cyc1opentadiene, a reactive electron-rich diene. The 
reaction was monitored by proton NMR. After six days at 55°C, dimerisation of 
cyc10pentadiene was complete. No other product was observed. 
The low reactivity of this system and the low stability of the bridged Diels-
Alder adduct make this system unsuitable for the preparation of prodrugs, but has led to 
a simple synthesis of methylthio substituted carbazoles. These results could be 
Chapter 2 1,1-BIS(METHYLTHIO)ETHENE AS A DIENOPHILE 49 
applicable to the synthesis of hyellazole, 60. This alkaloid could not be prepared from a 
simple Diels-Alder reaction of 1-phenylpyrano[3,4-bJindol-3-one with 1-
methoxypropyne because of the lack of reactivity of electron-rich alkynes with 
pyrano[3,4-bJindol-3-ones. An elaborate (5 steps) sequence had to be used43 . The 
above results suggest that the reaction of 1,1-bis(methoxy)propene with the appropriate 
pyrano[3,4-b Jindol-3-one and the subsequent loss of methanol may be a suitable 
strategy for the preparation of 60. 




The Diels-Alder reaction of several pyranones with 1,1-bis(methylthio)ethene 
has been investigated. A summary of these results is given in Table 2.2, along with a 
comparison with the oxygen analogue, where available. 
With the dienes tried, 1,1-bis(methylthio)ethene is a less reactive dienophile 
than its oxygen analogue, 1,1-bis(methoxy)ethene. The similar size of carbon and 
oxygen atoms Cause oxygen to have strong 1t-donor properties. Therefore methoxy 
substituents have a stronger electron-donating resonance effect than me thy lthio groups. 
This high electron density raises the energy of the HOMO orbital of the methoxy 
substituted dienophile, making it a more reactive diene in inverse electron-demand 
Diels-Alder reactions. 
In all cases only one product was observed, either the bridged adduct or the 
aromatic product. The product that formed was generally the same for the sulfur and 
oxygen case for each diene. It appears that the more reactive the diene, the more likely 
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1, 1-Bis(methylthio)ethene 19 1, 1-Bis(methoxy)ethene 27 






reflux, 22 hrs 
toluene 
reflux, 9 days 
toluene 
reflux, 24 hrs 
bromobenzene 
120°C, 4.5 days 
bromobenzene 
120°C, 14 days 






21 % benzene 30 (A) 
reflux, 24 hrs 32 (C) 
78% toluene 43 (A) 






t As described in Figure 2.2; A = bridged Diels-Alder adduct, C = aromatic product 
Table 2.2: Summary of the Diels-Alder reactions between 1, 1-bis(methylthio)ethene and its 
oxygen analogue with various pyranones 
the bridged Diels-Alder adduct can be isolated. Dienes that are less reactive in inverse 
electron-demand situations are likely to form an adduct that is more susceptible to the 
normal electron-demand retro-Diels-Alder, that is, the extrusion of carbon dioxide. 
The pyrano[3,4-b]indol-3-one case suggests that l,l-bis(methylthio)ethene is 
capable of undergoing normal electron-demand Diels-Alder reactions with electron-
rich dienes. The ability of sulfur to stabilise an adjacent negative charge in a dipolar 
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transition state, probably by polarisation, could cause l,l-bis(methylthio)ethene to react 
as a normal electron-demand dienophile. 
These are probably concerted, non-synchronous Diels-Alder reactions: the 
high regioselectivity observed suggests a non-synchronous mechanism; however, the 
lowering of the activation energy by increasing the pressure (for the reaction with the 
benzopyranone) suggests that this is a concerted process. 
The previously unreported potential of l,l-bis(methylthio)ethene as a 
dienophile with several all-carbon, neutral dienes has hence been examined. The failure 
to prepared a stable bridged adduct which, upon bridge cleavage, would give tricyclic 
hetero-aromatic compound means that this chemistry may be of limited utility in the 
preparation of the envisaged cancer chemotherapeutic prodrugs. 
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Chapter 3 
THERMAL DECOMPOSITION OF 
THE DIELS·ALDER ADDUCTS 
3.1. Introduction 
The thermal stability of the two bridged Diels-Alder adducts successfully 
prepared in Chapter 2 was investigated. The durability of the benzopyranone, 1,1-
bis(methylthio)ethene adduct, with respect to bridge cleavage, is of interest because it 
models an envisaged prodrug. A certain level of adduct stability is required so that 
premature decarboxylation does not occur in vivo. This would have the unfavourable 
consequence of producing the active drug prior to tumour-selective activation. Upon 
exposure to thermal conditions, the adducts were expected to decompose by 
eliminating carbon dioxide and/or methanethiol; eventually resulting in the formation 
of aromatic products (as outlined in Figure 2.2). 
3.2. Decomposition of the methyl coumalate, 
1,1-bis(methyl·thio)ethene Diels-Alder adduct 
The methyl coumalate, 1,1-bis(methylthio)ethene adduct, 28, was heated neat 
at 145 DC and the reaction monitored by proton NMR. This thermally induced 
decomposition gave a clean mixture of three products. These products were separated 
by radial silica chromatography. One product was methyl coumalate, 25 (Figure 3.1). 
This must result from a reversal of the reaction used to prepare this adduct. It is 
surprising that this retro-Diels-Alder reaction can successfully compete with 
decarboxylation. The expected substituted benzene compound, 63, was also present. 
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Figure 3.2: The thermal decomposition of 3- and 5-carboxymethylpyran~2-one, enol ether 
Diels-Alder adducts 
This is formed when the initial adduct loses carbon dioxide and methanethiol. The 
other product isolated was an unexpected cyglohexadiene, 62. This is presumedly due 
to decarboxylation of 28 followed by rearrangement. The diene, 61, was not observed. 
The driving force of this rearrangement appears to be the resonance 
stabilisation available to 62 due to the conjugation of the ester carbonyl, the diene and 
possibly the sulfur's outer shell electrons. This conjugation does not occur to the same 
extent in the intermediate, 61. An insight into the relative stabilities of dienes 61 and 62 
can be gleaned from the reported thermal decarboxylations of 64 and 661 (Figure 3.2). 
In this report Mark6 and Evans isolated the resulting dienes, 65 and 67, by rapid 
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chromatography. They noted that the conjugated dienes, 65, were more stable than their 
analogues, 67. The conjugated diene, 62, was also formed if the Diels-Alder reaction of 
25 with 19 was left for a longer period. 
The cyclohexadiene, 62, was stable enough to be isolated and examined with 
standard spectroscopic methods. However it eliminated methanethiol within a few days 
to give 63. 62 had a strong infra-red absorption at 1700 cm-1 characteristic of a 
conjugated carbonyl group and an ultra-violet maximum absorption at 342 nm (£ = 
9610) which is consistent with a conjugated diene, carbonyl system. The chemical 
shifts and coupling constants observed in the proton NMR spectrum for 62 are shown 
in Figure 3.3 and these correlations were confirmed by a COSY (COrrelation 
SpectroscopY) 2D-NMR experiment. To verify the structure of 62, the Diels-Alder 
reaction of it with maleic anhydride was attempted. After 2 hours at room temperature 
in ethyl acetate there was no reaction. After 2 hours at reflux, the major product was 63, 
the result of methanethiol elimination. The reaction mixture was examined with proton 
NMR and mass spectrometry, but there was no indication of the presence of the Diels-
Alder adduct or subsequent decomposition products. 
Figure 3.4 shows the progress for one particular decomposition. The rate of 
decomposition was not reproducible in the conditions used, but the general reaction 
profile was similar in each case. This change in rates could be due to the presence of 
residual impurities and/or it could be an artefact of a radical driven process. The initial 
adduct, 28, can undergo two possible retro-Diels-Alder reactions. The first is the 
reverse of the reaction that formed the adduct originally. This results in the formation 
of methyl coumalate, 25, and 1,1-bis(methylthio)ethene, 19. The gradual build up of the 
pyranone can be seen in Figure 3.4. The build up of 19 is not observed. This could be 
due to it being lost from the system as a result of its volatility. The second possible 
retro-Diels-Alder reaction is the extrusion of carbon dioxide to fonn the diene, 61. As 
this compound was not observed, it must rapidly lose methanethiol to give the 
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substi tuted benzene, 63; or rearrange by way of a [l ,5J-methylthio shift to give 62. The 
greater build up of 62 and 63 compared to 25 suggests that the latter is the more 
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Figure 3.4: The methyl coumaiate, 1, 1-bis(methylthio)ethene Diels-Alder adduct was heated 
neat at 145°C in a nitrogen atmosphere. The proportion of each compound present (as 
described in Figure 3.1) is plotted as a function of time. The formation of the decomposi1ion 
products was monitored by proton NMR. The measurements were made by comparing the 
in1egration of the methyl ester peak corresponding to each compound. 
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As both dienophiles from these two retro-Diels-Alder reactions appear to be 
lost from the system, the reverse reaction to fonn 28 again cannot occur. Under these 
conditions it is an irreversible reaction. The cyclohexadiene derivative, 62, builds up to 
become the major component of the mixture (Figure 3.4), suggesting that for 61, the 
[1,5J-methylthio migration is more facile than the elimination of methanethiol. It is 
only after this point that the aromatic compound, 63, is formed at an appreciable rate. 
This suggests that 63 is formed predominantly via the [1,5J-methylthio migration 
pathway rather than directly from 61. 
3.3. [1,5]-Methylthio migrations 
Many migrations of arylthio and alkylthio groups have 
been observed previously2, although only a few are related to the 
one described above. The most common migrations are [1,3J in 
nature and, in the case of arylthio groups, are thought to involve a 
Ar-~ 
68 
trigonal bipyrarnidal intermediate, 68. This is stabilised by the ability of sulfur to 
expand its octet, encouraged by the shrinking of the sulfur's d-orbitals by the electron-
withdrawing aryl substituent. The rearrangement can also occur bimolecularly3: ionic if 
acid or base catalysed, or radical if exposed to light4•5. For the cases where a mixture of 
allyl sulfides has been examined, a combination of all the possib~ cross-over products 
has been obtained3•6•7•8 indicating an intermolecular mechanism. Alkylthio groups 
cannot rearrange by a concerted mechanism because they are not able to stabilise an 
intermediate of type 68. A radical process can be initiated by the presence of an 
alkylthio radical, formed in situ by the irradiation of the appropriate disulfide9 or 
alkylthioPo. The radical mechanism then occurs as shown in Figure 3.5. The 
symmetrical radical intennediate, 69 (R = H), has been detected by ESR spectroscopy9. 
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Figure 3.5: The radical rearrangement of allylic methyl sulfides (R = H or CH3) 
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A [1,3]-methylthio shift has also been observed in acidic conditions ll . In the 
preparation of dimethylthio substituted pyridines, a methylthio group migrated to form 
a more stable carbocation. It was not established whether this was an inter- or intra-
molecular process. The possible pathway given is outlined in Figure 3.6. 
The [l,5]-methylthio shift postulated in this work could be concerted or 
bimolecular in mechanism. The latter could either occur in a radical or ionic sense. 
There have been several reports of [1,5]-arylthio shifts (or two successive [1,3] shifts) 
in acid catalysed8,12,13 or photo-initiated5 processes; however, reports of [1,5]-alkylthio 
shifts are comparatively rare. Vishwakarma et al. observed that upon heating 70 with 
dimethyl acetylenedicarboxylate in xylene in a sealed tube at 160-170 DC, 74 was 
obtained in 16% yield14. The explanation given for this reaction involves a [1,5]-
methylthio shift (Figure 3.7). The first step in this mechanism is the formation of the 
cyclobutane, 71, via a [2+2] cycloaddition. This is followed by ring opening and then 
electrocyclic ring closure to give 72. This intermediate appears to undergo a [1,5]-
methylthio shift to give 73. It is postulated that this then undergoes electrocyclic ring 
opening to give the S-methyl ester, which on intramolecular ring closure and 
elimination of dimethyl sulfide yields the isolated product, 74. This rearrangement 
occurs in thermal, neutral conditions, similar to those present when 62 was formed. 
Apparao et al. 7 observed that the reaction of 75 (R = CH3, or CH2CH3) with 
sodium hydride at 40-45 DC gave the stereochemically pure diene 77 as the result of a 
base catalysed [1,3]-proton shift followed by a [1,5]-alkylthio shift (Figure 3.8). 
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Figure 3.6: A preparation of substituted pyridine involving a [1 ,3]-methyI1hio shift 
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Figure 3.7: The suggested mechanism for 1he reaction of 70 with dimethyl 
acetylenedicarboxylate and subsequent decomposition to give 74 
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Figure 3,8: The mechanism for the rearrangement of 75 to give 77, involving a [1 ,5]-alkylthio 
shift 
Attempts to isolate the intermediate, 76, were unsuccessful. Mechanistic 
studies suggested that this was an ionic intermolecular rearrangement. The reaction was 
unaffected by the presence of radical inhibitors. When a mixture of 7 S (Ar = Ph, R = 
CH3) and 7S (Ar = P-CH30C6H4, R = CH2CH3) was exposed to the same conditions, 
the nine possible products resulting from intermolecular rearrangements were observed. 
Apparao et of. noted that these results do not eliminate the possibility of a thermal 
concerted process for the rearrangement, but that the ionic pathway appears to 
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Figure 3,9: The suggested radical mechanism for the [1 ,5]-methylthio shift observed in the 
thermal deccmposition of 28 
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It is difficult to obtain further information on the [1,5]-rearrangement observed 
in this work due to the transitory nature of the suggested precursor and the instability of 
the product. This rearrangement and the one proposed in the formation of 74 (Figure 
3.7) both occurred in neutral conditions suggesting that in these cases the mechanism is 
not ionic in nature. Because we are dealing with a migrating alkylthio group instead of 
a stabilised arylthio one, this is probably a radical process rather than a concerted one. 
All three cases described above have a carbonyl functionality conjugated with the diene 
system. This would allow delocalisation in both radical and ionic intermediates. The 
nature of the stabilisation is shown for the ionic case in Figure 3.8 and the radical case 
in Figure 3.9. It appears that the presence of an appropriately positioned carbonyl-like 
moiety may be crucial for the observance of a [1,5]-alkylthio shift. To test this 
hypothesis it was decided to replace the carbomethoxy substituent with an aromatic 
entity. The initial aim was to prepare 5-phenyl-2-pyranone and react this with 1,1-
bis(methylthio )ethene. The resulting Die1s-A1der adduct could then be subjected to the 
same conditions as for the methyl coumalate case, that is, heating neat at 145 DC. 
Examination of the thermal decomposition products may reveal whether a [1,5]-
methylthio shift has occurred. 
3.4. Preparation of phenylpyran-2-ones 
The preparation of pyran-2-ones has recently been reviewed15. There are a 
number of methods for the synthesis of 5-phenylpyran-2-one, 7916,17 (Figure 3.10 and 
3.11). The synthesis outlined in Figure 3.10 was attempted first. The radical addition of 
carbon tetrachloride to ethyl vinyl ether gave the tetrachlorinated ether18 . Subsequent 
thermally induced, regiospecific elimination of HCl19 was implemented without 
complications. However, the ensuing acid-catalysed, aldol-like reaction with 
phenylacetaldehyde16 proved more difficult. Only a very small yield of 78 was 
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Figure 3.10: A synthesis of 5-phenylpyran-2-one 
Reagents and conditions: (a) benzoyl peroxide, pyridine, reflux; (b) 130-150 DC, neat; 
(c) CH3C02H, water, 0 DC; (d) CH3C02H, reflux 
achieved. This could not be improved on and so this strategy for the preparation of 5-
phenylpyran-2-one was abandoned. 
The synthesis outlined in Figure 3.1117 was then attempted. This strategy has 
the advantage that it produces four phenylpyran-2-ones for which the Diels-Alder 
chemistry and the thermal decomposition of the subsequent adducts could be studied. 
The disadvantage is that 79 is the minor product. Methyl (Z)-3-chloropropenoate, 80, 
was prepared as outlined in Figure 3.11. This involves the addition of bromine to 
fumaric acid to give dibromosuccinic acid2o . Base induced double elimination of HBr 
gave the alkyne which upon decarboxylation, gave propynoic acid21 . Copper(I) 
chloride catalysed addition of HCI selectively gave (Z)-3-chloropropenoic acid22. The 
methyl ester, 8023 , was prepared and then used in the synthesis of phenyl-2-pyranones 
as described by Boulanger and Katzenellenbogen17 . The triester resulting from the 
reaction of 80 with the sodium salt of diethyl phenylmalonate, was saponified and 
decarboxylated to give the two geometrical isomers of 2-phenylglutaconic acid, 81. In 
my hands, the decarboxylation was spontaneous upon acidification of the 
saponification mixture; the reported procedure involved refluxing the triacid in 
1 mol L-1 HCI for an hour. 
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Figure 3.11: A synthesis of 5-phenYlpyran-2-one 
Reagents and conditions: (a) H20, reflux; (b) KOH, ethanol (- 2HBr); (c) 3 mol L-1 H2S04; 
(d) H20, 1'1; (e) HCI, CuCI; (f) methanol, H2S04; (g) NaH, tetrahydrofuran, reflux; (h) NaOH, 
reflux; (i) HCI; (j) acetyl chloride, sealed tube, 100°C; (k) Zn, CH3C02H, tetrahydrofuran, room 
temperature 
Cyclization was achieved by heating the 2-phenylglutaconic acid in acetyl 
chloride in a sealed tube at 100°C overnight. This reaction gives a messy mixture of 
products. A proton NMR spectrum of the crude reaction mixture showed that both of 
the chlorophenylpyran-2-ones, 82 and 83, were present; 83 in much lower yield. 
Purification of these two products using radial chromatography only gave 82, the 
unwanted pyranone. This could then be cleanly reduced to 84. Reduction of a small 
amount of the crude cyclization mixture gave both 79 and 84. This mixture was more 
conducive to separation by chromatographic techniques. 
This complex, low yielding synthesis of 5-phenylpyran-2-one, 79, was not 
investigated any further. Even if the preparation of 5-phenylpyran-2-one had been more 
successful, it was not at all certain that a stable l,l-bis(methylthio)ethene Diels-Alder 
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adduct could be prepared, let alone whether the presence or absence of a [1,5]-
methylthio shift could be precisely observed. 
3.5. Decomposition of the benzopyranone, 
1,1-bis(methylthio)ethene Diels-Alder adduct 
Thermal decomposition of the methyl coumalate, 1,I-bis(methylthio)ethene 
adduct proved to be complex with two competing retro-Diels-Alder reactions and a 
methylthio migration observed. The thermal decomposition of the benzopyranone, 1,1-
bis(methylthio)ethene Diels-Alder adduct, 42, was then examined. The decomposition 
chemistry was much more simple for this adduct, with only one product being isolated; 
the substituted naphthalene, 86 (Figure 3.12). No intermediates resulting from 
methylthio migration or just decarboxylation (85) were observed. 42 was expected to 
be more stable than 28 due to the initial loss of benzenoid aromaticity upon 
decarboxylation. This was found to be the case: 97% of 42 remained after 25 hours of 
heating neat at 145 °e, compared with 35% of 28. The stability of the benzopyranone 
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Figure 3.12: The thermal decomposition of the benzopyranone, 1, 1-bis(methylthio)ethene 
Diels-Alder adduct 
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3.6. Conclusion 
During the thermal decomposition of the methyl coumalate, 
l,l-bis(methylthio)ethene Diels-Alder adduct, a [1,5]-methylthio shift was observed. 
This type of migration has little precedent. It was suggested that this occurs by way of a 
radical process and that the carboxy substituent was crucial for the rearrangement to 
take place. An attempt was made to synthesise 5-phenylpyran-2-one in an effort to 
clarify the mechanistic details. Difficulty experienced in this synthesis and the 
transitory nature of the precursor and product of this rearrangement thwarted this 
investigation. 
As predicted, the benzopyranone, l,l-bis(methylthio)ethene Diels-Alder 
adduct has a greater thermal stability than the equivalent methyl coumalate adduct. This 
has been attributed to the initial loss of aromaticity required by 42 upon 
decarboxylation. This observation bodes well for the preparation of stable bridged 
adducts, similar to 42, required for the synthesis of potential prodrugs. 
Chapter 3 THERMAL DECOMPOSITION OF THE DIELS-ALDER ADDUCTS 68 
3.7. References 
1. Marko, I.E.; Evans, G.R Tetrahedron Lett. 1993,34(45),7309-7312. 
2. Kwart, H. Phosphorus Sulfur 1983,15(3),293-310. 
3. Brownbridge, P.; Warren, S. 1. Chern. Soc., Perkin Trans. 11976,2125-2132. 
4. Kozikowski, A.P.; Huie, E.; Springer, lP. 1. Am. Chern. Soc. 1982,104,2059-
2060. 
5. Blatcher, P.; Warren, S. 1. Chern. Soc., Perkin Trans. 11985, 1055-1066. 
6. Apparao, S.; Ila, H.; Junjappa, H. 1. Chern. Soc., Perkin Trans. 1 1983,2837-
2844. 
7. Apparao, S.; Bhattacharjee, S.S.; Ila, H.; Junjappa, H. 1. Chern. Soc., Perkin 
Trans. 11985,641-645. 
8. Kataoka, T.; Matsumoto, H.; Iwama, T.; Shimizu, H. Chemistry Letters 1995, 
(6),459-460. 
9. Krusic, P.J.; Kochi, J.K. 1. Am. Chern. Soc. 1971,93,846-860. 
10. Huyser, E.S.; Kellogg, RM. 1. Org. Chern. 1965,30,2867-2868. 
11. Gupta, A.K.; Ila, H.; Junjappa, H. Tetrahedron Lett. 1988, 29(50), 6633-6636. 
12. Brownbridge, P.; Warren, S. 1. Chern. Soc., Perkin Trans.11977, 1131-1141. 
13. Brownbridge, P.; Hunt, P.G.; Warren, S. 1. Chern. Soc., Perkin Trans. 1 1986, 
1695-1705. 
14. Vishwakarma, J.N.; Ila, H.; Junjappa, H. 1. Chern. Soc., Perkin Trans. 11983, 
1099-1102. 
15. Kvita, V.; Fischer, W. Chirnia 1992,46,457-468. 
16. VanKerckhoven, H.F.; Gilliams, Y.K.; Stille, lK. Macromolecules 1972,5(5), 
~41-546. 
17. Boulanger, W.A.; Katzenellenbogen, lA. 1. Med. Chern. 1986, 29(7), 1159-
1163. 
18. Glickman, S.A. Chemical Abstracts 1952, 46, 1023f. 
Chapter 3 THERMAL DECOMPOSITION OF THE DIELS-ALDER ADDUCTS 69 
19. Schirmann, J.; Dreux, J.; Doris, J. Bull. Soc. Chirn. Fr. 1967,3896-3904. 
20. Rhinesmith, H.S. argo Synth. Coll. Vol. 111943, 177-179. 
21. Perkin, W.H.; Simonsen, J.L. 1. Chern. Soc. 1907,91,816-840. 
22. Kurtz, A.N.; Billups, W.E.; Greenlee, R.B.; Hamil, H.F.; Pace, W.T. 1. argo 
Chern. 1965,30,3141-3147. 
23. House, H.O.; Roelofs, W.L.; Trost, B.M. 1. argo Chern. 1966,31,646-655. 
Chapter 4 
REACTION OF I-METHYLTHIO-




l,l-Bis(methylthio)ethene, 19, has proved to be a fairly unreactive inverse 
electron-demand dienophile, and upon reaction with pyrano[3,4-b ]indol-3-ones, may 
even have been reacting in a normal electron-demand sense (Section 2.6). It was 
postulated therefore, that oxidising one of the sulfides to a sulfone would provide an 
electron-deficient dienophile that would be more reactive in normal electron-demand 
reactions. That is, the electron-withdrawing capabilities of the sulfone should cause the 
dienophile to react favourably in Diels-Alder reactions involving electron-rich dienes. 
Increased reactivity would lead to cycloaddition reactions occurring under milder 
conditions, increasing the likelihood of isolating the resulting bridged Diels-Alder 
adducts. Spontaneous decarboxylation may cease to be a problem. 
Viny I sulfones have received much attention as useful intermediates in organic 
synthesis; both as Michael acceptors and in cycloaddition reactions l , Sulfonyl 
substituents have proved to be suitable electron-withdrawing groups for the activation 
of Diels-Alder reactions. They have been used in this capacity to replace carbomethoxy 
substituents on pyranones2 and there have been occasional reports of the reaction of 
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vinyl sulfones with electron-rich pyranones and pyridones3. This chapter describes the 
preparation of I-methylthio-l-(p-tolylsulfonyl)ethene, 87, and its reaction with various 
pyranones. 
4.2. The preparation of 1-methylthio-1-(p-tolylsulfonyl)ethene 
91 92 
Figure 4.1: Two methods for the synthesis of 1-methylthio-1-(p-tolylsulfonyl)ethene 
Reagents and conditions: (a) (i) NaH, tetrahydrofuran, 0 DC, (ii) Phenyl benzoate, reflux; 
(b) (i) NaH, tetrahydrofuran, 0 °c, (ii) paraformaldehyde, reflux; (c) (i) n-BuU, tetrahydrofuran, 
-78 ec, (ii) CH31, room temperature; (d) S02CI2, chloroform, room temperature; (e) 90 °c, neat 
Two methods for the synthesis of 87 are outlined in Figure 4.1. The first 
strategy begins with the acylation of methylthiomethyl p-tolyl sulfone, 88. Reaction of 
t~~ product, 89, with formaldehyde should give the intermediate, 90, which will then 
undergo a benzoyl transfer, from carbon to oxygen, followed by elimination of the 
benzoate anion to give the required alkene, 87. The precedent for this rearrangement is 
described for various compounds with alkyl groups instead of the methylthio 
substituent4 . The second strategy involves the methylation of the same starting 
material, 88, to give 91. Chlorination of this product followed by elimination of HCI 
has been reported to give 875. 
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Methylthiomethyl p-tolyl sulfone, 88, is a readily available compound which 
can be efficiently prepared from dimethyl sulfoxide, acetic anhydride and sodium p-
toluenesulfinate6 , or it can be purchased. This starting material, 88, was acy lated with 
phenyl benzoate, using sodium hydride as the base, to give 897 . However, the 
subsequent reaction of the anion of 89 with formaldehyde was not successful. The 
alternative method was therefore investigated. 
There are several conditions reported for the methylation of 886,8,9. The 
formation of the anion of 88 using n-butyllithium as the base and subsequent reaction 
with iodomethane gave 91 in excellent yield. This product was chlorinated using 
sulfuryl chloride to give 929,1°. The elimination of Hel from 92 has been reported by 
Katsuyuki and Takeo1o. It involved refluxing 92 in chloroform for 32 hours. In my 
hands, these conditions gave about 20% reaction, whereas heating 92 at 90 De neat for 
5 hours gave 90% reaction (although the yield of isolated pure product was 
considerably less than this). The use of triethylamine in benzene at room temperature 11 
to eliminate Hel was not successful. 
I-Methylthio-l-(p-tolylsulfonyl)ethene, 87, was then reacted with the 
pyranones described earlier (Chapter 2) and its reactivity and regioselectivity compared 
to that of l,l-bis(methylthlo)ethene, 19. 
4.3. The reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene 
with two simple pyran-2-ones 
I-Methylthio-l-(p-tolylsulfonyl)ethene, 87, was reacted with methyl 
coumalate, 25, and methyI4,6-dimethy1coumalate, 26. The conditions were the same as 
for the l,l-bis(methylthio)ethene case; however in this case, even after longer reaction 
times, the yield of products was low. The products were the same substituted aromatics, 
63 and 31, seen previously (Figure 4.2). The bridged Diels-Alder adducts were not 
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25 R = H, 26 R = CH3 87 63 R = H, 31 R = CH3 
Figure 4.2: The reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene with methyl coumalates 
observed and therefore no information on the stereochemistry of the cyc1oaddition was 
obtained. The regioselectivity was the same as for the l,l-bis(methylthio)ethene case. 
The lower reactivity of 87 with methyl coumalates is expected because this 
involves the reaction of a less electron-rich dienophile with electron-deficient dienes. 
Elimination of p-toluenesulfinic acid may be rather facile for this type of adduct. This 
elimination, happening first, would trigger decarboxylation due to the unstable nature 
of bridged cyc1ohexadienes. 
4.4. The reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene 
with a benzopyranone 
40 87 86 93 
Figure 4.3: The reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene with 
4-methyl-1-phenylbenzopyran-3-one 
l-Methylthio-l-(p-tolylsulfonyl)ethene, 87, was reacted with 4-methyl-l-
phenylbenzopyran-3-one, 40. The rate of reaction was comparable to the reaction of 
l,l-bis(methylthio)ethene with the same diene. However, in this case, no bridged 
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adduct was obtained, again suggesting that a facile p-toluenesulfinic acid elimination 
has triggered decarboxylation. The high regioselectivity observed for 19 was not 
observed for 87. The two regioisomers, 86 and 93 (Figure 4.3), were obtained in a ratio 
of 2:5 respectively. 
4.5. The reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene 




56 R == H, 94 R == CH3 95 96 R == H, 97 R == CH3 
Figure 4.4: A previously reported reaction of a vinyl sulfone with pyrano[3,4-b]indol-3-ones 
The reaction of vinyl sulfones with pyrano[3,4-b ]indol-3-ones has been 
reported previously 12,13. For example, the reaction of 56 and 94 with 95 gave 96 and 97 
respectively (Figure 4.4). This was the only product observed in each case; that is, the 
substituted carbazole resulting from a Diels-Alder reaction followed by 
decarboxy lation and elimination of benzenesulfmic acid. 
I-Methylthio-l-(p-tolylsulfonyl)ethene, 87, was reacted with l-methylpyrano-
[3,4-bJindol-3-one, 56. The two aromatic regioisomers, 58 and 98, were isolated 
(Figure 4.5). No adducts were observed. The addition of a methylthio group to the 
dienophile (87 compared to 95) has resulted in a decrease in regioselectivity. 87 
appeared to be more reactive with the pyrano[3,4-b]indol-3-one than 19 was, as would 
be expected for this electron-rich diene. However the yield of products was low due to 
the decomposition of the diene. The pyrano ring appeared to have been hydrolysed to 
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the keto-acid even though the reactions were preformed under anhydrous conditions. 
This decomposition was not observed in the 1,1-bis(methylthio)ethene case. 
~SCH' I ~ ~ I 58 eyyo N 
I ~ N ~ 0 SCH3 H CH3 + ==< .. + 
H CH3 
S02Toi ~ 98 56 87 ~ N ~ SCH3 H CH3 
Figure 4.5: The reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene with 
1-methylpyrano[3,4-b]indol-3-one 
4.6. A summary of the reactions of 1-methylthio-1-(p-tolyl-
sulfonyl)ethene and 1, 1-bis(methylthio)ethene with 
pyranones 
A summary of the results of the Diels-Alder reactions of 1-methylthio-
1-(p-tolylsulfonyl)ethene and 1,1-bis(methylthio)ethene with pyranones is shown in 
Table 4.1. Hemi-sulfone, 87, is less reactive than the thioether, 19, with electron-poor 
pyranones, such as the coumalates, but has an increased reactivity with electron-rich 
dienes, such as 1-methylpyrano[3,4-b ]indol-3-one. This is attributed to the electron-
withdrawing capacity of the sulfonyl substituent. The conditions required for reaction 
are such that no bridged adducts were isolated. The elimination of p-toluenesulfinic 
acid appears to be too facile. This elimination, occurring at a greater rate then the 
elimination of methanethiol, results in the isolation of methy lthio substituted aromatic 
compounds only. 
1-Methy lthio-1-(p-toly lsulfony l)ethene appears to be a fairly unreactive 
dienophile. The electron-withdrawing capacities of the sulfonyl substituent may have, 
to some extent, been cancelled out by the electron-donating methylthio substituent. 
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This could also explain the loss of regioselectivity shown by the dienophile, 87 
(compared to 19). The l,l-bis(methylthio)- dienophile, 19, having an electron-rich end 
gives high regioselectivity; whereas 87, having two electronically conflicting 











Conditions Products+ % rxn Conditions Products+ % rxn 
toluene 
refl ux, 22 hrs 
toluene 
reflux, 9 days 
toluene 




bromobenzene 5B (C) 
120°C, 4.5 days 
bromobenzene 59 (C) 
120°C, 14 days 
74% toluene 63 (C) 
reflux, 136 hrs 
21% toluene 31 (C) 
reflux, 9 days 
78% toluene B6 (C) 
reflux, 20 hrs 93 (D) 
24% bromobenzene 5B (C) 








:t: As described in Figure 2.2; A = bridged Diels-Alder adduct, C and D = aromatic products 
Table 4.1: Summary of the Diels-Alder reactions of 1, 1-bis(methylthio)ethene and 1-methylthio-
l-(p-tolylsulfonyl)ethene with various pyranones 
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4.7. Conclusion 
The reaction of a l-alkylthio-l-(arylsulfonyl)ethene with various pyranones 
has been investigated. This slightly electron-deficient alkene has low reactivity as a 
Diels-Alder dienophile. The elimination of p-toluenesulfinic acid proved to be too 
facile, under the conditions required for cyc1oaddition, to allow the isolation of the 
bridged adducts. A drop in regioselectivity was observed for this dienophile compared 
with l,l-bis(methylthio)ethene. This type of system appears to be unsuitable for the 
preparation of bridged prodrugs. 
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The lack of reactivity of I-methylthio-1-(p-tolylsulfonyl)ethene, 87, towards 
pyranones makes this an unsuitable class of Diels-Alder reactions for the production of 
bridged adducts. The conditions required for cycloaddition are such that elimination of 
p-toluenesulfinic acid is facile. Isobenzofurans are highly reactive dienes1,2 and hence 
may compensate for the low reactivity of 87. This could allow the use of milder 
conditions; increasing the possibility of isolating bridged adducts. The Diels-Alder 
reactions of 1-( alky lthio )isobenzofurans with several electron-deficient dienophiles 












~ -ToIS02H ~ 
~SO;:OI ----~~S-R** 
HO H S-R OH 
R* R* , , 
S 
~ ~SH ~ ~SH 
OH 
Figure 5.1: Two possible methods of activation of a 1-(alkylthio)isobenzofuran, 1-alkylthio-1-(p-
tolylsulfonyl)ethene adduct (either R* or R** could be a trigger) 
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appropriate conditions3. l-(Methylthio)isobenzofuran Diels-Alder adducts have already 
been investigated as possible models of prodrugs of intercalating agents3a. The prodrug 
form of this model system could have an appropriate trigger attached to either the 
bridgehead sulfur or the 'dienophile' sulfur. Activation of either trigger will result in 
the opening of the oxygen-bridge and the production of an extended planar aromatic 
system (Figure 5.1). 
5.2. The preparation of 1-(methylthio)isobenzofurans 
° 
S ~H3 cq a ~o b • :::::,-., :;:,.... 
R R R 
(R = H) 100 102 104 
(R = Ph) 101 103 105 
Figure 5.2: Preparation of 1-(methylthio )isobenzofurans, 104 and 105 
Reagents and conditions: (a) Lawesson's reagent ((p-CH30C6H4-PS2)2), toluene, reflux; 
(b) (i) lithium diisopropylamide, tetrahydrofuran, -78°C, (ii) iodomethane, room temperature 
Two isobenzofurans were prepared as shown in Figure 5.23a. The phthalides, 
100 and 101, were reacted with Lawesson's reagent to give the respective 1,3-
dihydroisobenzofuran-1-thiones, 102 and 103. These compounds were deprotonated 
with stoichiometric amounts of anhydrous base (lithium diisopropylamide) and 
alkylated with iodomethane to give the isobenzofurans, 104 and 105. Isobenzofurans, 
with a few exceptions, are too unstable to be isolated2 and so in this case they were 
trapped in situ with the dienophile of interest. This therefore becomes a 'one-pot' 
procedure, from the thionolactones through to the final Diels-Alder adduct. 
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5.3. The reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene 
with 1-(methylthio)isobenzofuran 
0£: SCH3 CCtt2TO I "":::::: 0 ' 8CH3 lo:ra] o 0 -,, 8CH3 0 8CH3 802Tol +=< 106a 107a .. 802Tol 0£: SCH3 cctfCHa 104 87 I : 0 " 802Tol o 0 _', 802 Tol 
8CH3 
106b 107b 
Figure 5.3: The Diels-Alder reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene with 
1-(methylthio)isobenzofuran 
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The Diels-Alder reaction of 87 with 104 gave all the four possible regio- and 
stereo- isomers, 106a, 106b, 107a and 107b (Figure 5.3). A proton NMR of crude 
reaction mixtures showed the ratio of the isomers 106a:106b:107a:107b to be 
12:49: 13:26 respectively. The slight preference for the formation of the isomers 106b 
and 107b can be attributed to steric effects. An exo p-tolylsulfonyl group avoids 
unfavourable steric interactions that would otherwise raise the energy of the Diels-
Alder transition state. Only three of the isomers could be isolated by chromatography; 
106a decomposed on the silica. The regio- and stereo- chemistries of the other isomers 
were proposed on the basis of proton NMR chemical shifts, coupling constants and nOe 
(Nuclear Overhauser Effect) measurements. The three resonances corresponding to the 
protons of the methyl groups of each isolated isomer were irradiated. The positive nOes 
observed in difference spectra are shown in Figure 5.4. 





Figure 5.4: The nOes observed (when the signals corresponding to the methyl protons were 
irradiated) and some chemical shifts and multiplicities observed in the proton NMR of 106b, 
107a and 107b (5 = singlet, d = doublet, dd = doublet of doublets) 
Isomer 106b, underwent elimination of p-toluenesulfinic acid and bridge 
opening within a few hours in the NMR solvent Cd-chloroform) to give the previously 
reported naphthol, 1084 , This product slowly oxidised in air to give the 
naphthoquinone, 1095,6, which showed moderate activity against the in vitro P388 anti-
tumour assay, corresponding to an IDso of 196 ng/mL C see Section A.5), This 
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previously for in vivo anti-tumour activity in mice7 . It showed slight to moderate 
activity. The adducts with an artha regiochemistry, 107a and 107b, appear to have 
greater stability. 
5.4. The reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene 
with 1-methylthio-3-phenylisobenzofuran 
~H' 0 
+ =<SCH3 )0 .. ~ ~ :::- S02Toi // SCH3 Ph Ph Pli OH 
105 87 110 111 
Figure 5.5: The Diels-Alder reaction of 1-methylthio-1-(p-tolylsulfonyl)ethene with 
1-(methylthio )-3-phenylisobenzofuran and the subsequent decomposition of the adduct formed 
When 105 was reacted with 87, only one adduct, of the four possible isomers, 
was observed (Figure 5.5). This compound decomposed rapidly in most solvents 
making elucidation of regio- and stereo- chemistry by NMR very difficult. The product 
of this decomposition was 111. A nOe was not observed when the methyl protons were 
irradiated. Despite this, an X-ray crystal structure demonstrated the regiochemistry to 
be that shown (Figure 5.6). A strong hydrogen bond was observed between the alcohol 
and the carbonyl of a neighbouring molecule in the crystaL This is outlined in Figure 
5.7. The position of the methylthio substituent in 111 implies that the two methylthio 
groups of the initial adduct were orientated meta. From sterlc arguments and the results 
of the Diels-Alder reaction between 104 and 87, it is suspected that the p-tolylsulfonyl 
group is exo. This stereochemistry of 110 is assumed in Figure 5.5. 
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Figure 5.6: The X-ray crystal structure of 111 




Figure 5.7: Details of the hydrogen bonding observed in the X-ray crystal structure of 111 
The reaction of 105 with 87 was comparatively slow and a 
major product did not involve reaction with the vinyl sulfone. This 
product was found to be the keto-S-methyl ester, 112. This structure 
was confirmed by X-ray crystallography. (Figure 5.8). The formation 112 
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of this type of compound has been observed before in Diels-Alder reactions of 
isobenzofurans with poor dienophiles8 and as the product of prolonged exposure of 
isobenzofuran solutions to the atmosphere9. In the case of 112, it was probably formed 
by the oxidation of unreacted diene during work-up. 
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Figure 5.8: The X-ray crystal structure of 112 
(For tables of structural data see Appendix AA) 
5.5. Mechanism of degradation 
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A proposed mechanism for the formation of 108 and 111 is given in Figure 
5.9. Following the elimination of p-toluenesulfinic acid, the lone pair of electrons on 
the bridgehead sulfur facilitates opening of the bridge. When R is a hydrogen, 
elimination of this group leads to the stable aromatic, 108. However when R is a phenyl 
su bstituent, this elimination is no longer facile. __ The sulfonium cation is hence 
susceptible to nucleophilic attack by water in the NMR solvent. The resulting l,4-diol, 
113, eliminates methanethiol to give the observed product 111. 
A similar mechanism has been used to explain the products of Diels-Alder 
reactions of carbomethoxy alkynes with 1-(ethylthio)-3-phenylisobenzofuran3b,9 
(Figure 5.10). The Diels-Alder adduct was not isolated, but underwent a rearrangement 
that includes an unusual [l,2]-phenyl shift. In the degradation of 110 (described in 
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R R HO R 
106b R = H 
1 W 110 R=Ph ~ (R = Ph) (R = H) 
0 a)"; ~ ~ -CH3SH ~ SCH3 ~ SCH3 ~ ~ SCH3 
HO Ph HO Ph OH 
111 113 108 
Figure 5.9: A possible mechanism for the degradation of adducts 1 06b and 110 
0" Et SEt 
86 
( SEt Q)R S-~c AC20, reflux o&rR ~R , - I "" ( I - I~ R 'RC:=CR ~ R ~ '"" 'J R Ph 
Ph Ph 80 Ph 0 
Figure 5.10: The proposed mechanism for the rearrangement of the adduct from the Diels-
Alder reaction of carbomethoxy alkynes (R = C02CH3, R' = H or C02CH3) with 1-(ethylthio)-3-
phenylisobenzofuran 
Figure 5,9), the sulfonium cation has been trapped by water before a comparable shift 
can occur, although the phenyl would also be migrating to a less electrophilic centre. 
5.6. Conclusion 
l-(Methylthio)isobenzofurans have proved to be sufficiently reactive dienes to 
allow the isolation of bridged Diels-Alder adducts upon reaction with I-methylthio-
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l-(p-tolylsulfonyl)ethene. However, the reaction involving l-(methylthio)-
isobenzofuran, 104, occurred with low regio- and stereo- selectivity and the adducts 
formed were of low stability. The reaction of I-methylthio-3-phenylisobenzofuran, 105, 
with the same dienophile gave only one of the four possible isomers, but this adduct 
was also relatively unstable. I-Methylthio-l-(p-tolylsulfonyl)ethene has again (see 
Chapter 4) been shown to be an unsuitable diene for the preparation of stable Diels-
Alder adducts due to the facile elimination of p-toluenesulfinic acid. 
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The preparation of the type of prodrugs described in Chapter 1 requires the 
synthesis of stable bridged adducts with an appropriately attached thio substituent. 
Cleavage of this bridge must result in the formation of an intercalating agent. That is, a 
planar compound with at least three rings, preferably heterocyclic. The reaction of 1,1-
bis(methylthio)ethene with pyranones did provide stable adducts (Chapter 2). 
However, due to difficulties encountered in the preparation of an appropriate diene, the 
extension of this system to the preparation of adducts capable of producing polycyclic 
hetero-aromatics was not successful. The Diels-Alder adducts from the reaction of 
pyranones with I-methylthio-l-(p-tolylsulfonyl)ethene were not isolated (Chapter 4). 
The low reactivity of this system meant that, under the conditions required for reaction, 
the elimination of p-toluenesulfinic acid was facile, triggering aromatisation. This 
property and the loss in regioselectivity made this dienophile unsatisfactory. To this 
point, the envisaged pro drugs would have had the trigger attached to the dienophile 
component of the adduct. The adducts resulting from the ~eaction of I-methylthio-l-
(p-tolylsulfonyl)ethene with l-(methylthio)isobenzofurans (Chapter 5) could have the 
trigger attached to either the diene or the dienophile component. Some adducts obtained 
from this more reactive system were isolated, but were unstable and there was still the 
problem of low regioselectivity. The diene would also require modification if, upon 
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cleaving the bridge of the adduct, planar, tricyclic compounds containing hetero-atoms 
were to be obtained. 
This chapter reports the preparation of adducts where the envisaged attachment 
of the trigger is to the diene component only. Using the same dienes as in Chapter 5, 
the Diels-Alder chemistry involving arynes was investigated. The arynes used were 
benzyne (1 ,2-didehydrobenzene) and pyridyne (3 ,4-didehydropyridine). Cleaving the 
bridge of the resulting adducts provides a route to tricyclic compounds and the use of 
3,4-didehydropyridine provides a synthetically s~mple method for the introduction of a 
nitrogen ring-atom. This therefore provides a simple, direct method for the preparation 
of bridged precursors of three-ring, heterocyclic compounds similar in structure to 
some conventional intercalating agents (Section 1.1.8). 
6.2. Arynes as dienophiles 
Arynes are very reactive dienophiles. This presents the potential problem of 
preparing both the dienophile and the isobenzofuran in situ. The method required for 
the preparation of the arynes must be compatible with the isobenzofuran chemistry. The 
method chosen was the base promoted elimination of HX from a haloarene (Figure 
6.1). Arynes are susceptible to nucleophilic attack and therefore the bulky base, lithium 
2,2,6,6-tetramethylpiperidide, was used l . Literature precedent for this preparation of 
arynes in the presence of isobenzofurans involves alkoxy substituted isobenzofurans2,3. 
Figure 6.1: The preparation of an aryne (Y = CH or N) by base promoted elimination of a 
haloarene (X = CI or Br) and the subsequent potential for nucleophilic attack 
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The prcparation of pyridyne involving the reaction of 3-halopyridincs with a 
strong basc has bccn obscrvcd to producc 3,4-didchydropyridinc rathcr than the 
regioisomcr, 2,3-didchydropyridinc4 . This has bccn cxplained using the results of D/H 
exchange studics of pyridinc with NaND2 in ND3. Thc relativc rates of exchange of the 
2-, 3- and 4- hydrogen atoms of pyridine are in the ratio 1: 100: 1000 rcspectively. 
Moreover, theoretical calculations have showed 3,4-didehydropyridinc to be the most 
stablc class of didchydropyridines. 
6.3. The reaction of 1 ,2-didehydrobenzene with 1-methylthio-
3-phenyl iso benzofuran 
The Diels-Alder reaction of 1,2-didehydrobenzenc with 105 gavc one product, 
115 (Figure 6.2). This product has been reported previously from unrelated chcmistry5. 
The ccntral ring of the transient Dicls-Alder adduct, 114, is a similar oxygen-bridged 
cyclohexadiene to that obtained when p-toluenesulfinic acid is eliminated from the 
I-methylthio-l-(p -tolylsulfony l)ethene Diels-Alder adduct, 110 ( C hapte r 5). 
Conscquently 114 has degraded in a similar manner to 110, resulting in the anthrone, 
115; a product analogous to 111. This could have occurred during work-up or 
chromatography. 
~H' 10 SCH3 0 c¢b -c¢o • ~ :0-... ~ ~ ~ ~
Ph Ph Ph OH 
105 114 115 
Figure 6.2: The Diels-Alder reaction of 1 ,2-didehydrobenzene with 1-methylthio-3-phenyl-
isobenzofuran and the subsequent decomposition of the adduct formed 
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6.4. The reaction of 3,4-didehydropyridine with 1-methylthio-
3 .. phenylisobenzofuran 
The reaction of the nitrogen-containing dienophile, 3,4-didehydropyridine, 
was then investigated. The dienophile was formed from 3-bromopyridine and upon 
reaction with 105 gave equal amounts of the two possible bridged adducts, 116a and b 
(Figure 6.3). The lack of regioselectivity of this dienophile is consistent with previous 
results3 . In an attempt to separate these two isomers by chromatography, 116a was 
isolated; 116b had decomposed to 117b, thE; product analogous to 115. Similar 











Figure 6.3: The Diels-Alder reaction of 3,4-didehydropyridine with 1-methylthio-3-phenyl-
isobenzofuran and the subsequent decomposition of the adducts formed 
6.5. The reaction of 3,4 .. didehydropyridine with 
1-(methylthio)isobenzofuran 
The isolation of bridged adducts which, upon bridge cleavage, produced 
tricycles containing hetero-atoms was encouraging for the successful preparation of a 
prodrug of an intercalating agent. This preparation was a 'one-pot' synthesis involving 
readily available starting materials. However, it is difficult for the resulting adducts to 
achieve planarity, as is seen in the formation of the non-planar compounds: 115, 117a 
and 117b. Even if planarity was achieved, the bulky aromatic substituent is not likely to 













Figure 6.4: The transformation of abridged adduct to a planar, aromatic compound upon 
cleavage of a trigger (R*) 
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assist the binding of the resulting intercalating agent. Therefore it preferable to remove 
the phenyl group from the isobenzofuran. An adduct resulting from a Diels-Alder 
reaction involving a 3-unsubstituted-isobenzofuran is more likely to achieve planarity 
upon bridge-cleavage (Figure 6.4). 
The reaction of 3,4-didehydropyridine with l-(methylthio)isobenzofuran was 
attempted. A proton NMR of the crude reaction mixture showed the presence of the 
expected Diels-Alder adducts, 118a and b (Figure 6.5). These isomers were identified 
using data from subsequent reactions (see Section 6.6). An attempt to purify and 
separate these isomers by chromatography gave a complex mixture of products. One 
product was isolated and identified as the known compound, 2-azaanthraquinone, 
104 
SCH3 ] ~9H(N) ~N(CH) 
118a (b) 
o 
c¢o~ I~ ~ ,.;N 
o 
119 
Figure 6.5: The Diels-Alder reaction of 1-(methylthio)isobenzofuran with 3,4-didehydropyridine 
Azaanthraquinones are known physiologically active compounds 8 • 
2-Azaanthraquinone has specifically been noted as an insect teratogen; application to 
insect eggs causing mutation7,9. Some 3-substituted-l-azaanthraquinones, 120, have 
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shown potent anti-tumour activity against human cancer cell 
lines 10, The substituents (R) are thought to be capable of 
alkylating the DNA, increasing the residence time of the 
intercalating agent. The reported cytotoxic activity of this type 0rR o 
of compound is encouraging for the preparation of successful 120 
cancer prodrugs by the reaction of 3,4-didehydropyridines 
with 1-( alky lthio )iso benzofurans. 
6.6. The reaction of 3,4-didehydropyridine with 
1-methy Ith iO-3-(tri methy Is ilyl)isobenzofu ran 
The method for the preparation of llSa and b requires refinement to allow 
their isolation in reasonable yields. The reaction of 3,4-didehydropyridine with 104 has 
the complication that the addition of lithium 2,2,6,6-tetramethylpiperidide to induce the 
formation of the aryne, could lithiate the unsubstituted site of the furan ring, The 
protection of this position has been described previously for the reaction of alkoxy 
substituted isobenzofurans with arynes2,3, In these reports protection was achieved by 
the addition of a trimethylsilyl substituent. Therefore 121 was prepared by the lithiation 
of 104 and subsequent reaction with trimethylsilyl chloride (Figure 6.6). The resulting 
o:r' 10 
SCHs 
a *9H (NI .. .. ~ :::,...,. // ~N (CH) 
Si(CHsb Si(CHsb 
104 121 1228 (b) 
Figure 6.6: The preparation and Diels-Alder reaction of 1-methylthio·3-(trimethylsilyl)-
isobenzofuran with 3,4-didehydropyridine 
Reagents and conditions: (a) (i) lithium diisopropylamide, tetrahydrofuran, -78 DC, 
(ii) trimethylsilyl chloride, room temperature 
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disubstituted isobenzofuran was reacted with 3,4-didehydropyridine in the usual 
manner. This was a 'one-pot' synthesis; from the thionolactone, 102, through to the 
Diels-Alder reaction. The sequence of reactions starts with deprotonation of the 
thionolactone fonowed by methylation, lithiation of the isobenzofuran, followed by 
silylation, addition of bromopyridine and finally the formation of 
3,4-didehydropyridine in situ by the addition of lithium 2,2,6,6-tetramethylpiperidide. 
This process was successful in al10wing the isolation and characterisation of the Diels-
Alder adducts, l22a and b (Figure 6.6). These two isomers were formed in equal 
amounts. Removal of the protecting group is required to give the desired adducts, U8a 
and b. 
Deprotection of the mixture of adducts was carried out using 
tetrabutylammonium fluoride (TBAF) in tetrahydrofuran; a source of 'naked' fluoride 
ions. The removal of the trimethylsilyl substituent is driven by the formation of the 
strong silicon-fluorine bond. These conditions brought about clean deprotection of 
l22a and b to give the corresponding mixture of isomers, U8a and b (Figure 6.7). A 
successful preparation of a bridged precursor of a tricyclic hetero-aromatic compound 







Figure 6.7: The deprotection of the 1-methylthio-3-(trimethylsilyl)isobenzofuran, 
3,4-didehydropyridine Diels-Alder adduct 
Reagent and conditions: (a) TBAF, tetrahydrofuran, a °C 
Cleavage of the bridge of lISa and b was achieved by the addition of a 
catalytic amount of trifluoroacetic acid (TFA). These conditions gave a similar complex 
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a 
o 
118a (b) 119 
Figure 6.8: Cleavage of the bridge of the deprotected Diels-Alder adduct 
Reagent and conditions: (a) TFA, CDCI3, room temperature 
mixture of products to that obtained from 'the direct Diels-Alder reaction of 
l-(methylthio)isobenzofuran with 3,4-didehydropyridine (Section 6.5), including the 
azaanthraquinone, 119 (Figure 6.8). 
The protection of the unsubstituted site of the furan ring of 104 with a 
trimethylsilyl group has allowed the isolation of the Diels-Alder adducts resulting from 
reaction with 3,4-didehydropyridine. Deprotection of this isomeric pair of adducts 
allowed the preparation of the required Diels-Alder adducts, 118a and b. Cleavage of 
the oxygen-bridge gave, amongst other products, 2-azaanthraquinone, a known 
biologically active compound. 
6.7. Conclusion 
Reaction of l-(methylthio)isobenzofurans with arynes was successful, and in 
some cases the bridged adducts formed were stable enough to be isolated. The use of 
3,4-didehydropyridine allowed the straightforward preparation of bridged tricycles 
containing a nitrogen atom. The reaction involving the 3-unsubstituted isobenzofuran 
required the protection of this position to allow adduct isolation. The adducts prepared 
were precursors to a planar tricyclic compound containing a nitrogen ring-atom. 
Polycyclic, hetero-aromatic structures are characteristic of known intercalating agents. 
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Moreover, the chromophore obtained is known to have significant effects on the 
biochemistry of DNA, a regioisomer of which is a potent intercalating agent against 
human cancer cell lines. 
Major inroads have been made into achieving the aim of this thesis. Chemistry 
relevant to the preparation of compounds which are possible cancer chemotherapeutic 
prodrugs has been investigated. A bridged precursor of a known biologically active 
compound has been isolated and this latent activity released upon cleavage of the 
bridge. 
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Radial chromatography was performed using aI, 2 or 4 mm silica plate. The 
silica was gradient eluted with the stated solvents. Gradient eluting involves eluting the 
silica with 0 to 100% of the more polar solvent combined with the less polar solvent. 
The plate was washed and reactivated using methanol. 
Melting points (m.p.) were determined on a Reichert Hotstage microscope and 
are uncorrected. 
Infra-red (IR) spectra were scanned on a Shimadzu FTIR-8201PC or a Perkin-
Elmer 1600-FTIR spectrophotometer. The sample was presented as a CDCb solution in 
a 0.1 or 1.0 mm NaCI solution cell, as an oil or as a Nujol® mull on NaCI plates. 
Positions of maximum absorptions (umax) are recorded in wavenumbers (cm-I) and 
relative intensities denoted as weak (w), medium (m) or strong (s). 
Ultra-violet (UV) spectra were scanned on a Hewlett Packard 8452A diode 
array spectrometer and the wavelengths (nm) of maximum absorptions ("'max) 
recorded. The intensities of the maxima are expressed as molar absorptivities (£). 
Proton nuclear magnetic resonance (lH NMR) and two dimensional nuclear 
magnetic resonance spectra were performed on a Varian Unity 300 MHz Fourier 
transform spectrophotometer. Peaks are quoted in ppm (8) relative to tetramethylsilane 
(TMS) and multiplicities are denoted as singlet (s), doublet (d), triplet (t), quartet (q), 
mutiplet (m) or broad (br). Coupling constants (1) are quoted in Hertz (Hz). 
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Carbon-13 nuclear magnetic resonance (l3C NMR) spectra were performed at 
75 MHz on a Varian Unity 300 MHz or a Varian XL 300 MHz Fourier transform 
spectrophotometer. Peaks are quoted in ppm (0) relative to TMS. 
NMR spectra were referenced (to residual protonated solvent) as follows: 
Deuterated Sol vent Abbreviation IHNMR (0) l3CNMR (0) 
Chloroform CDCb 7.24 77.00 
Acetone d6-acetone 2.17 29.20 (methyl) 
Benzene C6D6 7.27 128.40 
Dimethy lsulfoxide d6-DMSO 2.60 39.60 
Methanol CD30D 3.30 (methyl) 49.30 
Water D20 4.70 
Electron ionisation mass spectra (m/z) were performed on a Kratos MS80RFA 
operating at 4 kV and electron impact at 70 e V ([EI(70)]). Where possible, the high 
resolution mass of the parent ion is compared with the expected calculated value. The 
relative intensities of the fragment ions are quoted as a percentage. 
Elemental microanalyses of crystalline samples were performed at the 
Chemistry Department, University of Otago, New Zealand. 
X-ray crystallographic data were collected as follows: The unit cell parameters 
were obtained by least-squares refinement of the setting angles of reflections from a 
Siemens P4 diffractometer. A unique data set was measured (m scans). The unique 
reflections obtained were used in the full-matrix least-squares refinement [SHELXL-
93] 1. The intensities of 3 standard reflections were measured every 97 reflections 
throughout the data collection to check for decay. The structure was solved by direct 
methods [SHELXS-86J2. Hydrogen atoms were fixed in idealised positions. All non-
hydrogen atom parameters were refined using anisotropic atomic displacement 
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parameters. Neutral scattering factors and anomalous dispersion corrections for non-
hydrogen atoms were taken from Ibers and Hamilton3. 
Solvents were purified as follows: 
• Acetonitrile was pre-dried over potassium carbonate and distilled from 
phosphorus pentoxide. 
• Dichloromethane was pre-dried over calcium chloride and distilled from 
calcium hydride. 
• Carbon tetrachloride and chloroform were distilled from phosphorus 
pentoxide. 
• Dimethylformamide was pre-dried over calcium hydride and distilled in vacuo. 
• Ethanol and methanol were distilled from the appropriate magnesium 
alkoxide. 
• Ether (diethyl ether) was pre-dried over calcium chloride and distilled from 
cone. sulfuric acid. Especially dry ether was further distilled from sodium wire 
using benzophenone as an indicator. 
• Ethyl acetate was pre-dried over calcium chloride and distilled from calcium 
hydride. 
• Petroleum ether was distilled from phosphorus pentoxide; the fraction 
distilling between 50 and 70 DC was collected. 
• Tetrahydrofuran was pre-dried over calcium chloride and distilled from 
sodium wire using benzophenone as an indicator. 
• Toluene and benzene were pre-dried over calcium chloride and distilled from 
calcium hydride. 
Reagents: 
These were purified in accordance with the recommendations collected in 
Perrin and Armareg04 or used as obtained from commercial sources. 
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7.2. Preparation of 1, 1-bis(methylthio)ethene (19) 
Methyl dithioacetate (24)5 
1) Mg/ether 
CH31 2) CS2 
3) NH40H 
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A few drops of iodomethane and a crystal of iodine were added to dry ether 
(300 roL) and magnesium turnings (17.2 g, 0.71 mol, 1.0 eq.). The mixture, in a dry 
nitrogen atmosphere, was gently warmed until reaction started. The rest of the 
iodomethane (44 roL, 0.70 mol, 1.0 eq.) was added slowly. The solution was left 
refluxing, with stirring, for a further 25 mins. The solution was cooled in ice, and 
carbon disulfide (50 roL, 0.83 mol, 1.2 eq.) was added slowly. The solution was left 
stirring in ice overnight. (CAUTION: very strong odour present throughout the rest of 
this experiment.) The ice cold solution was then poured slowly onto crushed ice (400 
roL) and aqueous ammonia (sp.gr. = 0.880,50 roL) was added. The precipitate formed 
was filtered off through fluted filter paper. The aqueous layer was separated and the 
organic layer extracted with water (2 x 50 roL). Dimethyl sulfate (30 rnL, 0.24 mol, 
0.34 eq.) was added to the combined aqueous extracts. This solution was left stirring 
under dry nitrogen over two days. The resulting biphasic solution was extracted with 
CH2Cl2 (6 x 50 roL). The combined organic extracts were dried (K2C03) and filtered. 
The solvent was removed by distillation and the crude product purified by vacuum 
distillation. 
Yield of 24: 2.2 g, 20.7 mmol, 3%; yellow oil; b.p. 37-38 °C/12 mmHg; IH 
NMR (CDC}3): 82.63 (3H, s), 2.87 (3H, s). 
1,1-Bis(methylthio)ethene (ketene dimethyl thioacetal) (19) 
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n-Butyllithium (4.2 roL of 1.6 mol L- J solution in hexanes, 6.67 mmol, 1.25 
eq.) was added dropwise to a stirred solution of diisopropylamine (0.9 roL, 6A1 mmol, 
1.2 eq.) in tetrahydrofuran (6 mL) under dry nitrogen in an ice-salt bath. The solution 
was stirred for 20 minutes at this temperature and then cooled further in an acetone/dry 
ice bath. A solution of methyl dithioacetate (567 mg, 5.34 mmol, 1.0 eq.) in 
tetrahydrofuran (8 roL) was added dropwise. The solution was stirred under nitrogen at 
-78°C for 2.5 hours. Iodomethane (0.84 roL, 13.3 mmol, 2.5 eq.) was added dropwise 
and the resulting mixture allowed to warm to room temperature and left stirring 
overnight. The tetrahydrofuran was removed by distilling through a Vigreux column at 
atmospheric pressure. Ether (6 roL) and water (6 mL) were added to the residue, the 
organic layer separated and the aqueous layer extracted with ether (2 x 4 mL). The 
combined organic layers were dried (MgS04), filtered, and the ether removed by 
distillation through a Vigreux column at atmospheric pressure to give the crude 
product. 
Yield of 19: 610 mg, 5.07 mmol, 95%; yellow oil; IH NMR (CDCI3): 02.33 
(6H, s), 5.21 (2B, s) (lit. 6 0 2.28 (6H, s), 5.08 (2H, s)). 
7.3. Preparation of methyl coumalate (25) 
MethyI2-oxo-2H-pyran-S-ylcarboxylate (methyl coumalate) (25)7 
Concentrated sulfuric acid (8.5 mL) was added to malic acid (10.3 g, 
0.077 mol, 2.0 eq.). To this suspension were added three 2.5 mL portions of 20% 
fuming sulfuric acid at 45 minute intervals, Once all the solid had dissolved the 
solution was heated on a steam bath for 1.5 hours. The reaction mixture was cooled, 
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methanol (15 mL, 0.37 mol, 10 eq.) was added, the mixture vigorously shaken to make 
it homogeneous., The solution was then heated on a steam bath for another hour, cooled 
and poured slowly onto crushed ice (40 g) with stirring. The solution was neutralised 
with sodium carbonate, filtered and the filtrate extracted with dichloromethane (4 x 
20 mL). The combined organic extracts were washed with water, dried (MgS04), 
filtered and concentrated in vacuo. The crude product was recrystallised twice from 
petroleum ether/ethyl acetate. 
Yield of 25: 1.88 g, 12.2 mmol, 32%; p~le yellow crystals; m.p. 68-69 ac; IR 
(CDCb): Umax 1755 (s), 1728 (s), 1638 (w), 1558 (w), 1445 (m), 1303 (s) cm- I; IH 
NMR (CDCb): 83.89 (3H, s), 6.35 (lH, dd, J::::: 1.5,9.8 Hz), 7.80 (1H, dd, J == 2.4,9.8 
Hz), 8.32 (1H, dd, J == 1.5,2.4 Hz). 
7.4. Preparation of methyl 4,6-dimethylcoumalate (26) 
Methyl 4,6-dimethyl-2-oxo-2H-pyran-5-ylcarboxylate (methyl 4,6-
dimethylcoumalate) (26)8 
To concentrated sulfuric acid (5.1 mL), cooled to 10 ac, was added methyl 
acetoacetate (5.4 mL, 50 mmol) at such a rate that the temperature of the mixture 
remained below 15 ac. This solution was left standing at room temperature for 4 days 
with occasional stirring and was then poured onto ice (10 g). The product was extracted 
with ether (20 mL, 2 x 10 mL) and the combined organic extracts washed with aqueous 
N aHC 03 (half saturated, 4 x 5 mL), brine (5 mL), dried (NaS04), filtered and 
concentrated in vacuo. The crude product was recrystallised from petroleum ether/ethyl 
acetate. 
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Yield of 26: 830 mg, 4.56 rnmoI, 18%; white crystals; m.p. 62-64 °C; IH 
NMR (CDC13): (52.22 (3H, d, J = 1.0 Hz), 2.40 (3H, s), 3.88 (3H, s), 6.03 (lH, s). 
7.5. Diels-Alder reaction between 1, 1-bis(methylthio)ethene 
(19) and methyl coumalate (25) 
7,7 -Bis(methylthio )-3-carbomethoxy-5-oxabicyclo[2.2.2]oct-2-en-6-one (28) 
Methyl 2-oxo-2H-pyran-5-ylcarboxylate (40 mg, 0.26 mmol, 1.0 eq.) and 
1,I-bis(methylthio)ethene (94 mg, 0.78 rnmol, 3.0 eq.) were dissolved in toluene 
(10 mL). The solution was refluxed under nitrogen for 22 hours and then concentrated 
in vacuo. The crude product was purified using radial chromatography, eluting with 
90% petroleum etherll 0% ethyl acetate. The product can be recrystallised from 
petroleum ether/ethyl acetate. 
Yield of 28: 53 mg, 0.19 mmol, 74%; white needles; m.p. 92-93.5 °C; 1R 
(CDCI3): u max 2955 (w), 2921 (w), 1758 (s), 1726 (s), 1635 (m) cm- I ; IH NMR 
(CDCI3): 0 2.10"(3H, s), 2.12 (IH, dd, J = 2.0,14.2 Hz), 2.17 (3H, s), 2.47 (lH, dd, J = 
3.9, 14.2 Hz), 3.83 (3H, s), 3.88 (IH, d, J = 6.4 Hz), 5.70 (lH, ddd, J = 2.0, 2.0, 3.9 
Hz), 7.28 (lH, dd, J = 2.0,6.4 Hz); 13C NMR (CDCI3): (5 12.41, 12.62,40.56,51.28, 
52.35,57.09,73.05, 135.38, 139.07, 162.44, 168.87; mlz [E1 (70)J: 274.0337 (found), 
274.03335 (caled.); 274 (M+, 10%),227 (M+-SCH3, 14%), 182 (M+-C02, -SCH3, -H, 
100%),124 (M+-C02, -SCH3, -C02CH3, 88%). 
Anal. Calcd. for CllH1404S2: C, 48.16; H, 5.14; S, 23.37. Found: C, 47.98; H, 
4.98; S, 23.23%. 
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7.S. Diels-Alder reaction between 1, 1-bis(methylthio)ethene 
(19) and methyl 4,S-dimethylcoumalate (2S) 
MethyI2,6-dimethyl-4-(methylthio)benzoate (31) 
Methyl 4,6-dimethyl-2-oxo-2H-pyran-~-ylcarboxylate (45 mg, 0.25 mmol, 
1.0 eq.) and 1,1-bis(methylthio)ethene (89mg, 0.74 mmol, 3.0 eq.) were dissolved in 
toluene (10 mL). The solution was refluxed under nitrogen for 9 days and then 
concentrated in vacuo. A IH NMR spectrum of the crude reaction mixture showed that 
the reaction was 50% complete. The reaction was stopped at this stage and the product 
was purified using radial chromatography, eluting with petroleum ether. Some starting 
material (9 mg, 20%) was recovered. 
Yield of 31: 11 mg, 0.05 mmol, 21 %; pale yellow oil; IR (CDC13): 'Umax 2953 
(w), 2926 (w), 1720 (s), 1590 (m), 1438 (m), 1273 (s) em-I; IH NMR (CDCb): 02.30 
(6H, s), 2.46 (3H, s), 3.89 (3H, s), 6.90 (2H, s); BC NMR (CDC13): 0 15.21, 19.94, 
51.82, 125.01, 130.28, 136.01, 140.19, 170.11; m/z [EI (70)]: 210.0716 (found), 
210.07145 (ealcd.); 210 (M+, 95%),179 (M+-OCH3, 100%). 
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Anhydrous AIC13 (68 g, 0.51 mol, 3.2 eq.) was carefully added to crotonic acid 
(l4.05 g, 0.16 mol, 1.0 eq.) in dry benzene (l1O mL, 1.24 mol, 7.8 eq.). The resulting 
solution was refluxed for 5 hours and then the reaction quenched by pouring carefully 
into ice water (350 mL) in an ice bath. The resulting mixture was split in two and each 
half worked up as follows: Conc BCI (l0 mL) and ethyl acetate (20 mL) was added .. 
The aqueous layer was separated and extracted with ethyl acetate (2 x 30 mL). The 
organic layers were combined and washed with aqueous NaOB solution (4 mol L-1, 2 x 
50 mL) and water (2 x 50 mL), dried (MgS04), filtered and concentrated in vacuo. The 
< 
crude product was purified by vacuum distillation. 
Yield of 36: 9.18 g, 62.8 mmol, 38%; pale yellow oil; b.p. 70-74 °CIl mmHg; 
IB NMR (CDC13): 8 1.41 (3B, d, J = 6.8 Bz), 2.28 (lB, dd, J = 3.4,19.1 Hz), 2.94 
(lB, dd, J = 7.3, 19.1 Bz), 3.45 (lB, m), 7.38 (lB, br t), 7.51 (lB, br d), 7.62 (lB, br t), 
7.74 (lB, br d). 
I-Methyl-3-phenyl-1H -indene (38) 
1) PhMgBr 




Magnesium turnings (1.10 g, 0.043 mol, 1.4 eq.) were stirred in freshly dried 
ether (24 mL). A few drops of bromobenzene solution (5.0 mL, 0.048 mol, 1.5 eq.; in 8 
mL of ether) and a crystal of iodine were added to initiate the reaction. The remainder 
of the bromobenzene solution was added at such a rate as to maintain reflux. The 
solution was allowed to reflux for a further 10 minutes and then cooled to 0 °C. 
3-Methylindan-1-one (4.50 g, 0.031 mol, 1.0 eq.) in ether (8 mL) was added slowly. 
The white precipitate formed was acidified with 10% sulfuric acid and the organic layer 
separated, dried (MgS04), filtered and concentrated in vacuo. The residue was taken up 
in toluene (30 mL) and refluxed over P20S (4.0 g, 0.028 mol, 0.9 eq.) for one hour. 
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After decantation of the organic solution and removal of the toluene, the residue was 
purified by vacuum distillation. 
Yield of 38: 3.64 g, 17.65 mmol, 57%; yellow oil; b.p. 116-120 DCIl mmHg; 
IH NMR (CDCb): 8 1.39 (3H, d,.7 = 7.8 Hz), 3.59 (lH, dq,.7 = 2.0,7.8 Hz), 6.52 (lH, 
d,.7 = 2.0 Hz), 7.24-7.62 (9H, m). 
(2~ Benzoylphenyl)propanoic acid (39) 
-RuCb 
1-Methyl-3-pheny1-1H-indene (2.47 g, 11.9 mmol, 1.0 eq.) was added to a 
solution of sodium metaperiodate (10.45 g, 48.9 mmol, 4.1 eq.) in carbon tetrachloride 
(24 mL), acetonitrile (24 mL) and water (36 rnL). To this biphasic solution, ruthenium 
trichloride hydrate (60 mg, 0.27 mmol, 0.02 eq.) was added, and the entire mixture 
stirred vigorously for 22 hours at room temperature. Dichloromethane (120 mL) and 
water (160 mL) were added, the organic layer removed, and the aqueous layer extracted 
with dichloromethane (3 x 20 mL). The combined organic extracts were extracted with 
aqueous sodium hydroxide solution (2 mol L-1, 100 mL, 3 x 50 mL), the aqueous layer 
acidified with cone. HCI and the precipitate formed extracted with dichloromethane (3 
x 50 mL). The combined organic extracts were washed with water (50 mL), dried 
(MgS04) , filtered and concentrated in vacuo. The crude product was recrystallised 
twice from benzene/petroleum ether. 
Yield of 39: 1.75 g, 6.87 mmol, 57%; white crystals; m.p. 85-86 DC; IH NMR 
(CDCl)): 0 1.55 (3H, d,.7 = 6.8 Hz), 4.02 (1H, q,.7 = 6.8 Hz), 7.33-7.43 (2H, m), 7.50-
7.71 (5R, m), 7.90 (2H, br d). 
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2-(2-Benzoylphenyl)propanoic acid (49 mg, 0.19 mmol, 1.0 eq.) was dissolved 
in cone. H2S04 (0.16 mL) with gentle warming on a water bath to give an orange 
solution. Water (20 mL) was added to produce a deep red precipitate which was rapidly 
extracted with ethyl acetate (20 mL) containing maleic anhydride (95 mg, 0.97 mmol, 
5.0 eq.). The aqueous layer was further extracted with ethyl acetate (10 mL). The 
solution was left standing for 3.5 hours after which time the red colour had faded to a 
pale orange. The solution was washed with saturated aqueous NaHC03 (10 mL), water 
(10 mL), dried (MgS04), filtered and concentrated in vacuo. 
Yield of 41: 46 mg, 0.14 mmol, 71%; white crystals; m.p. 218-220 DC 
(decomp. 205°C); IH NMR (CDCI3): 8 2.09 (3H, s), 3.66 (lH, d, J = 9.3 Hz), 4.68 
(lH, d, J = 9.2 Hz), 6.99 (lH, d, J = 8.3 Hz), 7.36 (lH, br t), 7.45 (lH, br d), 7.51-7.59 
(4H, m), 7.82 (2H, m). 
11,11-Bis(methyl thio )-I-methyl-9-oxa -8-phenyltricyclo [6.2.2.02,7] dodec-2,4,6. 
trien-l0-one (42)9 
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2-(2-Benzoylphenyl)propanoic acid (45 mg, 0.18 mmol, 1.0 eq.) was dissolved 
in cone. H2S04 (0.18 rnL) with gentle warming on a water bath to give an orange 
solution. Water (25 rnL) was added to produce a deep red precipitate which was 
extracted with ethyl acetate (2 x 20 rnL), dried (MgS04), filtered and concentrated in 
vacuo (not to dryness). Toluene (20 rnL) was added, and the solution concentrated in 
vacuo to remove any remaining ethyl acetate. Another 20 rnL of toluene was added and 
the solution concentrated in vacuo to a final volume of 12 mL. 
1,1-Bis(methylthio)ethene (54 mg, 0.45 mmol, 2.5 eq.) was added and the solution was 
refluxed under nitrogen for 24 hours, after which time the red colour had faded to a 
pale orange. The solvent was removed and the crude product purified using radial 
chromatography, eluting with 90% petroleum etherllO% ethyl acetate. 
Yield of 42: 49 mg, 0.14 mmol, 78%; white crystals; m.p. 138-141 °C; IH 
NMR (CDCl)): 8 1.92 (6H, s), 2.24 (3H, s), 2.81 & 2.95 (2H, ABq, J = 14.6 Hz), 6.65 
(lH, d, J = 7.3 Hz), 7.23 (lH, m), 7.40-7.59 (7H, m). 
Crystal data and structure refinement for 42 
C20H2002S2, M 356.51, crystal dimensions 0.86 x 0.43 x 0.37 mm; 
orthorhombic, a 7.633(2), b 8.196(2), c 28.343(4) A; ex 90, f3 90, r 90 0; V 
1773.0(7) A3, space group Pna21, Z = 4, P(OOO) 752.0, Deale. 1.335 Mg m-3, absorption 
coefficient 0.31.mm-1, 8 range for data collection 2.0 to 27.0, index ranges 0 :::; h:::; 9, 0 
:::; k:::; 10, 0 :::; I :::; 36; data/restraints/parameters 2273/1/220, goodness of fit on p2 was 
1.055, final R indices [1>2O'(1)J R1 = 0.0249; R indices (all data) Rl = 0.0285, WR2 = 
0.0672, largest difference peak and hole 0.23 and -0.22 e A -3. 
The unit cell parameters were obtained by least-squares refinement of the 
setting angles of 22 reflections with 10.12 :::; 28 :::; 28.00 o. A unique data set was 
measured at 130 K within 28max. = 540 limit (m scans). Of the 2273 reflections 
obtained, 2081 were unique and were used in the full-matrix least-squares refinement. 
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The intensities of 3 standard reflections, measured every 97 reflections throughout the 
data collection, showed no significant decay. 
The crystal structure data are reported in Appendix A.1. 
ll-Ethoxy-l-methyl~9-oxa-8-phenyltricyclo[6.2.2.02,7]dodec-2,4,6-trien-lO-one (44) 
c/?0 Hs elR° H OEt + S r; 0-';;' r; 0-"";;; ° Et Pn Pn 2) 9Et CHFQ. H 
2-(2-Benzoylphenyl)propanoic acid (l00 mg, 0.39 mmol, 1.0 eq.) was 
dissolved in cone. H2S04 (0.33 mL) with gentle warming on a water bath to give an 
orange solution. Water (45 mL) was added to produce a deep red precipitate which was 
extracted with ethyl acetate (2 x 40 mL), dried (MgS04), filtered and concentrated in 
vacuo (not to dryness). Toluene (25 mL) was added, and the solution concentrated in 
vacuo to 12 mL. Ethyl vinyl ether (0.39 mL, 4.08 mmol, 10.0 eq.) was added and the 
solution was refluxed under nitrogen for 3 hours after which time the red colour had 
disappeared. The solution was washed with saturated aqueous NaHC03 (l2 mL), water 
(l2 mL), dried (MgS04), filtered and concentrated in vacuo. 44a and 44b9 were formed 
in the ratio 22:78. The major of the two isomers was separated and purified by 
fractional recrystallisation from ethyl acetate/petroleum ether. 
Combined yield of 44a and 44b: 98 mg, 0.32 mmol, 81 %. 44b (endo): white 
crystals; m.p. 173-175 DC; IH NMR (CDC13): <5 1.11 (3H, t, J = 6.9 Hz), 1.83 (3H, s), 
2.28 (lH, dd, .J = 13.9, 2.2 Hz), 2.87 (lH, dd, .J = 13.9, 8.1 Hz), 3.46 (lH, dq, J = 9.8, 
7.0 Hz), 3.58 (lH, dq, J = 9.8, 7.0 Hz), 3.91 (lH, dd, .J = 8.1, 2.2 Hz), 6.62 (lH, d, J = 
7.4 Hz), 7.15-7.20 (lH, m), 7.35-7.38 (2H, m), 7.45-7.59 (5H, m). 44a (exo, not 
isolated): IH NMR (CDC13): 8 1.20 (3H, t,.l = 6.8 Hz), 1.82 (3H, s), 2.42 (lH, dd,.J = 
13.7,2.9 Hz), 2.79 (lH, dd, 13.7,8.3 Hz), 3.44 (lH, dq,.l = 9.3,6.8 Hz), 3.61 (lH, dd, 
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J = 8.3, 2.9 Hz), 3.65 (lH, dq, J = 9.3,6.8 Hz), 6.62 (lH, d, J = 7.8 Hz), 7.13-7.20 (lH, 
m), 7.34-7.60 (7H, m). 
Crystal data and structure refinement for 44b (endo) 
C20H2003, M 308.36, crystal dimensions 0.79 x 0.43 x 0.34 mm; monoclinic, 
a 8.509(3), b 8.564(2), c 22.247(5) A; a 90, ~ 94.710(10), r 90 0; V 1615.7(8) A3, 
space group P21/n, Z = 4, F(OOO) 656, Deale 1.268 Mg m-3, absorption coefficient 
0.084 mm-1, 8 range for data collection 2.50 to 25.00, index ranges O:=:; h:=:; 10, 0 :=:; k:=:; 
10, -26 :=:; 1 :=:; 26; data/restraints/parameters 28~1/0/218, goodness of fit on F2 was 
1.057, final R indices [1>20'(1)] Rl = 0.0505, WR2 = 0.1189, R indices (all data) Rl = 
0.0834, WR2 = 0.1398, largest difference peak and hole 0.243 and -0.334 e A-3. 
The unit cell parameters were obtained by least-squares refinement of the 
setting angles of 38 reflections with 10 :=:; 28 :=:; 14°. A unique data set was measured at 
302(2) K within 28max = 57° limit (OJ scans). Of the 3026 reflections obtained, 2821 
were unique (Rint = 0.0177) and were used in the full-matrix least-squares refinement. 
The intensities of 3 standard reflections, measured every 97 reflections throughout the 
data collection, showed < 2% decay. 
Note: The reflections were obtained at room temperature because the crystals 
cracked if cooled to low temperatures. 
The crystal structure data are reported in Appendix A.2. 
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Water (350 mL), iron(ll) sulfate heptahydrate (210 g, 0.76 mol, 9.5 eq.), conc. 
HCI (1.0 mL, 0.012 mol, 0.15 eq.) and 2-nitrobenzaldehyde (12 g, 0.08 mol, 1.0 eq.) 
were combined in that order. The mixture was stirred and heated to 90 DC. Aqueous 
ammonia (sp.gr. = 0.880, 50 mL) was added, and then three more portions (20 mL) of 
aqueous ammonia were added at 2 minute intervals. Immediately after the last portion 
was added, the mixture was stearn distilled with the receiver cooled in ice. The 
distillation was stopped once 500 mL of distillate had been collected. Sodium chloride 
(150 g) was added to the distillate and the precipitate formed was collected by 
filtration. The product was dried under vacuum, 
Yield of 2-aminobenzaldehyde: 7.9 g, 65.2 mmol, 82%; yellow needles; m.p. 
38.5-41 DC; IB NMR (CDCI3): (57.71-7.81 (2B, m), 7.93 (lB, dd, J = 6.9, 2.5 Hz), 
8.09 (lB, dd, J = 6.9,2.5 Hz), 10.39 (lB, s). 
2-0xobutanoic acid 
10% 
Sodium (2.28 g, 0.1 mol, 1.0 eq.) was added in small portions to freshly dried 
ethanol (35 mL, 0.6 mol, 6.0 eq.) at a rate sufficient to keep the ethanol refluxing. 
External heating was required to dissolve the last portions of sodium. The excess 
ethanol was removed by distillation. The remaining ethanol was removed by azeotropic 
distillation with toluene. After cooling the sodium ethoxide formed, freshly dried ether 
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(70 mL) and diethyl oxalate (13.6 mL, 0.1 mol, 1.0 eq.) were added. After 20 minutes 
stirring, ethyl propanoate (ll.5 mL, 0.1 mol, 1.0 eq.) was added and the mixture stirred 
for 2.5 days, during which an orange precipitate formed. 
The mixture was hydrolysed by the addition of water (70 mL), the layers 
separated and the ethereal layer washed with saturated NaHC03 solution (3 x 20 mL) 
and the ether layer discarded. The combined aqueous layers were acidified with cone. 
HCI (20 mL) and the layers separated. The aqueous layer was extracted with ether (3 x 
20 mL), and the combined organic layers dried (MgS04), filtered, and concentrated in 
vacuo. 
10% sulfuric acid (100 mL) was added to the resulting oil and the mixture 
refluxed for 6 hours, becoming homogeneous. The solution was extracted with ether (4 
x 30 mL) and the solvent removed in vacuo to give the crude product, purified by 
vacuum distillation. 
Yield of 2-oxobutanoic acid: 3.82 g, 37.42 mmol, 37 %; colourless oil; b. p. 
80 DC/20 mmHg; IR (CDCb): 'Omax 3419 (m), 2986 (m), 1783 (s), 1725 (s), 1602 (m), 
l380 (m), 1330 (m), 1102 (m) em-I; IH NMR (CDCI3): (51.17 (3H, t, J = 7.1 Hz), 2.98 
(2H, q, J = 7.1 Hz), 4.65 (lH, br s). 
2-Carbomethoxy-3-methylquinoline (45a) 11 
+ 
1) NaOCH3 
2) c. H2S04, 
CH 30H 
Sodium (1.46 g, 0.064 mol, 1.9 eq.) was added in small portions to dry 
methanol (150 mL). Once all of the sodium had reacted, 2-oxobutanoic acid (3.82 g, 
0.037 mol, 1.1 eq.) and 2-aminobenzaldehyde (4.0 g, 0.033 mol, 1.0 eq.) were added 
and the solution heated under reflux for 16 hours. After cooling, cone. H2S04 (3.2 mL, 
0.058 mol) was cautiously added and the resultant solution heated under reflux for a 
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further 24 hours. The mixture was neutralised by the addition of saturated aqueous 
NaHC03 (50 mL), and then extracted with dichloromethane (150 mL. 6 x 50 mL). The 
combined organic extracts were dried (NaS04), filtered and concentrated in vacuo. The 
crude product was purified by short path vacuum distillation followed by further 
purification using radial chromatography, eluting with 67% petroleum ether/33% ethyl 
acetate. 
Yield of 45a: 1.91 g, 9.49 mmol, 29%; yellow oil; b.p, 165 °C/0.1 rnmHg; IH 
NMR (CDC13): (52.70 (3H, d, ] = 0.9 Hz), 4.06 (3H, s), 7.60 (lH, ddd, ] = 8.3, 6.8, 1.0 
, 
Hz), 7.71 (lH, ddd, ] = 8.3, 6.8, 1.5 Hz), 7.79 (1H, dd, ] = 8.3, 1.5 Hz), 8.05 (lH, s), 
8.20 (lH, dd, ] = 8.3, 1.0 Hz). 
3-Bromomethyl-2-carbomethoxyquinoline (46a) 
A mixture of2-carbomethoxy-3-methylquinoline (650 mg, 3.23 mmol, 1.0 eq.) 
and N-bromosuccinimide (NBS) (575 mg, 3.23 mmol, 1.0 eq.) in refluxing carbon 
tetrachloride (175 mL) was irradiated overnight with a 200 W light bulb. The mixture 
was cooled, filtered and the filtrate washed with water (50 mL), aqueous NaOH 
solution 0.25 mol L-1, 2 x 50 mL) and water (2 x 50 mL). The organic layer was dried 
(MgS04), filtered and concentrated in vacuo. The crude product was purified using 
radial chromatography, eluting with 25% carbon tetrachloridel75% dichloromethane. 
Yield of 46a: 374 mg, 1.34 mmol, 41 %; white crystals; m.p. 84-86 °C; IH 
NMR (CDC13): (54.11 (3H, s), 5.06 (2H, s), 7.67 (lH, ddd, ] = 8.3,6.9, 1.4 Hz), 7.80 
(1H, ddd, ] = 8.3, 6.9, 1.4 Hz), 7.86 (1H, dd ] = 8.3, 1.4 Hz), 8.24 (1H, dd ] == 8.3, 1.4 
Hz), 8.30 (1H, s). 
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2-Carbomethoxy-3-cyanomethylquinoline (47a) 12 
KeN 
3-Bromomethyl-2-carbomethoxyquinoline (460 mg, 1.64 mmol) in methanol 
(16 mL) was added to dried potassium cyanide (174 mg, 2.46 mmol, 1.6 eq.) and the 
solution stirred overnight at room temperature. The solution was then refluxed for two 
hours, cooled and water (30 mL) added. The resulting solution was extracted with 
dichloromethane (4 x 18 mL). The combined organic layers washed with water (20 
mL), dried (MgS04), filtered and the solution concentrated in vacuo. The crude product 
was recrystallised twice from methanol. 
Yield of 47a: 200 mg, 0.88 mmol, 54%; orange crystals; m.p. 128-130 DC; lR 
(CDCI3): Umax 3690 (w), 1724 (s), 1602 (w), 1458 (w), 1441 (w), 1327 (w), 1308 (m), 
1292 (m), 1198 (m), 1172 (m), 1141 (s) cm-1; IH NMR (CDCI3): 04.09 (3H, s), 4.39 
(2H, s), 7.72 (1H, t, J = 7.7 Hz), 7.84 (1H, t, J = 7.7 Hz), 7.92 (1H, d, J = 7.7 Hz), 8.27 
(1H, d, J = 7.7 Hz), 8.46 (1H, s); mlz [El (70)]: 226.0743 (found), 226.0742 (calcd.); 
226 (M+, 73%), 194 (M+-OCH3, -H, 100%), 168 (M+-C2H202, 76%),166 (M+ 




To 2-carbomethoxy-3-cyanomethylquinoline (47 mg, 0.21 mmol) stirring in 
anhydrous tetrahydrofuran (3 mL), at -78 DC, was added a PhMgBr/tetrahydrofuran 
solution (prepared in the usual way, 1.32 mol L-1, 0.19 mL, 0.25 mmol, 1.2 eq.). The 
solution was allowed to warm to room temperature over 2.5 hours. Water (15 mL) was 
added and the mixture concentrated in vacuo to remove the tetrahydrofuran. The 
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aqueous layer was extracted with dichloromethane (10 mL). Aqueous HCI (2 mol L-l, 
0.2 mL) was added and the mixture extracted with dichloromethane (S mL); this 
process was repeated. The combined organic layers were dried (MgS04), filtered and 
concentrated in vacuo. 
Yield of 48a: 47 mg, 0.17 mmol, 83%; pale yellow crystals; IH NMR 
(CDCI3): 84.20 (2H, d, ] = 1.0 Hz), 7.S1 (2H, t, ] = 7.3 Hz), 7.65 OH, tt, ] = 7.3, 1.4 
Hz), 7.72 (1H, ddd, ] = 7.8,6.8, 1.0 Hz), 7.82 (lH, ddd, ] = 8.3, 6.8, 1.4 Hz), 7.95 (lH, 
dd, ] = 8.3, 1.4 Hz), 8.03 (2H, dd, ] = 7.3, 1.4 Hz), 8.14 (1H, d, ] = 8.8 Hz), 8.48 (1H, 
s); mJz [EI (70)]: 272 (M+, 80%), 243 (M+-CHO, 97%), 140 (M+-HCN, -COC6HS, 
23%), 105 (COC6HS+, 100%),77 (C6HS+, 97%). 
2-0xopentanoic acid 
10% 
Sodium (9.2 g, 0.4 mol, 1.0 eq.) was added in small portions to freshly dried 
ethanol (120 mL, 2.0 mol, Seq.) at a rate sufficient to keep the ethanol refluxing. 
External heating was required to dissolve the last portions of sodium. The excess 
ethanol was then removed by distillation. The remaining ethanol was removed by 
azeotropic distillation with toluene. After cooling the sodium ethoxide formed, freshly 
dried ether (260 mL), diethyl oxalate (S4 mL, 0.4 mol, 1.0 eq.) and ethyl butanoate (S3 
mL, 0.4 mol, 1.0 eq.) were added and the mixture stirred for 40 hours. 
The mixture was hydrolysed by the addition of water (200 mL), the layers 
separated and the ethereal layer washed with water (3 x SO mL) and the ether layer 
discarded. The combined aqueous layers were acidified with cone. HCI (40 mL) and 
the layers separated. The aqueous layer was extracted with ether (3 x 50 mL), and the 
combined organic layers dried (MgS04), filtered, and concentrated in vacuo. 
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10% sulfuric acid (350 mL) was added to the resulting oil and the mixture 
refluxed for 5.5 hours, becoming homogeneous. The solution was extracted with ether 
(100 roL, 3 x 50 roL) and the solvent removed in vacuo to give the crude product, 
purified by vacuum distillation. 
Yield of 2-oxopentanoic acid: 15.6 g, 134.4 mmol, 33%; colourless oil; b.p. 
92-98 aC/20 mrnHg; IR (CDCI3): u max 3418 (m), 2969 (m), 1782 (s), 1723 (s), 1345 
(s) cm-1; IH NMR (CDCb): 00.99 (3H, t, J = 7.6 Hz), 1.71 (2H, g, J = 7.3 Hz), 2.93 
(2H, t, J;;;; 7.1 Hz), 7.87 OH, br s). 
2-Carbomethoxy-3-ethylquinoIine (45b) 
1) NaOCH3 
Sodium (0.91 g, 0.040 mol, 1.8 eg.) was added in small portions to dry 
methanol (100 roL). Once all of the sodium had reacted, 2-oxopentanoic acid (2.88 g, 
0.025 mol, 1.1 eq.) and 2-aminobenzaldehyde (2.68 g, 0.022 mol, 1.0eq.) were added 
and the solution heated under reflux for 16 hours. After cooling, conc. H2S04 (2.2 mL, 
1.8 eg.) was cautiously added and the resultant solution heated under reflux for a 
further 24 hours. The mixture was neutralised by the addition of saturated aqueous 
NaHC03 (30 mL), and then extracted with dichloromethane (100 roL, 3 x 50 roL). The 
combined organic extracts where dried (NaS04), filtered and concentrated in vacuo. 
The crude product was purified by vacuum distillation. 
Yield of 45b: 1.17 g, 5.44 romol, 25%; brown oil; b.p. 126-128 aCIO.OI 
mrnHg; IH NMR (CDCI3): 0 1.35 (3H, t, J = 7.3 Hz), 3.06 (2H, q, J = 7.3 Hz), 4.06 
(3H, s), 7.59 (lH, ddd, J = 8.3, 6.8, 1.0 Hz), 7.71 OH, ddd, J = 8.3, 6.8, 1.5 Hz), 7.81 
OH, dd, J = 8.3, 1.5 Hz), 8.08 OH, s), 8.18 OH, dd, J = 8.3, 1.0 Hz). 
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(1-Bromoethy 1)-2-carbomethoxyquinoline (46b) 
NBS 
-hv 
A mixture of 2-carbomethoxy-3-ethylquinoline (2.82 g, 0.013 mol, 1.0 eq.) 
and N-bromosuccinimide (NBS) (2.57 mg, 0.014 mol, 1.1 eq.) in refluxing carbon 
tetrachloride (710 rnL) was irradiated overnight with a 200 W light bulb. The mixture 
was cooled, filtered and the filtrate washed with water (180 rnL), aqueous NaOH 
solution (1.25 mol L -1, 2 x 150 rnL) and water (2 x 150 rnL). The organic layer was 
dried (MgS04), filtered and concentrated in vacuo. 
Yield of 46b: 3.08 g, 10,47 mrnol, 80%; brown oil; IH NMR (CDCI3): (52.18 
(3H, d, J = 6.9 Hz), 4.10 (3H, s), 6.18 (lH, q, J = 6.9 Hz), 7.66 (1H, ddd, J = 8.3, 6.9, 
1.5 Hz), 7.79 (1H, ddd, J = 8.3,6.9, 1.5 Hz), 7.89 (lH, dd J = 6.9, 1.5 Hz), 8.21 (lH, dd 




3-(1-Bromoethyl)-2-carbomethoxyquinoline (408 mg, 1.39 mrnol) in methanol 
(12 mL) was added to dried potassium cyanide (144 mg, 2.21 mrnol, 1.6 eq.) and the 
solution stirred overnight at room temperature. The solution was then refluxed for six 
hours, concentrated by distilling off the methanol, cooled and water (25 rnL) added. 
The resulting solution was extracted with dichloromethane (4 x 15 rnL). The combined 
organic layers were washed with water (15 rnL), dried (MgS04), filtered and the 
solution concentrated in vacuo, The crude product was purified using radial 
chromatography, eluting with dichloromethane. 
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Yield of 51: 177 mg, 0.72 mmol, 52%; white solid; m.p. 47°C; IR (CDCl3): 
'Umax 2981 (w), 2934 (w), 1728 (s), 1456 (w), 1289 (m), 1208 (m), 1139 (s), 1111 (m) 
em-I; IH NMR (CDC13): 0 1.56 (3H, d, J = 6.3 Hz), 3.32 (3H, s), 4.07 (3H, s), 5.07 
OH, q, J = 6.3 Hz), 7.63 (lH, ddd, J = 9.3,6.8, 1.0 Hz), 7.76 (lH, ddd, J = 8.3,6.8, 1.4 
Hz), 7.88 (lH, d, 8.3 Hz), 8.21 (lH, d, J = 9.3 Hz), 8.42 (lH, s); l3C NMR (CDCl3): 0 
23.63, 53.02, 56.91, 75.40, 127.57, 128.33, 128.98, 129.80, 130.03, 134.42, 136.73, 
.146.30, 147.90, 166.72; rnJz [EI (70)J: 245 (M+, 62%), 230 (M+-CH3, 100%),214 (M+ 
-OCH3, 18%), 198 (M+-CH3, -CH30H, 97%) 170 (M+-COCH3, -CH30H, 67%), 154 
(M+-C02CH3, -CH30H, 69%). 
Anal. Calcd. for CI4HI5N03: C, 68.56; H, 6.16; N, 5.71. Found: C, 68.34; H, 
6.09; N, 5.54%. 




1,4,7,10,13, 16-Hexaoxacyclooctadecane (18-crown-6) (9 mg, 0.03 mmol, 0.09 
eq.) and 3-(1-bromoethyl)-2-carbomethoxyquinoline (l08 mg, 0.37 mmol, 1.0 eq.) 
were dissolved in acetonitrile (0.6 mL). This solution was added to dried potassium 
cyanide (51 mg, 0.78 mmol, 2.1 eq.). The heterogeneous mixture was stirred under 
reflux for 2.5 hours. The resulting mixture was filtered and the residue washed with 
acetonitrile (0.5 mL). Water (2 mL) was added to the combined filtrates and the 
mixture extracted with dichloromethane (3 x 2 mL). The combined organic layers were 
dried (MgS04), filtered and concentrated in vacuo. The crude product was purified 
using radial chromatography, eluting with 25% petroleum etherl75% dichloromethane. 
The resulting product was recrystallised from methanol. 
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Yield of 52: 20 mg, 0.1 rnmol, 27%; white needles; m.p. 155-156 °C; IR 
(CDC13): 'Umax 1778 (s), 1729 (w), 1580 (w), 1504 (m), 1377 (m), 1304 (m) cm-1; 1 H 
NMR (CDC13): 0 1.71 (3H, d, J = 6.3 Hz), 5.75 (lH, q, J = 6.3 Hz), 7.66 (lR, ddd, J = 
8.3,6.8, 1.0 Hz), 7.79 (lH, ddd, J = 8.3, 6.8, 1.5 Hz), 7.91 (1H, d, J = 8.3 Hz), 8.24 
(lR, s), 8.31 (lH, d, J = 8.3 Hz); 13C NMR (CDC13): 020.84,76.23, 128.01, 129.10, 
129.28, 130.05, 130.84, 130.91, 138.54, 144.78, 149.80, 167.91; mJz [EI (70)J: 
199.0637 (found), 199.06332 (caled.); 199 (M+, 76%), 184 (M+-CR3, 32%), 156 (M+ 
-CO, -CH3, 77%), 154 (M+-C02H, 32%),128 (M+-C02, -C2H3, 100%). 
Anal. Calcd. for C12H9N02: C, 72.35; H, 4.55; N, 7.03. Found: C, 72.13; H, 
4.56; N, 7.02%. 




18-Crown-6 (60 mg, 0.23 mmol, 0.3 eq.) and 3-(l-bromoethyl)-
2-carbomethoxyquinoline (249 mg, 0.85 mmol, 1.0 eq.) were dissolved in acetonitrile 
(1.8 mL). This solution was added to dried potassium cyanide (153 mg, 2.35 mmol, 2.8 
eq.). The heterogeneous mixture was stirred at room temperature overnight. The 
resulting mixture was filtered and the residue washed with dichloromethane (2 x 1 mL). 
Water (5 mL) was added to the eombined filtrates and the mixture extracted with 
dichloromethane (3 x 5 mL). The combined organic layers were dried (MgS04), 
filtered and concentrated in vacuo. The crude product was purified using radial 
chromatography, eluting with 66% petroleum ether/34% ethyl acetate. 
Yield of 47b: 56 mg, 0.23 mmol, 28%; orange oil; IR (CDCb): 'Umax 1724 (s), 
1458 (m), 1382 (m), 1290 (m) cm-1; lH NMR (CDCb): 0 1.73 (3H, d, J = 7.3 Hz), 4.07 
(3R, s), 5.08 (lH, q, J = 7.3 Hz), 7.69 (lH, ddd, J = 7.8, 6.8, 1.4 Hz), 7.81 (lR, ddd, J 
= 8.3, 6.8, 1.4 Hz), 7.90 (IH, d, J = 7.8 Hz), 8.23 (lH, d, J = 8.3 Hz), 8.50 (lR, s); 13C 
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NMR (CDC13): 821.56,27.90,53.28, 121.20, 127.30, 128.48, 129.20, 129.81, 130.36, 
130.79, 136.33, 145.44, 146.19, 165.86; rnlz [EI (70)]: 240.0894 (found), 240.08987 
(calcd.); 240 (M+, 45%), 225 (M+-CH3, 7%), 208 (M+-CH30H, 16%), 180 (M+-H, 






To 2-carbomethoxy-3-(l-cyanoethyl)quinoline (175 mg, 0.73 mmol) stirring in 
anhydrous tetrahydrofuran (8 mL), at -78°C, was added a PhMgBr/tetrahydrofuran 
solution (prepared in the usual way, 1.15 mol L- I, 0.76 mL, 0.87 mmol, 1.2 eq.). The 
solution was allowed to warm to room temperature and the mixture left stirring 
overnight. Water (40 mL) was added and the mixture concentrated in vacuo to remove 
the tetrahydrofuran. The aqueous layer was extracted with dichloromethane (10 mL). 
Aqueous HCl (2 mol L-I) was added until the white precipitate dissolved. The mixture 
was extracted with dichloromethane (3 x 20 mL). The combined organic layers where 
dried (MgS04), filtered and concentrated in vacuo. The crude product was purified 
using radial chromatography, eluting with 80% petroleum ether/20% ethyl acetate. 
Yield of 48b: 151 mg, 0.53 mmol, 72%; yellow oil; IR (CDC13): 'Umax 2248 
(m), 1667 (s), 1597 (m), 1455 (m), 1288 (m) em-I; IH NMR (CDC13): 8 1.73 (3H, d, ] 
= 6.9 Hz), 4.60 (lH, q, ] = 6.9 Hz), 7.50 (2H, ddd, ] = 7.8, 7.3, 1.5 Hz), 7.62-7.72 (2H, 
m), 7.80 (IH, ddd, ] = 8.3, 6.8, 1.5 Hz), 7.95 (1H, dd, ] = 8.3, 1.4 Hz), 8.00 (2H, dd, ] 
= 8.8, 1.5 Hz), 8.12 (lH, d, ] = 8.8 Hz), 8.54 (1H, s); 13C NMR (CDC13): 8 21.74, 
27.54, 121.06, 127.51, 127.95, 128.40, 128.55, 128.68, 129.58, 129.70, 130.67, 130.95, 
133.92, 135.64, 135.79, 145.69, 194.06; rnlz [EI (70)J: 286.11069 (found), 286.11061 
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(calcd.); 286 (M+, 51 %), 257 (M+-CHO, 50%), 105 (C6HSCO+, 100%),77 (C6HS+, 
74%). 
3-Chloro-4-methyl-1-phenylbenzo[b ][1, 7]naphthyridine (53) 
CN 
ccx:": ": CH3 /./ ;-; 0 1\1 
Ph 
HCI 
6 mol L-1 
CI 
Ph 
2-Benzoyl-3-(1-cyanoethyl)quinoline (142 mg, 0.50 mmol) was dissolved in 
6 mol L-1 hydrochloric acid (40 mL) and the solution was refluxed for 4 hours. The 
resulting mixture was extracted with dichloromethane (2 x 10 mL). The combined 
organic layers were dried (MgS04), filtered and concentrated in vacuo to give the crude 
product, which was recrystallised from methanol. 
Yield of 53: 80 mg, 0.26 mmol, 53%; yellow needles; m.p. 195-199 DC; IR 
(CDCI3): Umax 1562 (m), 1506 (m), 1444 (m), 1406 (m), 1344 (m), 1033 (m) cm-1; lH 
NMR (CDCI3): 82.82 (3H, s), 7.53 (3H, m), 7.60 (1H, t, J = 7.8 Hz), 7.77 (lH, ddd, J 
= 8.3, 6.8, 1.5 Hz), 7.98 (1H, d, J = 8.3 Hz), 8.20 (1H, d, J = 8.8 Hz), 8.34 (2H, dd, J = 
7.5,1.6 Hz), 8.81 (lH, s); 13C NMR (CDCI3): 8 15.12,123.46, 127.75, 127.86, 127.94, 
128.18, 129.39, 130.01, 130.57, 130.71, 131.59, 131.71, 137.45, 140.79, 142.78, 
148.67, 158.99; mlz [EI (70)]: 304.07690 (found), 304.07673 (calcd.); 304 (M+, 74%), 
303 (M+-H, 59%), 268 (M+-HCI, 8%),143 (100%). 
Attempted preparation of 2-benzoyl-3-(1-carboxyethyl)quinoline (49b) 
CH3 
o;¢": ": CN /./ ;-; 0 N 
Ph 
.--------.,.. 
A 10% aqueous sulfuric acid solution (20 mL) was added to 2-benzoyl-3-
(1-cyanoethyl)quinoline (114 mg, 0.40 mmol) and the mixture refluxed for 28 hours. 
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The resulting mixture was added to water (210 mL) and then extracted with 
dichloromethane (3 x 30 mL). The combined organic layers were dried (MgS04), 
filtered and concentrated in vacuo. The crude product was purified using radial 
chromatography, eluting with 50% petroleum ether/50% ethyl acetate and then 
recrystallised from benzene/petroleum ether. 
Yield of unknown compound: 50 mg, 0.16 mmol, 41 %; orange glass; m.p. 61-
65°C; IR (CDCh): 'Umax 0 1756 (m), 1711 (s), 1671 (s), 1597 (m), 1454 (m), 1281 
. (m), 1177 (m) cm-1; IH NMR (CDCb): 0 1.60 (3H, d, J = 7.3 Hz), 4.16 (1H, q, J = 7.3 
Hz), 7.41 (2H, t, J = 7.8 Hz), 7.55 (1H, t, J = 7.8 Hz), 7.62 (1H, ddd, J = 8.3, 6.8, 1.5 
Hz), 7.73 (1H, ddd, J = 8.8, 6.8,1.5 Hz), 7.86 (lH, dd, J = 8.3, 1.5 Hz), 7.95 (2H, d, J = 
7.8 Hz), 8.07 (lH, d, J = 8.3 Hz), 8.29 (lH, s); 13C NMR (CDCh): 18.00, 40.20, 
127.47, 127.75, 127.95, 128.15, 128.84, 130.13, 130.77, 132.02, 133.68, 135.69, 
135.77,145.09,155.18,176.77,195.06; rnIz [EI (70)]: 305.10458 (found), 305.10519 
(caled.); 336 (28%), 305 (M+, 40%), 277 (M+-CO, 16%),260 (M+-C02H, 93%),232 
(M+-C02H, -CO, 85%),217 (M+-C02H, -CO, -CH3, 14%),200 (M+-C6H5CO, 13%), 
154 (M+-C02H, -C6H5CO, -H, 22%),105 (C6H5CO+, 79%), 77 (C6H5+, 100%). 
2-0xopentane-l,5-dioic acid (a-ketoglutaric acid)13 
Sodium (9.27 g, 0.4 mol, 1.0 eq.) was added in small portions to freshly dried 
ethanol (141 mL, 2.4 mol, 6 eq.) at a rate sufficient to keep the ethanol refluxing. 
External heating was required to dissolve the last portions of sodium. The excess 
ethanol was removed by distillation. The remaining ethanol was removed by azeotropic 
distillation with toluene. After cooling the sodium ethoxide formed, freshly dried ether 
(260 mL), diethyl oxalate (54 mL, 0.4 mol, 1.0 eq.) and diethyl succinate (66.5 mL, 0.4 
mol, 1.0 eq.) were added and the mixture stirred overnight. 
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The mixture was hydrolysed by the addition of water (200 mL), the layers 
separated and the ethereal layer washed with water (60 mL) and then discarded. The 
combined aqueous layers were acidified with conc. HCI (40 mL) and the layers 
separated. The aqueous layer was extracted with ether (2 x 60 mL), and the combined 
organic layers dried (MgS04), filtered, and concentrated in vacuo. 
Water (400 mL) and conc. HCI (200 mL) were added to the resulting oil and 
the mixture refluxed for 4 hours, becoming homogeneous. The solution was 
concentrated in vacuo to give the crude product, which was recrystallised from 
toluene/acetone. 
Yield of 2-oxopentane-1,5-dioic acid: 26.86 g, 184 mmol, 46%; white powder; 
m.p. 111-120 DC; IR (Nujol): umax 3506 (m), 2725 (m), 2660 (m), 1693 (br s), 1408 
(m), 1310 (m), 1290 (m), 1252 (m), 1202 (m), 914 (m) cm-I; IHNMR (CDCl}): 02.57 
(2H, t, J = 6.3 Hz), 3.09 (2H, t, J = 6.3 Hz). 
Attempted preparation of 2-carbomethoxy-3-( carbomethoxymethyl) quinoline (55) 
1) l\laOCH3 
.--------- ...... 
Sodium (920 mg, 0.040 mol, 3.0 eq.) was added in small portions to dry 
methanol (60 mL). Once all of the sodium had reacted, 2-oxopentane-1,5-dioic acid 
(2.13 g, 0.015 mol, 1.1 eq.) and 2-aminobenzaldehyde (1.61 g, 0.013 mol, 1.0 eq.) were 
added and the solution heated under reflux overnight. After cooling, conc. H2S04 
(2.2 mL, 0.040 mol) was cautiously added and the resultant solution heated under 
reflux for a further 24 hours. The mixture was neutralised by the addition of saturated 
aqueous NaHC03 (20 mL). Saturated aqueous NaCI (50 mL) was added and the 
mixture was extracted with dichloromethane (100 mL, 3 x 50 mL). The combined 
organic extracts were dried (MgS04), filtered and concentrated in vacuo. The crude 
mixture of products was separated into its components using radial silica 
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chromatography, gradient eluting with petroleum ether/ethy I acetate. The products 
were examined with IH NMR, UV and mass spectroscopy. These spectra were not 
consistent with those expected of the required product. 
DimethyI2-oxopentane-l,5-dioate (dimethyl a-ketoglutarate) 
HCI(g) 
• 
A solution of 2-oxopentane-l ,5-dioic acid (524 mg, 3.6 mmol) in dry methanol 
(5 rnL) was saturated with hydrogen chloride gas. The solution was refluxed overnight 
and then concentrated in vacuo. 50% NaHC03 solution (5 mL) was added to the 
residue and the product extracted with dichloromethane (3 x 3 rnL). The combined 
organic layers were dried (MgS04), filtered and concentrated in vacuo. The crude 
product was purified using radial silica chromatography, eluting with 50% petroleum 
etherl50% ethyl acetate. 
Yield of dimethyl 2-oxopentane-1,5-dioate: 101 mg, 0.58 mmol, 16%; 
colourless oil; IH NMR (CDCI3): 02.66 (2H, t, J = 6.4 Hz), 3.15 (2H, t, J = 6.4 Hz), 
3.67 (3H, s), 3.87 (3H, s) (lit.l4 (CC14): 02.43 (2H, t, J = 5 Hz), 2.92 (2H, t, J = 5 Hz), 
3.42 (3H, s), 3.60 (3H, s)). 
Attempted preparation of 2-carbomethoxy-3-( carbomethoxymethyl)quinoline (55) 
Sodium (25 mg, 1.09 mmol, 3.0 eq.) was added in small portions to dry 
methanol (2.5 mL). Once all of the sodium had reacted, dimethyl 2-oxopentane-
1,5-dioate (79 mg, 0.45 mmol, 1.2 eq.) and 2-aminobenzaldehyde (46 mg, 0.38 mmol, 
1.0 eq.) were added and the solution heated under reflux overnight. More 
2-aminobenzaldehyde (46 mg, 0.38 mmol, 1.0 eq.) in methanol (0.5 mL) was added. 
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The solution was heated under reflux for another 24 hours. The mixture was poured 
into water (5 mL) and was extracted with dichloromethane (4 x 5 mL). The combined 
organic extracts were dried (MgS04), filtered and concentrated in vacuo. The crude 
mixture of products was separated into its components using radial silica 
chromatography, gradient eluting with petroleum ether/ethyl acetate. The products 
were examined with 1 H NMR, UV and mass spectroscopy. These spectra were not 
consistent with those expected of the required product. 
7.10. Preparation of 1-methylpyrano[3,4-b]indol-3-one (56)15 
Freshly distilled boron trifluoride ether ate (2 mL, 16.3 mmol, 1.4 eq.) was 
added in four portions over 1 hour to a stirred solution of indol-3-ylacetic acid (2.10 g, 
12 mmol, 1.0 eq.) in acetic anhydride (4.6 mL, 48 mmol, 4 eq.) at 0 DC. The mixture 
was allowed to warm to room temperature and stirred for a further 30 minutes. Ether 
(50 mL) was added and the orange solid filtered off, washed with ether (50 mL), 
triturated with aqueous NaHC03 (half saturated, 2 x 50 mL), washed with water (3 x 
40 mL) and dried in vacuo. 
Yield of 56: 1.49 g, 7.48 mmol, 62%; orange powder; m.p. 245 DC (d. 235 DC); 
IH NMR (d6-DMSO): 02.60 (3H, s), 6.64 OH, s), 7.11 (IH, t, J = 7.8 Hz), 7.32 (lH, d, 
J = 8.3 Hz), 7.62 (lH, t, J = 8.3 Hz), 8.08 OH, d, J = 7.8 Hz), 10.57 (lH, br s). 
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(CH3CObO I CH 
00..CH3 3 
To a cooled suspension of sodium hydride (385 mg of a 50% mixture of 
sodium hydride in parafin oil, 8.0 mmol, 5 eq., washed three 3 times with petroleum 
ether) in dimethylformamide (14 rnL) was added a suspension of I-methylpyrano-
[3,4-bJindol-3-one (308 mg, 1.6 mmol, 1.0 eq.) in dimethylformamide (19 rnL). The 
mixture was stirred in an ice bath for 10 minutes and then freshly distilled acetic 
anhydride (0.35 rnL, 3.7 rnmol, 2.3 eq.) was added and the mixture stirred for a further 
20 minutes. Water (25 mL) was slowly added, followed by saturated aqueous NaHC03 
(25 mL). Brine (250 mL) and ether (50 mL) were added and the aqueous layer 
extracted with ether (5 x 50 mL). The combined organic layers were washed with brine 
(50 mL), dried (NaS04), filtered and concentrated in vacuo. The crude product was 
recrystallised from ethanol. 
Yield of 57: 119 mg, 0.49 mmol, 32%; orange crystals; m.p. 166-168 °C; IH 
NMR (CDCh): 8 2.51 (3H, s), 2.66 (3H, s), 6.44 (1H, d, J = 0.9 Hz), 7.37 (1H, t, J = 
7.8 Hz), 7.63 (1H, t, J = 8.3 Hz), 7.74 (1H, d, 8.3 Hz), 7.84 OH, d, 7.8 Hz). 
7.12. Diels-Alder reaction between 1,1-bis(methylthio)ethene 
(19) and 1-methylpyrano[3,4-b]indol-3-one (56) 
l-Methyl-3-methylthiocarbazoIe (58) 
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1-Methylpyrano[3,4-bJindol-3-one (40 mg, 0.20 mmol, 1.0 eq.) and 
1,1-bis(methylthio)ethene (72 mg, 0.60 mmol, 3.0 eq.) were dissolved in 
bromobenzene (10 mL). The solution was heated at 120°C under nitrogen for 4.5 days 
and then concentrated in vacuo. An 1 H NMR spectrum of the crude reaction mixture 
showed that the reaction was 50% complete. The reaction was stopped at this stage and 
the product purified using radial chromatography, eluting with ether. Some starting 
material (13 mg, 33%) was recovered. 
Yield of 58: 11 mg, 0.05 mmol, 24%; b~own oil; IR (CDCh): umax 3473 (m), 
2924 (w), 1603 (w), 1491 (m), 1478 (m), 1439 (m) cm- I ; IH NMR (CDCh): 82.54 
(3R, s), 2.56 (3H, s), 7.20-7.28 (2H, m), 7.38-7.47 (2H, m), 7.93 (1H, s), 8.04 OH, d, J 
= 7.3 Hz), 8.08 (lH, br s); (d6-DMSO): 82.62 (3H, s), 2.63 (3H, s), 7.24 OR, ddd, J = 
8.3,7.8, 1.0 Hz), 7.30 OH, dd, J = 1.0, 1.9 Hz), 7.47 (lH, ddd, J = 8.3, 7.3, 1.5 Hz), 
7.59 (lH, d, J = 7.3 Hz), 8.04 (lH, d, J = 1.9 Hz), 8.20 OH, d, 7.8 Hz), 11.31 (lH, br 
s); l3C NMR (CDC13): 0 16.79, 18.98, 110.81, 118.93, 119.68, 120.41,120.51,123.19, 
123.57, 126.00, 127.57, 128.28, 137.65, 139.66; mJz [EI (70)]: 227.0770 (found), 
227.07687 (calcd.); 227 (M+, 100%),212 (M+-CH3, 83%), 180 (M+-SCR3, 9%), 167 
(M+-C2H4S,20%). 
7 .13. Diels~Alder reaction between 1, 1-bis(methylthio )ethene 
(19) and 9-acetyl..;1-methylpyrano[3,4-b]indol-3-one (57) 
9-Acetyl-l-methyl-3-methylthiocarbazole (59) 
eyyo -:?" -:?" S C H I I 3 ~ N ~ 0 + CH2=q 
I . CH SCH3 
oACH3 3 
9-Acetyl-1-methylpyrano[3,4-b]indol-3-one (50 mg, 0.21 mmol, 1.0 eq.) and 
1,1-bis(methylthio)ethene (62 mg, 0.52 mmol, 2.5 eq.) were dissolved in 
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bromobenzene (8 mL). The solution was heated at 120°C under nitrogen for 14 days 
and then concentrated in vacuo. An IH NMR spectrum of the crude reaction mixture 
showed that the reaction was 15% complete. The reaction was stopped at this stage and 
the product purified using radial chromatography, eluting with 90% petroleum 
ether/lO% ethyl acetate. Some starting material (40 mg, 80%) was recovered. 
Yield of 59: 8 mg, 0.03 mmol, 14%; yellow oil; IR (CDCb): U max 2926 (w), 
1702 (s), 1478 (m), 1431 (rn), 1366 (rn), 1284 (s) em-I; IH NMR (d6-acetone): 02.56 
(3H, s), 2.71 (3H, s), 2.90 (3H, s), 7.38 (lH, dd, 1. = 1.9, 1.0 Hz), 7.50 (lH, ddd, J = 7.3, 
7.3, 1.0 Hz), 7.62 OH, ddd, J = 8.6,7.3, 1.5 Hz), 8.03 (lH, d, J = 2.0 Hz), 8.10 OH, dd, 
J == 8.3, 1.0 Hz), 8.26 (1H, dd, J = 8.1, 1.3 Hz); 13C NMR (CDCl3): 0 17 .12, 21.29, 
27.04,114.48,116.15,120.11,123.43,125.29,127.04, 127.37, 128.21, 129.03, 129.59, 
133.69, 139.97, 170.57; m/z [EI (70)J: 269.0877 (found), 269.08743 (caled.); 269 (M+, 
56%), 227 (M+-COCH2, 100%), 212 (M+-COCH2, -CH3, 64%), 167 (M+-COCH2, 
-C2H4S, 19%). 
7.14. Attempted Diels-Alder between 1,1-bis(methylthio)ethene 
(19) and cyclopentadiene 
- --- ...... 
1,1-Bis(rnethylthio)ethene (1 drop) was added to freshly distilled 
cyclopentadiene (3 drops) in CDCl3 (0.7 mL). The solution was heated at 55 DC and 
monitored by I H NMR. The dimerisation of cyclopentadiene was complete after six 
days, with no other product being observed. 
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7.15. Thermal decomposition of 1, 1-bis(methylthio)ethene 
Diels-Alder adducts (28 and 42) 
MethyI4-(methylthio)benzoate (63), methyI4,6-bis(methylthio)-1,3-
cyclohexadienoate (62) and methyI2-oxo-2H-pyran-5-ylcarboxylate (25) 
7,7-Bis(methylthio)-3-carbomethoxy-5-oxabicyclo[2.2.2]oct-2-en-6-one 
131 
(10 mg, 0.04 mmol) was heated neat under nitrogen at 145 DC for 17 hours. The 
resulting mixture was separated into its components using radial silica chromatography. 
63 was obtained when rhe silica was eluted with 90% petroleum etherllO% ethyl 
acetate. 62 and 25 were obtained when the silica was eluted with 80% petroleum 
ether/20% ethyl acetate. 
Yield of 63: 1 mg, 0.01 mmol, 15%; white crystals; m.p. 78-80 DC; IR 
(CDC!]): umax 1717 (s), 1596 (w), 1560 (w), 1437 (w), 1289 (m) cm- 1; lH NMR 
(CDC13): (5 2.52 (3H, s), 3.90 (3H, s), 7.25 (2H, dd, J = 6.8, 1.9 Hz), 7.94 (2H, dd, J = 
6.8, 1.9 Hz); 13C NMR (CDC13): (5 14.82, 52.02, 124.90, 126.25, 129.87, 145.40, 
166.86; mlz [EI (70)]: 182.0402 (found), 182.04015 (caled.); 182 (M+, 100%), 152 
(M+-OCH2, 16%),123 (M+·C02CH3, 17%), 108 (M+-C02CH3, -CH3, 21 %). 
Yield of 62: 2 mg, 0.01 mmol, 24%; yellow oil; IR (CDC13): umax 1700 (s), 
1540 (s), 1437 (w), 1282 (m), 1243 (m), 1090 (m) cm- i ; UV (cyclohexane): Amax 342 
(£ = 9610) nm; lH NMR (CDC13): (52.08 (3H, s), 2.36 (3H, s), 2.62 (1H, dd, J = 17.6, 
1.5 Hz), 2.98 OH, ddd, J = 17.6,7.3,2.4 Hz), 3.79 (3H, s), 4.01 (lH, dd, J = 7.3, 1.5 
Hz), 5.72 (1H, dd, J::: 6.4, 2.4 Hz), 7.16 (lH, d, J = 6.4 Hz); l3C NMR (CDC!]): (5 
13.72, 14.31, 36.06, 38.23, 51.76, 112.24, 122.42, 133.64, 145.39, 166.87; mlz [EI 
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(70)]: 230.0438 (found), 230.04352 (calcd.); 230 (M+, 9%), 182 (M+-CH3SH, 100%), 
152 (M+-SCH3, -OCH3, 14%), 124 (M+-SCH3, -C02CH3, 32%). 
Yield of 25: 0.4 mg, 0.003 mmol, 8%; The product had the same spectral 
properties as described previously (Section 7.3). 
l-Methyl-2-methylthio-4-phenylnaphthalene (86) 
11, II-Bis(methylthio)-I-methyl-9-oxa-8-phenyltricyclo[6.2.2.02,7]dodec-
2,4,6-trien-l0-one (10 mg, 0.03 mmol) was heated neat under nitrogen at 145 DC for 20 
days. The resulting mixture was purified using radial chromatography, eluting with 
90% petroleum etherllO% ethyl acetate. 
Yield of 86: 5 mg, 0.02 mmol, 61 %; colourless oil; lR (CDCl3): u max 3676 
(m), 3064 (w), 2926 (w), 1718 (m), 1602 (m), 1560 (m) em-I; IH NNIR (CDCl3): 8 
2.54 (3H, s, SCH3), 2.81 (3H, s, Ar-CH3), 7.35-7.56 (8H, m), 7.83 (1H, d, J = 7.8 Hz), 
8.07 (lH, d, J = 7.3 Hz); 13C NMR (CDCb): 815.64, 16.86, 124.04, 125.03, 125.74, 
126.30, 126.67, 127.30, 128.26, 129.89, 130.13, 131.47, 132.96, 133.67, 138.92, 
140.57; rnJz [El (70)]: 264.0975 (found), 264.09727 (calcd.); 264 (M+, 100%), 249 
(M+-CH3, 27%), 234 (M+-CH3, -CH3, 20%),217 (M+-SCH3, 16%),215 (32%),202 
(M+·SCH3, -CH3, 17%). 
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7.16. Attempted preparation of 5-phenyl-2-pyranone (79) 
1,1,1,3-Tetrachloro-3-ethoxypropane 17 
CCI4 + r-OEt 
A solution of benzoyl peroxide (20 mg, 0.08 mmol, 0.002 eq.) and pyridine 
(10.6 ,uL, 0.13 mmol, 0.003 eq.) in dry ethyl vinyl ether (5 mL, 0.052 mol, 1.0 eq.) was 
added dropwise to a solution of pyridine (10.6~, 0.13 mmol, 0.003 eq.) in dry carbon 
tetrachloride (11.6 mL, 0.157 mol, 3.0 eq.) over two hours. The colourless solution was 
then refluxed for 1 hour. The excess carbon tetrachloride was removed under vacuum 
and the crude product was vacuum distilled. 
Yield of 1,1, 1,3-tetrachloro-3-ethoxypropane: 5.44 g, 24.08 mmol, 46%; 
colourless oil; b.p. 98-99 °C/19 mmHg; IH NMR (CDCI3): 15 1.27 (3H, d, J =: 7.3 Hz), 
3.39 (lH, dd, J =: 15.1, 2.6 Hz), 3.50 (1H, dd, J =: 15.1,7.3 Hz), 3.62 (1H, dq, J = 9.3, 









CI CI CI H 
1,1,1,3-Tetrachloro-3-ethoxypropane (2.92 g, 12.9 mmol) was heated neat at 
130-150 °C for 1.5 hours, by which stage the evolution of HCI had ceased. The reaction 
mixture was vacuum distilled resulting in a mixture of products, including 
1,1,3-trichloro-3-ethoxy-1-propene and 3,3-dichloropropenal. This mixture was used in 
the following reaction without further purification. 
Yield of product mixture: 2.3 g, 12.14 mmol, 94%; colourless oil; b.p. 100 
°C/19 mmHg; 50% 1,1,3-Trichloro-3-ethoxy-1-propene: 1 H NMR (CDCI3): 15 1.25 
(3H, t, J =: 7.3 Hz), 3.53 (lH, dq, J = 8.7, 7.3 Hz), 3.61 (1H, dq, J = 8.7, 7.3 Hz), 6.20 
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OH, d, J = 7.8 Hz), 6.25 (IH, d, J = 7.8 Hz); GCMS mlz [El (70)]: 153 (M+-CI, 57%), 
143 (M+-OCH2CH3, 12%), 125 (M+ H-CH2CH3, -CI, 100%). 33% 
3,3-Dichloropropenal: lH NMR (CDCI3): 6 6.42 OH, d, J = 6.3 Hz), 9.85 (1H, d, J = 
6.3 Hz); GCMS mlz [El (70)]: 124 (M+, 55%), 123 (M+-H, 82%),96 (M+-CO, 38%), 
61 (C2H2Cl+, 84%),60 (C2HCI+, 100%). 
5,5-Dichloro-2-phenyl-2,4-pentadienal (78) 19 
CI'-../~PEt Ph 
r T + < 
CI CI CHO 
- --- ---- -.... 
CI\ ;==<.Ph )=I CHO 
Cl 
To an ice cold solution of phenylacetaldehyde (1.06 mL, 9.0 mmol, 1.0 eq.) in 
glacial acetic acid (1.5 mL) was added an ice cold solution of 1,1,3-trichloro-3-ethoxy-
I-propene (2.05 g, 10.8 mmol, 1.2 eq.) in glacial acetic acid (2.2 mL). Water (0.24 mL) 
was added and two layers formed. The reaction mixture was kept in a refrigerator for 
2.5 days. The reaction mixture was poured into ice water (40 mL). The oil that 
separated was removed and the aqueous layer wa<; extracted with ether (2 x 10 mL). 
The combined organic layers were washed with saturated aqueous NaHC03 (2 x 
20 mL), washed with water (10 mL), dried (NaS04) and filtered. The ether was 
removed by distillation at atmospheric pressure. Only a small amount of 78 was ever 
observed by lH NMR. 
2,3-Dibromobutan-l,4-dioic acid (dibromosuccinic acid)20 
Water (200 mL) containing fumaric acid (100 g, 0.86 mol, 1.0 eq.) was heated 
to boiling in a flask connected to a double surface condenser, a dropping funnel and a 
mechanical stirrer. Bromine (45 mL, 0.87 mol, 1.01 eq.) was added slowly over 40 
minutes. The mixture was refluxed for a further 20 minutes and cooled in an ice bath. 
The product was collected by vacuum filtration and washed with cold water until the 
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filtrate was colourless. The product was dried overnight at room temperature. No 
further purification was required. 
Yield of 2,3-dibromobutan-1,4-dioic acid: 182.9 g, 0.66 mol, 77%; white 
crystals; m.p. 273-275 °C (sublimes); IH NMR (d6-DMSO): 04.63 (2H, s). 
Propynoic acid (propiolic acid)21 
1) KOH, EtOH 2) H2S04 III 
3) 11, H20 C02H C02-K+ 
II 
Dibromosuccinic acid (183 g, 0.66 mol, 1.0 eq.) was dissolved in hot ethanol 
(480 mL) and then allowed to cool. A solution of potassium hydroxide (85%, 200 g, 
3.03 mol, 4.6 eq.) in ethanol (700 mL) was added slowly, keeping the temperature of 
the stirred solution less than 40 0c, The mixture was then refluxed for one hour, cooled 
in an ice bath and the precipitate formed filtered and washed twice with ethanol. The 
potassium salt was dissolved in water (700 rnL) and cold 3 mol L-1 H2S04 (165 rnL) 
was added. The mixture was left stirring overnight and the precipitate fonned filtered 
and heated in water (430 rnL) at 95 °C for 1 hour. By this stage the precipitate had 
dissolved and the solution was refluxed for 1.5 hours, cooled, acidified (cone. RCI), 
saturated with ammonium chloride and extracted with ether (150 mL, 12 x 100 rnL). 
The combined organic layers were dried (MgS04), filtered and concentrated in vacuo. 
The crude product was vacuum distilled. 
Yield of propynoic acid: 11.17 g, 0.159 mol, 24%; colourless oil; b. p. 60-64 
°C/20 mmHg; lR NMR (CDC13): 03.00 (lR, s). 
(Z)-3-Chloropropenoic acid (cis-3-chloroacrylic acid)22 
HC! 
-CuC! 
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Propynoic acid (11.1 g, 0.158 mol, 1.0 eq.) was added over 25 minutes to a 
stirred solution of freshly prepared copper(I) chloride (1.0 g, 0.01 mol, 0.06 eq.) in 
concentrated HCI (27 rnL). The solution was cooled in an ice bath during addition, 
keeping the temperature below 12 DC. The solution was stored overnight at 0 DC. The 
crystals formed were extracted with dichloromethane (3 x 25 mL). The combined 
organic layers were washed with 2 mol L- 1 HCI (20 mL), dried (MgS04), filtered and 
concentrated in vacuo. 
Yield of (Z)-3-chloropropenoic acid: 11: 11 g, 0.104 mol, 66%; white crystals; 
m.p. 58-60 DC; lR NMR (CDCI3): 86.23 (lH, d, J = 8.3 Hz), 6.84 (1R, d, J = 8.3 Hz). 
Methyl (Z)-3-chloropropenoate (methyl cis-3-chloroacrylate) (80)23 
A solution of (Z)-3-chloropropenoic acid (11.1 g, 0.104 mol) and concentrated 
H2S04 (2.2 mL) in freshly dried methanol (120 rnL) was refluxed overnight. The 
solution was then poured into ice water (200 mL) and extracted with ether (100 mL, 4 x 
50 mL). The combined organic layers were dried (MgS04), filtered and concentrated in 
vacuo. The crude product was purified by vacuum distillation. 
Yield of 80: 6.76 g, 0.056 mol, 54%; colourless oil; b.p. 52-55 DC120 mmHg; 
lH NMR (CDCI3): 83.75 (3H, s), 6.19 (1H, d, J = 8.3 Hz), 6.70 (1H, d, J = 8.3 Hz). 
Methyll,l-his( carboethoxy )-1-phenyl-2-hutenoate24 
Sufficient sodium hydride (50% in oil) was washed with petroleum ether (3 x) 
to give 946 mg (39 mmol, 1.2 eq.) of clean reagent. Tetrahydrofuran (40 rnL) was 
added and the mixture stirred under nitrogen. Diethyl phenyl malonate (7.09 mL, 
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33 mmol, 1.0 eq.) was slowly added. After gas evolution had ceased, the solution 
became homogeneous. Methyl (Z)-3-chloro-2-propenoate (3.4 mL, 33 mmol, 1.0 eq.) 
was added and the solution refluxed overnight. The mixture was cooled and quenched 
with water (80 mL) and extracted with ether (3 x 40 mL). The combined organic layers 
were washed with saturated sodium chloride (40 mL), dried (MgS04), filtered and 
concentrated in vacuo. 
Yield of methyl 1,1-bis(carboethoxy)-1-phenyl-2-butenoate: 9.39 g, 0.029 
mol, 89%; pale orange oil; lH NMR (CDCl}): 8 ).22 (6H, t, J = 7.3 Hz), 3.58 (3H, s), 
4.21 (4H, q, J = 7.3 Hz), 6.13 (lH, d, J = 12.2 Hz), 6.94 (lH, d, J = 12.2 Hz), 7.26-7.37 
(3H, m), 7.49 (2H, dd, J = 8.3, 2.0 Hz). 
2-Phenyl-2-penten-1,5-dioic acid (2-phenylglutaconic acid) (81)24 
Sodium hydroxide (6.1 g, 0.152 mol, 5.2 eq.) in water (50 mL) was added to 
methy11,1-bis(carboethoxy)-1-phenyl-2-butenoate (9.39 g, 0.029 mol, 1.0 eq.) and the 
mixture refluxed overnight. The cooled solution was then washed with ether (20 mL) 
and acidified with cone. HCI causing the evolution of C02. The product was extracted 
with ether (40 mL, 2 x 20 mL). The combined organic layers were dried (MgS04) , 
filtered and concentrated in vacuo to give the product as a mixture of stereoisomers. 
Yield of 81: 6.05 g, 29.34 mmol, 100%; cream coloured solid; m.p. 166-
168°C; IH NMR (d6-DMSO) E-isomer: 83.17 (2H, d, J = 7.3 Hz), 7.19 (lH, t, J = 7.3 
Hz), 7.26 (2H, dd, J = 7.8, 1.5 Hz), 7.36-7.51 (3H, m); Z-isomer: 83.56 (2H, d, J = 7.3 
Hz), 6.43 (lH, t, J = 7.3 Hz), 7.36-7.51 (5H, m). 
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3-Phenyl-6-chloro-2-pyranone (82)24 
CH3COCI lt O Ly6 
CI 
2-Phenylpent-2-en-1,5-dioic acid (6.05 g, 0.029 mol, 1.0 eq.) and acetyl 
chloride (41.9 mL, 0.588 mol, 20 eq.) were combined in a sealed tube and heated at 
100 DC overnight. The tube was cooled, opened and the excess acetyl chloride removed 
in vacuo. The residue was quenched with water (80 mL), and extracted with 
dichloromethane (3 x 40 mL). The combined organic layers were dried (MgS04), 
filtered and concentrated in vacuo. The product was separated from the crude mixture 
using radial chromatography eluted with 50% petroleum ether/50% dichloromethane. 
The product can be recrystallised from toluene/petroleum ether. 
Yield of 82: 402 mg, 1.95 mmol, 7%; orange needles; m.p. 101-102 DC; IH 
NMR (CDCl3): 06.33 (lH, d, J = 6.8 Hz), 7.36-7.43 (3H, m), 7.42 (lH, d, J = 6.8 Hz), 







3-Phenyl-6-chloro-2-pyranone (65 mg, 0.32 mmol, 1.0 eq.) and zinc dust 
(310 mg, 4.7 mmol, 15.0 eq.) were dried under vacuum. Tetrahydrofuran (1.5 mL) and 
acetic acid (1.5 mL) were added and the mixture stirred overnight at room temperature 
under nitrogen. Ether (15 mL) was added and the resulting mixture was filtered 
followed by ether washings (2 x 2 mL). The filtrate was concentrated in vacuo. Water 
was added and the mixture extracted with dichloromethane (3 x 2 mL). The combined 
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organic layers where dried (MgS04), filtered and concentrated in vacuo to give the 
crude product which can be recrystallised from toluene/petroleum ether. 
Yield of 84: 37 mg, 0.21 mmol, 68%; yellow needles; m.p. 102-105 °C; lH 
NMR (CDC13): (; 6.33 (lH, dd, J = 6.8, 4.9 Hz), 7.35-7.40 (3H, m), 7.42 (lH, dd, J = 
6.8, 1.9 Hz), 7.49 (lR, dd, J = 5.4, 1.9 Hz), 7.63 (2H, dd, J = 7.8, 1.5 Hz). 
7.17. Preparation of 1-methylthio~17(P"tolylsulfonyl)ethene (87) 
l-CMethylthio)phenacyl p-tolyl sulfone (89)25 
NaH 
Sufficient sodium hydride (50% in oil) was washed with petroleum ether (3 
times) to give 82 mg (3.42 mmol, 5.7 eq.) of clean reagent. Dry tetrahydrofuran (1 mL) 
was added and the mixture stirred under nitrogen at 0 °C. Methylthiomethyl p-tolyl 
sulfone (130 mg, 0.60 mmol, 1.0 eq.) in tetrahydrofuran (4 mL) was added and the 
mixture stirred for 15 minutes. Phenyl benzoate (179 mg, 0.90 mmol, 1.5 eq.) in 
tetrahydrofuran (2 mL) was added and the mixture stirred at the same temperature for 1 
hour and then refluxed for 2 hours. The reaction was quenched by adding water (5 mL). 
The product was extracted with dichloromethane (3 x 5 mL) and the combined organic 
layers were washed with aqueous N aOH (2 mol L- 1, 4 mL), dried (MgS04), filtered 
and concentrated in vacuo to give the product. 
Yield of 89: 82 mg, 0.26 mmol, 43%; yellow oil; lH NMR (CDC13): (; 2.26 
(3H, s), 2.43 (3R, s), 5.48 OH, s), 7.33 (2H, d, J = 7.9 Hz), 7.47 (2H, t, J = 7.8 Hz), 
7.60 (1H, t, J = 7.3 Hz), 7.86 (2R, d, J = 8.3 Hz), 7.93 (2H, d, J = 8.7 Hz). 
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n-Butyllithium (17.6 mL of 1.6 mol L-1 solution in hexanes, 28.2 mmol, 
1.15 eq.) was added to a solution (stirred under nitrogen) of methylthiomethyl p-tolyl 
sulfone (5.31 g, 24.5 mmol, 1.0 eq.) in dry tetrahydrofuran (60 mL) at -78 DC. The 
solution was stirred at -78 DC for 30 minutes then at room temperature for 3 hours. The 
solution was then cooled to -78 DC again and iodomethane (3.1 mL, 49 mmol, 2.0 eq.) 
was added. The solution was stirred for a further 30 minutes at -78 DC and then 
overnight at room temperature. Water (50 mL) was added and the mixture concentrated 
in vacuo to remove the tetrahydrofuran. The mixture was extracted with 
dichloromethane (50 mL, 2 x 25 mL) and the combined organic layers were dried 
(MgS04), filtered and concentrated in vacuo to give the crude product. 
Yield of 91: 5.53 g, 24.01 mmol, 98%; pale yellow oil; IH NMR (CDCb): (5 
1.52 (3H, d, J = 7.3 Hz), 2.27 (3R, s), 2.44 (3H, s), 3.84 (lH, q, J = 7.3 Hz), 7.34 (2H, 
d, J = 8.3 Hz), 7.80 (2H, d, J = 8.3 Hz). 
l-Chloro-l-(methylthio )ethylp-tolyl sulfone (92)26 
l-(Methylthio)ethyl p-tolyl sulfone (5.46 g, 23.7 mmol, 1.0 eq.) was dried 
under vacuum and dissolved in dry chlorofoffil (60 mL). The solution was cooled to 
o DC and sulfuryl chloride (2.1 mL, 26.1 mmol, 1.1 eq.) added dropwise. The solution 
was stirred at this temperature for 2 hours and then at room temperature for a further 
2 hours. The mixture was washed with water (50 mL, 25 mL) and the combined 
aqueous layers were extracted with dichloromethane (2 x 25 mL). The combined 
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organic layers where dried (MgS04), filtered and concentrated in vacuo to give the 
crude product. 
Yield of 92: 6.19 g, 23.38 mmol, 99%; pale yellow oil; IH NMR (CDCl3): 0 
1.99 (3H, s), 2.45 (3H, s), 2.47 (3H, s), 7.34 (2H, d, J = 8.3 Hz), 7.86 (2H, d, J = 8.3 
Hz). 
1 ~MethyIthio-l-(p ~ tolyIsulfonyl)ethene (87) 
-
neat 
1-Chloro-1-(methylthio)ethyl p-tolyl sulfone (6.34 g, 23.9 mmol) was heated 
neat at 90°C· for 5 hours. The resulting crude product was purified by vacuum 
distillation (155 °CIO.5 mmHg). Ether (7 mL) was added to the distillate and the 
solution kept in a freezer overnight. The resulting crystals were collected by vacuum 
filtration. 
Yield of 87: 1.1 g, 4.84 mmol, 20%; white platelets; m.p. 82-85 °C; IR 
(CDCb): Umax 1917 (w), 1597 (m), 1319 (s), 1157 (s) em-I; IH NMR (CDCb): 82.27 
(3H, s), 2,41 (3H, s), 5.64 (lH, d, J = 1.9 Hz), 6.53 (lH, d, J = 1.9 Hz), 7.31 (2H, d, J = 
7.8 Hz), 7.80 (2H, d, J = 7.8 Hz); l3C NMR (CDC13): 0 17.04,21.61, 121.24, 128.44, 
129.65, l35.76, 144.80, 150.06; rnJz [EI (70)]: 228.02767 (found), 228.02788 (caled.); 
228 (M+, 15%), 139 (Tol-SO+, 33%),91 (Tol+, 39%), 73 (M+-S02Tol, 100%). 
Anal. Caled. for ClOH1202S2: C, 52.60; H, 5.30; S, 28.08. Found: C, 52.37; H, 
5,41; S, 27.78 %. 
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7.18. Diels-Alder reaction between 1-methylthio-1-(p-
tolylsulfonyl)ethene (87) and methyl coumalate (25) 
Methy14-(methylthio)benzoate (63) 
142 
Methyl-2-oxo-2H-pyrano-5-carboxylate (46 mg, 0.30 mmol, 1.0 eq.) and 
1-methylthio-l-(p-tolylsulfonyl)ethene (137 mg, 0.60 mmol, 2.0 eq.) were dissolved in 
, 
toluene (12 mL). The solution was refluxed under nitrogen for 5.5 days and then 
concentrated in vacuo. The reaction mixture was separated into its components by 
radial silica chromatography. 
Yield of 63: 4 mg, 0.02 mmol, 7%; The product had the same spectral 
properties as described previously (Section 7.15). 
7.19. Diels-Alder reaction between 1-methylthio-1-
(p-tolylsulfonyl)ethene (87) and methyl 4,6-
dimethylcoumalate (26) 
Methy12,6-dimethyl-4-(methylthio ) benzoate (31) 
-ToIS02H 
-C02 
MethyI4,6-dimethyl-2-oxo-2H-pyrano-5-carboxylate (55 mg, 0.30 mmol, 
1.0 eq.) and I-methylthio-l-(p-tolylsulfonyl)ethene (137 mg, 0.60 mmol, 2.0 eq.) were 
dissolved in toluene (12 mL). The solution was refluxed under nitrogen for 9 days and 
then concentrated in vacuo. The reaction mixture was separated into its components by 
radial silica chromatography. 
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Yield of 31: 0.6 mg, 0.003 mmol, 1%; The product had the same spectral 
properties as described previously (Section 7.6). 
7.20. Diels-Alder reaction between 1-methylthio-1 ... (p-
tolylsu Ifonyl)ethene (87) and 4-methyl-1-phenyl-3H-2-
benzopyran-3-one (40) 
I-Methyl-2-methylthio-4-phenyJnaphthalene (86) and I-methyl-3-methylthio-4-
phenylnaphthalene (93) 




- ToIS02H o¢r-::?' SCH3 
CO .. ..... "- I 
- 2 " " 
Ph 
2-Benzoylphenylpropanoic acid (41 mg, 0.16 mmol, 1.0 eq.) was dissolved in 
cone. H2S04 (0.16 mL) with gentle warming to give an orange solution. Water (20 mL) 
was added to produce a deep red precipitate which was extracted with ethyl acetate (2 x 
15 mL). The combined organic layers were dried (MgS04), filtered and concentrated in 
vacuo to about 10 mL. Toluene (15 mL) was added and the solution again concentrated 
to about 10 mL. This process was repeated to remove any remaining ethyl acetate. The 
final volume was 12 mL. 1-Methylthio-l-(p-tolylsulfonyl)ethene (110 mg, 0.48 mmol, 
3.0 eq.) was added and the red solution was refluxed under nitrogen for 20 hours. By 
this stage the solution was pale yellow in colour and so was concentrated in vacuo and 
separated into its components by radial silica chromatography. The two regioisomers 
were collected when the silica was eluted with 90% petroleum etherllO% ethyl acetate. 
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Yield of 86: 5 mg, 0.02 mmol, 12%; The product had the same spectral 
properties as described previously (Section 7.15). 
Yield of 93: 11 mg, 0.04 mrnol, 26%; pale yellow oil; IR (CDCb): U max 3062 
(m), 2982 (m), 2926 (m), 1717 (w), 1601 (m), 1587 (s), 1556(m), 1508 (m), 1443 (s) 
cm- I ; IH NMR (CDC13): 0 2.45 (3H, s, SCH3), 2.77 (3H, s, Ar-CH3), 7.35 (IH, s), 
7.31-7.56 (8H, m), 7.99 (IH, d, J = 8.3 Hz); 13C NMR (CDCb): 0 16.29, 19.68, 
123.94, 124.05, 124.82, 126.13, 126.24, 127.57, 128.42, 130.38, 130.63, 132.92, 
134.04, 134.49, 135.63, 138.72; m1z [EI (70)J: 264.09713 (found), 264.09727 (caled.); 
264 (M+, 100%), 249 (M+-CH3, 17%), 234 (M+-CH3, -CH3, 83%), 215 (M+-SCHS, 
30%),202 (M+-CH3, -SCH3, 23%). 
7.21. Diels-Alder reaction between 1-methylthio-
1-(p-tolylsulfonyl)ethene (87) and 1-methylpyrano-
[3,4-b]indol-3-one (56) 
I-Methyl-2-methylthiocarbazole (98) and I-methyl-3-methylthiocarbazole (58) 






I-Methylpyrano[3,4-b Jindol-3-one (58 mg, 0.29 mmol, 1.0 eq.) and 
I-methylthio-1-(p-tolylsulfonyl)ethene (132 mg, 0.58 mmol, 2.0 eq.) were dissolved in 
bromobenzene (14 mL). The solution was heated at 120 DC under nitrogen. The 
reaction was monitored by I H NMR. After 4 hours there was no diene left. The reaction 
mixture was concentrated in vacuo and was separated into its components by radial 
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silica chromatography. The two regioisomers were collected when the silica was eluted 
with 80% petroleum etherl20% ethyl acetate. 98 was recrystallised from methanol. 
Yield of 58: 0.7 mg, 0.003 mmol, 1 %; The product had the same spectral 
properties as described previously (Section 7.12). 
Yield of 98: 2 mg, 0.01 mmol, 3 %; white platelets; m. p. 158-160 DC; 1 H NMR 
(CDCb): d 2.52 (3H, s), 2.59 (3H, s), 7.19 (2H, d, J = 7.9 Hz), 7:35-7.44 (2H, m), 7.87 
(lH, d, J = 8.3 Hz), 7.91 (lH, br s), 8.00 (lH, d, J = 8.3 Hz); rnJz [EI (70)]: 227.07661 
(found), 227.07687 (caled.); 227 (M+, 100%),212 (M+-CH3, 36%), 180 (M+-SCH3, 
13%),167 (M+-C2H4S, 27%). 
7.22. Preparation of 1 ,3-dihydroisobenzofuran-1-thione (102)27 
Lawesson's 
reagent 
Phthalide (824 mg, 6.1 mmol, 1.0 eq.) in toluene (20 mL) was refluxed with 
2,4-bis( 4-methoxypheny 1)-1 ,3-dithia-2,4-diphosphetane-2,4-disulfide, (Lawesson's 
reagent) (1.49 g, 3.7 mmol, 0.6 eq.) for 17 hours. The reaction solution was then 
concentrated in vacuo to give a yellow solid. This was then recrystallised twice from 
ether (15 mL) to give the pure product (filtering off the insoluble excess Lawesson's 
reagent). More product could be obtained by silica chromatography of the mother 
liquors, eluting with 80% petroleum ether/20% ethyl acetate. 
Yield of 102: 414 mg, 2.76 mmol, 45%; yellow needles; m.p. 111-114 DC; IH 
NMR (CDC13): 05.56 (2H, s), 7.47-7.53 (2H, m), 7.67 (lH, dt, J = 7.3, 1.0 Hz), 8.04 
(lH, d, J = 7.3 Hz). 
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7.23. Preparation of 3 .. phenyl-1,3-dihydroisobenzofuran .. 
1 .. thione (103)27 
reagent ~o cc$ Lawesson's 
Ph Ph 
146 
3-Phenylphthalide (1.03 g, 4.9 mmol, 1.0 eq.) in toluene (25 mL) was refluxed 
with Lawesson's reagent (1.18 g, 2.9 mmol, 0.6 eq.) for 17 hours. The reaction solution 
was then concentrated in vacuo to give a yellow oil. Excess Lawesson's reagent was 
removed by filtration after the addition of petroleum ether/ether. The mother liquor was 
concentrated in vacuo and the residue recrystallised twice from ether to give the pure 
product. More product could be obtained by silica chromatography of the mother 
liquors, eluting with 80% petroleum ether120% ethyl acetate. 
Yield of 103: 623 mg, 2.75 mmol, 56%; yellow needles; m.p. 98-101 DC; lR 
NMR (CDC13): (56.62 OR, s), 7.22-7.25 (2H, m), 7.30 (lH, dd, J = 7.3,1.0 Hz), 7.33-
7.37 (3H, m), 7.51 OR, t, J = 7.3 Rz), 7.63 (lR, dt, J = 1.0,7.3 Hz), 8.06 OR, d, J = 
7.3 Rz). 
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7.24. Diels-Alder reaction between 1-methylthio-
1-(p-tolylsulfonyl)ethene (87) and 1-(methyUhio)-
isobenzofuran (104) 
1,9-endo-Bis(methylthio )-11-oxa-9-exo -(p-toly lsulfony l)tricyclo[ 6.2.1.02, 7]. 
undeca-2,4,6-triene (106b), 
1,10-exo-bis(methylthio)-II-oxa-l0-endo-(p-tolylsulfonyJ)tricyclo[6.2.1.02,7]-
undeca-2,4,6-triene (107a) and 




00 1) LOA 2) CH31 
SCH3 
ojJP02TOI I ~ 0 SCH3 ~ + 
147 
n-Buty11ithium (0.24 mL of 1.6 mol L-1 solution in hexanes, 0.38 mmol, 1.2 
eq.) was added dropwise to a stirred solution of diisopropylamine (49 ilL, 0.35 mmol, 
1.1 eq.) in tetrahydrofuran (3.3 mL) under dry nitrogen in an ice-salt bath. The solution 
was stirred for 20 minutes at this temperature and then cooled further in an acetone/dry 
ice bath. A solution of 1,3-dihydroisobenzofuran-1-thione (48 mg, 0.32 mmol, 1.0 eq.) 
in tetrahydrofuran (3.3 mL) was added dropwise. The solution was stirred under 
nitrogen at -78 °C for 1 hour. Iodomethane (24 IlL, 0.38 mmol, 1.2 eq.) was added 
dropwise and the resulting mixture allowed to warm to room temperature over 2 hours. 
A solution of 1-methylthio-l-(p-tolylsulfonyl)ethene (87 mg, 0.38 mmol, 1.2 eq.) in 
tetrahydrofuran (0.9 mL) was added. The reaction solution was left stirring overnight 
under nitrogen at room temperature. The solution was then concentrated in vacuo to 
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remove excess tetrahydrofuran. The residue was partitioned between water (8 mL) and 
dichloromethane (8 mL). The aqueous layer was further extracted with 
dichloromethane (2 x 8 mL). The combined organic layers where dried (MgS04), 
filtered and concentrated in vacuo. The residue was separated into its components by 
radial silica chromatography. 106b, 107a and 107b were collected when the silica was 
eluted with 80% petroleum ether/20% ethyl acetate. 107b could be recrystallised from 
ethanol. 
Yield of 106b: 75 mg, 0.19 mmol, 60%; white solid; m.p. 67.5-69 °C; IH 
NMR (C6D6): is 1.69 OH, d, J = 13.1 Hz, endo H), 1.84 (3H, s, CH3S-CO), 1.96 (3H, 
s, CH3-Ar), 2.15 (3H, s, CH3S-C-SOz), 3.13 (lH, d, J = 13.2 Hz, exo H), 6.01 (lH, s, 
H-CO), 6.92 (2H, d, J = 7.8 Hz), 6.99-7.09 (3H, m), 7.20 (lH, d, J = 5.9 Hz), 8.01 (2H, 
d, J = 8.3 Hz); mlz [EI (70)]: 236.03300 (found), 236.03296 (caled.) -for M+-ToIS02H 
(the parent ion was not observed); 236 (M+-ToISOzH, 100%), 221 (M+-ToISOzH, 
-CH3, 63%), 189 (M+-TolSOzH, -SCH3, 16%), 177 (ClOH90S+, 15%), 164 (M+ 
-TolSOz(CH3S)C=CHz, 23%), 139 (Tol-SO+, 13%), 91 (Tol+, 31 %), 73 
(CH3S-C=CHz +, 12%). 
Yield of 107a: 6 mg, 0.02 mmol, 5%; white solid; m.p. 126-128 °C; IH NMR 
(CDCI3): is 2.05 (3H, s, CH3S-CO), 2.10 (3H, s, CH3-Ar), 2.43 (3H, s, CH3S-C-SOz), 
2.60 (lH, d, J = 12.7 Hz, endo H), 2.75 (lH, dd, J = 12.7,5.4 Hz, exo H), 5.52 (lH, d, J 
= 5.4 Hz, H-CO), 7.29-7.38 (5H, m), 7.54 (lH, d, J = 7.3 Hz), 7.78 (2H, d, J = 8.3 Hz). 
Yield of 107b: 25 mg, 0.06 mmol, 20%; white needles; m.p. 148-152 °C; IR 
(CDCI3): umax 2932 (m), 1597 (m), 1302 (m), 1142 (s) em-I; IH NNIR (CDCI3): is 1.38 
(lH, d, J = 13.2 Hz, endo H), 2.11 (3H, s, CH3S-CO), 2.42 (3H, s, CH3-Ar), 2.48 (3H, 
s, CH3S-C-SOz), 3.05 (lH, dd, J = 13.2, 5.4 Hz, exo H), 5.33 (lH, d, J = 4.9 Hz, H-
CO), 7.22-7.32 (5H, m), 7.49 (lH, d, J = 6.4 Hz), 7.99 (2H, d, J = 8.3 Hz); 13C NMR 
(CDCI3): is 13.94, 15.83,21.66,43.64,77.12,78.96, 101.20, 119.39, 121.86, 126.94, 
128.24, 128.90, 131.52, 135.30, 141.69, 144.56, 145.41; mlz [EI (70)]: 236.03293 
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(found), 236.03296 (caled.) -for M+ -ToIS02H (the parent ion was not observed); 236 
(M+-ToIS02H, 37%), 228 (ToIS02(CH3S)C=CH2+, 14%),221 (M+-ToIS02H, -CH3, 
11 %), 164 (M+-ToIS02(CH3S)C=CH2, 58%), 139 (Tol-SO+, 40%), 121 (C7HSS+, 
32%),91 (Tol+, 27%), 73 (CH3S-C=CH2+, 100%). 
AnaL Calcd. for C19H2003S3: C, 58.13; H, 5.14; S, 24.5. Found: C, 56.39; H, 
4.67; S, 23.93 %. 




undeca-2,4,6-triene decomposed within hours upon standing in chloroform. The residue 
was purified by radial silica chromatography. 108 was collected when the silica was 
eluted with petroleum ether. 
Yield of 108: 6 mg, 0.03 rnmol, 43%; white needles; m.p. 57-58 °C (lit. 28 61-
62 °C); IR (CDCI3): umax 3398 (br m), 2926(m), 1578 (s), 1499 (m), 1437 (m), 1418 
(m), 1366 (s), 1333 (s), 1238 (s) em-I; IH NMR (CDCl3): 02.36 (3H, s), 2.48 (3H, s), 
7.24 (lH, s), 7.54 OH, dd,J = 8.3,1.4 Hz), 7.58 (lH, dd, J::: 8.3, 1.4 Hz), 7.62 (1H, s), 
8.28 (2H, t, J::: 8.3 Hz); l3C NMR (CDC13): 0 18.42, 19.98, 113.40, 123.51, 124.06, 
125.03, 126.04, 126.11, 127.75, 132.87, 134.05, 152.88; mJz [EI (70)]: 236.03285 
(found), 236.03296 (caled.); 236 (M+, 100%),221 (M+ -CH3, 68%), 177 (21 %). 
2-(Methylthio )naphthalen-1,4-dione (2-(methylthio )-l,4-naphthaquinone) (109) 
[0] 
-
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2,4-Bis(methylthio )naphthalen-1-ol slowly oxidised to the naphthoquinone 
upon exposure to air. This was separated from the naphthol by radial silica 
chromatography eluting with 90% petroleum etherllO% ethyl acetate. 109 was 
crystallised from ethanol. 
Data for 109: yellow needles; m.p. 161-163 °C (lit.29 165-166 DC); IH NMR 
(CDCI3): 82.37 (3H, s), 6.56 (lH, s), 7.69 (lH, td, J = 7.3, 1.5 Hz), 7.74 (lH, td, J = 
7.3,2.0 Hz), 8.08 (lH, dd, J = 7.3, 2.0 Hz), 8.10 (lH, dd, J = 7.3,1.5 Hz). 
7.25. Diels-Alder reaction between 1-methylthio-
1-(p-tolylsulfonyl)ethene (87) and 1-methylthio-
3-phenylisobenzofuran (105) 
1,9-Bis (methylthio )-ll-oxa -8-phenyl-9-(p -toly lsulfony l)tricyclo [6.2.1.02,7 Jundeca-
2,4,6-triene (no) 
0=$ 1) LOA .. 2) CH31 
Ph 
n-Butyllithium (0.27 mL of 1.6 mol L-1 solution in hexanes, 0.43 mmol, 
1.25 eq.) was added dropwise to a stilTed solution of diisopropylamine (58 Jl.L, 
0.41 mmol, 1.2 eq.) in tetrahydrofuran (3.5 rnL) under dry nitrogen in an ice-salt bath. 
The solution was stirred for 35 minutes at this temperature and then cooled further in an 
acetone/dry ice bath. A solution of 3-phenyJ-1,3-dihydroisobenzofuran-l-thione 
(78 mg, 0.34 rnrnol, 1.0 eq.) in tetrahydrofuran (3.5 mL) was added dropwise. The 
bright red solution was stirred under nitrogen at -78°C for 1 hour. Iodomethane (28 
J.1L, 0.45 mmol, 1.3 eq.) was added dropwise and the resulting mixture allowed to warm 
to room temperature over 2 hours. A solution of I-methylthio-1-(p-tolylsulfonyl)ethene 
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(l57 mg, 0.69 mmol, 2.0 eq.) in tetrahydrofuran (0.7 mL) was added. The reaction 
solution was left stirring overnight under nitrogen at room temperature. The solution 
was then concentrated in vacuo to remove excess tetrahydrofuran. The residue was 
partitioned between water (6 mL) and ethyl acetate (6 mL). The aqueous layer was 
further extracted with ethyl acetate (2 x 6 mL). The combined organic layers where 
dried (MgS04), filtered and concentrated in vacuo. The residue was separated into its 
components by radial silica chromatography. The only isomer isolated, 110, was 
collected when the silica was eluted with 80% petroleum etherl20% ethyl acetate. 
Yield of 110: 80 mg, 0.17 mmol, 50%; yellow oil; IR (CDC13): u max 2978 
(m), 2930 (m), 1761 (w), 1448 (m), 1439 (m), 1144 (s), 1113 (s) cm- 1; lH NMR 
(CDC13): 8 1.32 (3H, s), 2.23 (3H, s), 2.35 (lH, d, J :::: 12.7 Hz), 2.38 (3H, s), 2.87 (lH, 
d, J:::: 12.7 Hz), 7.21 (2H, d, J:::: Hz), 7.32-7.48 (6H, m), 7.61-7.67 (3H, m), 8.15 (2H, 
dd, J :::: 8.3, 1.5 Hz); 13C NMR (CDC13): 8 12.14, 14.91,21.41,46.42, 83.07,92.53, 
119.53, 122.86, 127.63, 127.70, 128.13, 128.21, 129.12, 129.76, 133.76, 135.84, 
143.24, 143.91; rnJz [EI (70)J: 240.06105 (found), 240.06089 (ealed.) -for M+-
TolS02(CH3S)C=CH2 (the parent ion was not observed); 266 (M+-S02Tol,-SCH3, 
14%),240 (M+ -TolS02(CH3S)C::::CH2, 100%),228 (TolS02(CH3S)C=CH2+, 23%), 
226 (MH+ -TolS02(CH3S)C=CH2, -CH3, 43%), 197 (M+-TolS02(CH3S)C::::CH2, 
-CH3, -CO, 17%), 165 (C13H9+, 41 %), 1:39 (To1S0+, 46%),91 (Tol+, 22%), 77 (Ph+, 
18%),73 (CH3SC::::CH2+, 96%). 
S-MethyI2-(benzoyl)thiobenzoate (112) 
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Also isolated from the radial chromatography was thioester 112 when the 
silica was eluted with 90% petroleum ether/10% ethyl acetate. This product was 
recrystallised from petroleum ether. 
Yield of 112: 30 mg, 0.12 mmol, 41 %; white needles; m.p. 60-61.5 °C; IR 
(CDCb): 'Umax 3069 (w), 2932 (w), 1773 (m), 1668 (s), 1599 (m), 1450 (m), 1317 (m), 
1279 (s), 1265 (s), 1211 (s) cm-1; IH NMR (CDCb): 82.29 (3H, s), 7.41 (3H, t, ] = 7.3 
Hz), 7.50-7.62 (3H, m), 7.75 (2H, dd, ] = 7.4,1.4 Hz), 7.99 (1H, dd, ] = 7.3,1.9 Hz); 
13 C NMR (CDC13): 8 11.95, 128.10, 128.33, 12?39, 129.70, 132.15, 132.99, 133.04, 
136.71, 136.80, 139.30, 192.27, 196.87; mJz [EI (70)]: 209 (M+-SCH3, 100%), 180 
(MH+-Ph,22%), 152 (MH+-Ph, -CO, 92%), 105 (PhCO+, 59%),77 (Ph+, 80%). 
Crystal data and structural refinement for 112 
C15H1202S, M 256.31, crystal dimensions 0.79 x 0.33 x 0.03 mm; tric1inic, a 
7.9480(10), b 8.0680(10), c 11.0900(10) A; ex. 74.490(10), ~ 88.250(10), Y 69.980(10) 0; 
V 642.37(13) A3, spacegroup PT, Z = 2, F(Ooo) 268, Deale 1.325 Mg m-3 , absorption 
coefficient 0.242 mm-1, 8 range for data collection 2.73 to 25.00, index ranges 0 ~ h ~ 
9, -8 ~ k ~ 9, -13 ~ 1 :s:; 13; maximum and minimum transmissions 0.85 and 0.89, 
data/restraints/parameters 2231/0/163, goodness of fit on F2 was 0.797, final R indices 
[1>2cr(1)] Rl = 0.0353, WR2 = 0.0661, R indices (all data) Rl = 0.0671, WR2 = 0.0733, 
largest difference peak and hole 0.171 and -0.293 e A -3. 
The unit cell parameters were obtained by least-squares refinement of the 
setting angles of 37 reflections with 8 :s:; 28 :s:; 14°. A unique data set was measured at 
163(2) K within 28max = 50° limit (co scans). Of the 2416 reflections obtained, 2235 
were unique (Rint = 0.0194) and were used in the full-matrix least-squares refinement 
after being corrected for absorption by using the psi-scan method. The intensities of 3 
standard reflections, measured every 97 reflections throughout the data collection, 
showed only 8% decay. 
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The crystal structure data are reported in Appendix A.3. 
4-Hydroxy-3-methylthio-4-phenyl-4H -naphthalen-1-one (111) 
o1\H3 0 I ""= 0 - ToIS02~ ~""= o S02Toi 0 I SCH SCH3 
Ph 3 Pfl OH 
1 ,9-Bis(methylthio )-11-oxa-8-phenyl-9-(p-tolylsulfonyl)tricyclo[6.2.1.02,7]-
undeca-2,4,6-triene decomposed within a few h~urs in chloroform to give 111, which 
was recrystallised from methanol. 
Data for 111: white prisms; m.p. 210 °C (sublimes); lR (CDC!]): umax 3580 
(w), 1645 (s), 1601 (m), 1589 (w), 1564 (m), 1448 (w), 1321 (s) 1256 (w), 1132 (w) 
cm- I; IH NMR (CDC13): 0 2.30 (3H, s), 3.02 (lH, br s), 6.24 (lH, s), 7.22-7.31 (3H, 
m), 7.36-7.49 (5H, m), 8.12 (lH, dd, J= 6.9,1.5 Hz); (d6-DMSO): 02.37 (3H, s), 6.33 
(lH, s), 7.22 (lH, s), 7.26 (lH, ddd, J = 6.8,4.4, 1.4 Hz), 7.35 (2H, t, J = 7.3 Hz), 7.42 
(2H, dd, J = 8.8, 1.5 Hz), 7.49-7.53 (2H, m), 7.62 (lH, td, J = 7.3, 1.5 Hz), 8.06 (lH, 
dd, J = 8.3, 1.5 Hz); l3 C NMR (d{j-DMSO): 0 13.70,74.03, 118.19, 124.66, 125.24, 
127.18,127.77,127.86,128.44,129.07,132.84, 144.81, 149.25,173.18,180.62; mlz 
[EI (70)]: 282.07161 (found), 282.07145 (calcd.); 282 (M+, 21 %),266 (M+-O, 6%), 
235 (M+-SCH3, 100%),209 (W-SCH3, -C2H2, 66%), 181 (12%), 177 (M+-PhCO, 
12%), 152 (C12H8+, 15%), 105 (PhCO+, 37%), 77 (Ph+, 22%). 
Crystal data and structural refinement/or 111 
C17H1402S, M 282.34, crystal dimensions 0.76 x 0.33 x 0.13 rnrn; monoclinic, 
a 7.216(2), b 22.708(5), c 8.544(2) A; ex 90, p 104.51(3) Y 90 0; V 1355.4(6) A3, 
spacegroup P2I/C, Z = 4, P(OOO) 592, Deale 1.384 Mg m-3, absorption coefficient 0.236 
rrun- 1, 8 range for data collection 2.62 to 25.00, index ranges -8 ::; h ::; 0, 0 ::; k ::; 27, -9 
::; 1 ::; 10; data/restraints/parameters 2369/0/185, goodness of fit on p2 was 0.877, final R 
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indices [1>20'(1)] Rl = 0.0720, WR2 = 0.1699, R indices (all data) Rl = 0.1249, WR2 = 
0.1999, largest difference peak and hole 0.623 and -0.570 e A-3. 
The unit cell parameters were obtained by least-squares refinement of the 
setting angles of 30 reflections with 13 S 28 S 7 0. A unique data set was measured at 
163(2) K within 28max = 57° limit (co scans). Of the 2441 reflections obtained, 2372 
were unique (Rint = 0.0640) and were used in the full-matrix least-squares refinement. 
The intensities of 3 standard ref1ections, measured every 97 reflections throughout the 
data collection, showed only 2 % decay. 
The crystal structure data are reported in Appendix A.4. 




n-Butyllithium (0.36 mL of 1.6 mol L-1 solution in hexanes, 0.57 mmol, 
1.25 eq.) was added dropwise to a stirred solution of diisopropylamine (76 ~L, 
0.55 mmol, 1.2 eq.) in tetrahydrofuran (4.5 mL) under dry nitrogen in an ice-salt bath. 
The solution was stirred for 20 minutes at this temperature and then cooled to -78°C. A 
solution of 3-phenyl-l,3-dihydroisobenzofuran-l-thione (104 mg, 0.46 mmol, 1.0 eq.) 
in tetrahydrofuran (4 mL) was added dropwise. The resulting bright red solution was 
stirred under nitrogen at -78°C for 1 hour. Iodomethane (35 ~, 0.55 mmol, 1.2 eq.) 
was added and the resulting mixture allowed to warm to room temperature over 
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2 hours, becoming pale yellow in colour. The reaction mixture was then cooled to 0 °C 
and bromo benzene (145 ~L, 1.38 mmol, 3.0 eq.) was added, followed by the dropwise 
addition of a lithium tetramethylpiperidide solution. (The lithium tetramethylpiperidide 
solution was prepared by the addition of n-butyllithium (0.63 mL of a 1.6 mol L- I 
solution in hexanes, 1.01 mmol, 2.2 eq.) to tetramethylpiperidine (155 ~L, 0.92 mmol, 
2.0 eq.) in tetrahydrofuran (2.3 mL) at 0 0c. The solution was stirred at this temperature 
for 30 minutes). 
The reaction solution was stirred under nitrogen at 0 °C for 2 hours and then 
overnight at room temperature. The solution was then concentrated in vacuo to remove 
excess tetrahydrofuran. The residue was partitioned between water (25 mL) and 
dichloromethane (15 mL) and the aqueous layer further extracted with dichloromethane 
(2 x 10 mL). The combined organic layers were dried (MgS04), filtered and 
concentrated in vacuo. The product was isolated by radial silica chromatography 
eluting with 80% petroleum ether120% ethyl acetate. 115 was further purified by 
recrystallising from ethanol. 
Yield of 115: 42 mg, 0.15 mmol, 32%; white needles; m.p. 218-220 °C (lit,30 
210-212 °C); lR (CDCh): umax 3589 (m), 3071 (w), 1665 (s), 1601 (s), 1493 (w), 1456 
(m), 1448 (m), 1321 (s), 1302 (m), 1267 (s), 1159 (m) cm- I; IH NMR (CDCh): 03.10 
(lH, br s), 7.10-7.23 (3H, m), 7.31-7.41 (4H, m), 7.53 (2H, td, J;::: 7.8, 1.5 Hz), 7.59 
(2H, dd, J;::: 8.8, 1.4 Hz), 8.19 (2H, dd, J;::: 7.8, 1.0 Hz); 13C NMR (CDCb): 073.02, 
125.39, 126.80, 126.85, 128.17, 128.33, 128.36, 129.69, 134.09, 145.90, 147.72, 
183.76; m/z [El (70)]: 286.09882 (found), 286.09938 (calcd.); 286 (M+, 42%), 270 
(MH+-OH, 77%), 268 (M+ -H20, 20%), 241 (M+-CO, -OH, 16%), 239 (CI9Hll+, 
17%),209 (M+-Ph, 100%), 193 (M+-Ph, -0,11%),165 (M+-Ph, -C02, 11%),152 
(C12H8+, 16%), 105 (PhCO+, 8%), 89 (18%),77 (Ph+, 15%). 
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7.27. Diels~Alder reaction between 3,4-didehydropyridine and 
1-methylthio-3-phenylisobenzofuran (105) 
5,1 O-Dihydro-5,lO-epoxy -5-methylthio-lO-phenylbenzo[g ]isoquinoline (116a) and 
5, lO-dihydro-5,1O-epoxy-lO-methylthio-5-phenylbenzo[gJisoquinoline (116b) 




2) CH31 Ph 
b 
+ SCH3 ~ N
Ph 
n-Butyllithium (0.32 mL of 1.6 mol L- 1 solution in hexanes, 0.52 mmol, 
1.25 eq.) was added dropwise to a stirred solution of diisopropylamine (70 ~lL, 
0.50 mmol, 1.2 eq.) in tetrahydrofuran (4 mL) under dry nitrogen in an ice-salt bath. 
The solution was stirred for 20 minutes at this temperature and then cooled to -78 DC. A 
solution of 3-phenyl-1,3-dihydroisobenzofuran-1-thione (94 mg, 0.42 mmol, 1.0 eq.) in 
tetrahydrofuran (3.6 mL) was added dropwise. The resulting bright red solution was 
stirred under nitrogen at -78 DC for 1 hour. Iodomethane (31 ~L, 0.50 mmo!, 1.2 eg.) 
was added and the resulting mixture allowed to warm to room temperature over 
2 hours, becoming pale yellow in colour. The reaction mixture was then cooled to 0 DC 
and 3-bromopyridine (120 ~L, 1.25 mmol, 3.0 eq.) was added, followed by the 
dropwise addition of a lithium tetramethylpiperidide solution. (The lithium 
tetramethylpiperidide solution was prepared by the addition of n-butyllithium (0.57 mL 
of a 1.6 mol L- 1 solution in hexanes, 0.91 mmol, 2.2 eq.) to tetramethylpiperidine 
(140 J.LL, 0.83 mmol, 2.0 eq.) in tetrahydrofuran (2.2 mL) at 0 DC. The solution was 
stirred at this temperature for 30 minutes.) 
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The reaction solution was stirred under nitrogen at 0 °c for 2 hours and then 
overnight at room temperature. The solution was then concentrated in vacuo to remove 
excess tetrahydrofuran. The residue was partitioned between water (20 mL) and 
dichloromethane (15 mL) and the aqueous layer further extracted with dichloromethane 
(2 x 10 mL). The combined organic layers where dried (MgS04), filtered and 
concentrated in vacuo. The pair of regioisomers were purified by radial silica 
chromatography eluting with 80% petroleum ether120% ethyl acetate. 116a was 
isolated by further radial silica chromatography. 116b had decomposed to 117b which 
was collected when the silica was eluted with 67% petroleum ether/33% ethyl acetate. 
117b was further purified by recrystallising from chloroform. 
Yield of 116a and b: 26 mg, 0.08 mmol, 20%; colourless oil; IR : (CDCI3): 
umax 3069 (w), 3045 (w), 2224 (w), 1597 (m), 1450 (m), 1437 (w), 1414 (s), 1339 (w), 
1321 (m), 1196 (s), 1022 (m) cm- I ; rnJz [EI (70)J: 317.08710 (found), 317.08744 
(calcd.); 317 (M+, 91%), 302 (M+-CH3, 59%), 301 (M+-O, 16%),271 (MH+-SCH3, 
100%),270 (M+-SCH3, 90%),269 (M+-SCH3, -H, 72%), 242 (M+-SCH3, -CO, 44%), 
241 (M+-C6H4, 49%),240 (M+-C5H3N, 37%), 214 (16%), 213 (26%), 149 (62%), 105 
(PhCO+, 33%),77 (Ph+, 24%). 
IH NMR (CDCb): (5 (1J6a) 2.34 (3H, s), 7.05-7.14 (2H, m), 7.27-7.35 (3H, 
m), 7.49 (1H, tt, J = 7.3, 1.4 Hz), 7.57 (2H, td, J = 7.8, 1.5 Hz), 7.83 (2H, dd, J = 7.3, 
1.5 Hz), 8.38 (1H, d, J = 4.9 Hz), 8.54 (lH, d, J = 1.0 _Hz); (116b, not isolated) 2.37 
(3H, s), 7.01-7.12 (2H, m), 7.25-7.38 (3H, m), 7.45-7.51 (1H, m), 7.53-7.59 (2H, m), 
5 13 7.79 (2H, dd, J = 8.3, 1.5 Hz), 8.33 (1H, d, J = 4.4 Hz), 8. 3 (IH, d, J = 1.0 Hz); C 
NMR (CDCb): (5 (1J6a) 11.63,90.03,95.23, 115.43, 120.95, 121.02, 126.65, 126.90, 
126.98,128.49, 128.90, 128.96, 133.29, 140.37, 146.58, 147.99, 149.31, 158.27. 








Data for 117b: white crystals; m.p. 227-229 °C; IR (CDC13): 'Omax 3690 (w), 
3585 (w), 3069 (w), 1728 (w), 1701 (s), 1674 (s), 1601 (m), 1591 (m), 1448 (w), 1323 
(m), 1265 (m), 1250 (s), 1155 (w), 1030 (w) cm- I ; IH NMR (CDC13): 03.78 OH, br s), 
7.13-7.31 (5H, m), 7.43-7.47 (1H, m), 7.49 (1H, d, J = 5.9 Hz), 7.57-7.63 (2H, m), 8.22 
(lH, dd, J = 8.3, 1.0 Hz), 8.56 (1H, d, J = 4.8 Hz), 9.24 (lH, s); (du-acetone): 07.30 
OH, tt, J = 7.3, 1.5 Hz), 7.40 (2H, tt, J = 7.3, 1.5 Hz), 7.51 (2H, dd, J = 7.3, 1.5 Hz), 
7.63-7.69 (1H, m), 7.74 (1H, d, J = 5.3 Hz), 7.80 (2H, d, J = 3.9 Hz), 8.35 OH, dd, J = 
7.8, 1.0 Hz), 8.86 (1H, d, J = 5.4 Hz), 9.41 (1H, s); l3C NMR (protonated Cs only) (d6-
acetone): 0 115.00, 125.60, 126.23, 127.21, 128.45, 128.71, 128.91, 134.61, 148.70, 
153.86; mJz [EI (70)]: 287.09433 (found), 287.09463 (ealed.); 287 (M+, 72%), 269 
(M+-H20, 24%), 210 (M+-Ph, 100%), 127 (14%),78 (PhH+, 24%). 




5,10-Dihydro-5,10-epoxy-5-methylthio-10-phenylbenzo[g]iso quinoline slowly 
underwent decomposition to give 117a. 
Data for 117a: yellow oil; IH NMR (CDC13): 07.14-7.29 (5H, m), 7.39 (lR, 
td, J = 8.3,1.5 Hz), 7.53-7.63 (2R, m), 7.80 (lH, d, J = 4.8 Hz), 8.13 (lH, d, J = 7.9 
Hz), 8.34 OH, dd, J = 4.9, 2.0 Hz), 8.68 (lH, s); (d6-aeetone): 07.31 (lH, tt, J = 7.3, 
1.5 Hz), 7.41 (2H, t, J = 7.3 Hz), 7.55 (2H, dd, J = 7.8,2.0 Hz), 7.66 (lH, ddd, J = 8.3, 
5.4,2.4 Hz), 7.81-7.83 (2H, m), 8.09 (1H, dd, J = 4.9, 1.0 Hz), 8.33 OH, d, J = 7.4 Hz), 
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8.84 (lH, d, J = 5.3 Hz), 9.06 (lH, s); rnJz [EI (70)]: 287.09459 (found), 287.09463 
(caled.); 287 (M+, 44%), 269 (M+-H20, 14%),210 (M+-Ph, 100%), 149 (27%),127 
(13%),78 (PhH+, 22%). 
7.28. Diels·Alder reaction between 3,4-didehydropyridine and 
1-(methylthio)isobenzofuran (104) 
Benzo [g]isoquinolin~5,1 O~dione (2-azaanthraquinone) (119) 
o 
c¢o~ 1"1\1 h h 
o 
n-Butyllithium (0.38 mL of 1.6 mol L-1 solution in hexanes, 0.60 mmol, 
1.2 eq.) was added dropwise to a stirred solution of diisopropylamine (77 ~L, 
0.55 mmo!, 1.1 eq.) in tetrahydrofuran (5 mL) under dry nitrogen in an ice-salt bath. 
The solution was stirred for 20 minutes at this temperature and then cooled to -78°C. A 
solution of 1,3-dihydroisobenzofuran-1-thione (75 mg, 0.50 mmol, 1.0 eq.) in 
tetrahydrofuran (4 mL) was added dropwise. The resulting orange solution was stirred 
under nitrogen at -78 DC for 1 hour. Iodomethane (37 j.1L, 0.60 mmol, 1.2 eq.) was 
added and the resulting mixture allowed to warm to room temperature over 2 hours, 
becoming dark green in colour. The reaction mixture was then cooled to 0 °C and 
3-bromopyridine (240 J.lL, 2.50 mmol, 5.0 eq.) was added, followed by the drop wise 
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addition of a lithium tetramethylpiperidide solution. (The lithium tetramethylpiperidide 
solution was prepared by the addition of n-butyllithium (0.69 mL of a 1.6 mol L-1 
solution in hexanes, 1.1 mmol, 2.2 eq.) to tetramethylpiperidine (169 )..lL, 1.0 mmol, 
2.0 eq.) in tetrahydrofuran (2.4 mL) at 0 dc. The solution was stirred at this temperature 
for 30 minutes). 
The reaction solution was stirred under nitrogen at 0 °C for 2 hours and then 
overnight at room temperature. The solution was then concentrated in vacuo to remove 
excess tetrahydrofuran. The residue was partitioned between water (20 mL) and ethyl 
acetate (20 mL). The aqueous layer was further extracted with ethyl acetate (2 x 
15 mL). The combined organic layers where dried (MgS04), filtered and concentrated 
in vacuo. Many uncharacterised products were isolated by radi al silica 
chromatography; 119 was obtained when the silica was eluted with 80% petroleum 
etherl20% ethyl acetate. It could be further purified by recrystallisation from 
chloroform. 
Yield of 119: 6 mg, 0.03 mmol, 6%; yellow needles; m.p. 178-181 °C (1it.31 
179 DC (sublimes)); IH NMR (CDCI3): b 7.80-7.89 (2H, m), 8.05 (1H, dd, ] = 4.8, 1.0 
Hz), 8.27-8.33 (2H, ill), 9.09 (1H, d, ] = 4.9 Hz), 9.54 (1H, s); (dti-DMSO): b 8.04-8.12 
(2H, m), 8.15 (lH, d, ] = 5.4 Hz), 8.30-8.34 (2H, m), 9.25 (lH, d, ] = 5.3 Hz), 9.49 
(1R, s); l3C NMR (CDC13): b 102.91, 119.05, 126.75, 126.90, 132.91, 133.03, 134.90, 
135.22, 138.70, 148.37, 155.23, 182.35, 182.37; mlz [E1 (70)]: 209.04749 (found), 
209.04768 (caled.); 209 (M+, 100%), 181 (M+-CO, 37%), 153 (M+-2CO, 47%), 126 
(M+-2CO, -CHN, 27%). 
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7.29. Diels-Alder reaction between 3,4-didehydropyridine and 
1 .. methylthio-3-{trimethylsilyl)isobenzofuran (121) 
5,10-Dihydro-5,10-epoxy-5-methylthio-1 0-( trimethy lsHyl) benzo [g ]isoquinoline 
(122a) and 
5,1 0-dihydro-5,1 O-epoxy -1 0-methy lthio-5-( trimethylsilyl) benzo[g] isoquinoline 
(122b) 
(3-aza- and 2-aza- 9,10-epoxy-9-methyIthio-lO-(trimethylsilyl)anthracene) 
S 






n-Butyllithium (0.34 mL of 1.6 mol L- 1 solution in hexanes, 0.55 mmol, 
1.1 eq.) was added dropwise to a stirred solution of diisopropylamine (70 ~L, 
0.50 mmol, 1.0 eq.) in tetrahydrofuran (5 mL) under dry nitrogen in an ice-salt bath. 
The solution was stirred for 30 minutes at this temperature and then cooled to -78°C, A 
solution of 1,3-dihydroisobenzofuran-l-thione (75 mg, 0.50 mmol, 1.0 eq.) in 
tetrahydrofuran (4 mL) was added dropwise. The resulting orange solution was stirred 
under nitrogen at -78°C for 1 hour. Todomethane (34 ~L, 0.55 mmol, 1.] eq.) was 
added and the resulting mixture allowed to warm to room temperature over 1 hour, 
becoming dark green in colour. The reaction mixture was cooled to -78°C and n-
butyllithium (0.37 mL of 1.6 mol L-1 solution in hexanes, 0.60 mmol, 1.2 eq.) added 
dropwise. The mixture was left at -78 DC for 1 hour. Trimethylsilyl chloride (freshly 
distilled, 76 ~L, 0.60 mmol, 1.2 eq.) was added and the resulting mixture allowed to 
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warm to room temperature over 1 hour, becoming dark red in colour. The reaction 
mixture was then cooled to 0 °c and 3-bromopyridine (144 flL, 1.50 mrnol, 3.0 eq.) 
was added, followed by the dropwise addition of a lithium tetramethylpiperidide 
solution. (The lithium tetramethylpiperidide solution was prepared by the addition of 
n-butyllithium (0.69 mL of a 1.6 mol L-1 solution in hexanes, 1.1 mmol, 2.2 eq.) to 
tetramethylpiperidine (169 flL, 1.0 mmol, 2.0 eq.) in tetrahydrofuran (2.4 mL) at 0 DC. 
The solution was stirred at this temperature for 30 minutes). 
The reaction solution was stirred under nitrogen at 0 °c for 4.5 hours and then 
overnight at room temperature. The solution was then concentrated in vacuo to remove 
excess tetrahydrofuran. The residue was partitioned between water (20 mL) and 
dichloromethane (20 mL) and the heterogeneous liquid filtered through a Celite bed. 
The layers were separated and the aqueous layer further extracted with 
dichloromethane (2 x 20 mL). The combined organic layers where dried (MgS04), 
filtered and concentrated in vacuo. 122a and b were isolated by radial silica 
chromatography eluting with 89% petroleum ether/lO% ethyl acetate/l % triethylamine. 
No further effort was made to separate the two regioisomers. 
Yield of 122a and b: 29 mg, 0.09 mmol, 18%; yellow oil; IR (CDCb): Umax 
2963 (m), 2934 (m), 1595 (m), 1578 (m), 1456 (m), 1439 (m), 1414 (m), 1267 (m), 
1254 (s), 1219 (m), 1163 (m) cm-l; IH NMR (C6D6): I) 0.35 (a, 9H, s), 0.36 (b, 9H, s), 
2.07 (a, 3H, s), 2.07 (b, 3H, s), 6.85-6.90 (a, 2H, b, 2H, m), 6.90 (b, IH, dd, J = 4.9, 
1.0 Hz), 7.02 (a, 1H, dd, J = 4.9,1.0 Hz), 7.17-7.22 (a, 1H, b, IH, m), 7.29-7.34 (a, 
IH, b, 1H, m), 8.33 (b, 1H, d, J = 4.9 Hz), 8.33 (a, 1H, d, J = 4.9 Hz), 8.78 (a, IH, d, J 
= 1.0 Hz), 8.82 (b, IH, s); (CDCh): I) 0.39 (b, 9H, s), 0.41 (a, 9H, s), 2.26 (a, 3H, s), 
2.30 (b, 3H, s), 6.98-7.09 (a, 2H, b, 2H, m), 7.19 (a, IH, b, IH, ddd, J = 5.4, 4.4, 1.0 
Hz), 7.25-7.29 (a, 2H, b, 2H, m), 8.27 (b, 1H, d, J = 4.8 Hz), 8.31 (a, 1H, d, J = 4.4 
Hz), 8.42 (b, 1H, d, J = 1.0 Hz), 8.45 (a, IH, d, J = 1.0 Hz); DC NMR (C6D6): I) -2.34, 
11.68, 11.86, 83.47, 83.95, 97.10, 97.72, 116.22, 116.72,'121.30, 121.40, 121.51, 
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121.72, 126.51, 126.80, 126.88, 127.19, 141.19, 141.62, 144.86, 148.29, 148.62, 
148.78, 148.90, 149.16, 151.90, 152.77, 158.84,.162.42; rnJz [EI (70)J: 313.09573 
(found), 313.09567 (ealed.); 313 (M+, 27%), 298 (M+-CH3, 55%), 251 (M+-CH3, 
-SCH3, 9%),167 (MH2+-SCH3, -Si(CH3h, -CO, 11%),73 (Si(CH3h+, 100%). 
5,10-Dihydro-5,10-epoxy-5-methylthiobenzo[g]isoquinoUne (118a) and 
5,1 O-dihydro-5,10-epoxy-1 O-methylthiobenzo[g ]isoquinoline (118b) 
(3-aza- and 2-aza- 9,10-epoxy-9-methylthioanthracene) 
CH3 ofCH3 
o I "yH (N) T8A~ I ~ I "yH (N) 
.....::N (CH) ...-;;.....::N (CH) 
Si(CH3b 
Tetrabutylammonium fluoride (TBAF) (81 J.lL of 1 mol L- 1 solution in 
tetrahydrofuran, 0.081 mmol, 1.1 eq.) was added dropwise to a solution of a mixture of 
122a and b (23 mg, 0.073 mmol, 1.0 eq.) in tetrahydrofuran (1 mL) at 0 0c. The red 
solution was stirred overnight. Ether (10 mL) was added and the organic layer washed 
with brine (3 x 5 mL), dried (MgS04), filtered and concentrated in vacuo to give a 
mixture of 118a and b. No further purification was attempted. 
Yield of 118a and b: 12 mg, 0.05 mmol, 68%; brown oil; IH NMR (C{)D6): (5 
2.06 (a, 3H, s), 2.08 (b, 3H, s), 5.60 (b, IH, s), 5.67 (a, IH, s), 6.66 (b, IH, d,.T = 4.9 
Hz), 6.79-6.85 (a, 2H, b, 2H, m), 6.93-7.00 (a, IH, b, 1H, m), 6.95 (a, IH, d,.T = 3.9 
Hz), 7.25-7.30 (a, IH, b, IH, m), 8.30 (b, IH, d, .T = 4.4 Hz), 8.31 (a, 1H, d,.T = 4.4 
Hz), 8.49 (a, IH, s), 8.81 (b, IH, s); (CDCb): (52.27 (a, 3H, s), 2.31 (b, 3H, s), 6.04 (b, 
IH, s), 6.13 (a, 1H, s), 7.02-7.12 (a, 2H, b, 3H, m), 7.21-7.34 (a, 3H, b, 2H, m), 8.32 
(b, IH, d,.T = 4.9 Hz), 8.36 (a, 1H, d,.T = 4.4 Hz), 8.45 (b, IH, s), 8.51 (a, IH, s); DC 
NMR (C6D6): (5 11.74, 11.94, 79.86, 80.73, 96.87, 97.39, 115.90, 116.05, 121.21, 
121.24, 121.33, 121.42, 126.99, 127.01, 127.36, 127.40, 141.29, 141.40, 145.23, 
146.83,147.73, 148.56, 149.01, 149.19, 149.43, 150.19, 157.23, 158.87; rnJz [EI (70)J: 
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241.05612 (found), 241.05614 (calcd.); 241 (M+, 28%), 226 (M+-CH3, 73%), 209 
(16%),194 (M+-SCH3, 100%), 166 (M+-SCH3, -CO, 44%),139 (23%). 
Benzo [g Jisoquinolin -5,1 O-dione (2-azaanthraquinone) (119) 
TFA 
A drop of trit1uoroacetic acid (TFA) was added to a solution of a mixture of 
lISa and b in CDCh. A IH NMR of the red solution 20 minutes later showed no 
starting material was present and showed a mixture of products similar to those formed 
from the reaction of 3,4-didehydropyridine with 1-(methylthio)isobenzofuran (Section 
7.28), including 119. 
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Table A.1.1: Atomic coordinates (x 104) and equivalent isotropic displacement parameters (A2 
x 103) for 42. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
Atom x y z U(eq) 
811 8204.8(2) 4005.8(6) 9027.2(8) 18.17(12) 
811' 8515.3(2) 605.6(6) 7772.1 (8) 20.35(13) 
010 7955.9(5) 3397(2) 13430(2) 18.1 (3) 
C1 8183.7(6) 1396(2) 11216(3) 14.8(4) 
C2 8427.3(7) -131(2) 11917(3) 15.3(4) 
C3 8219.9(8) -1653(3) 12125(3) 22.1(4) 
C4 8480.0(8) -2912(3) 12886(4) 27.3(5) 
C5 8940.5(9) -2652(3) 13419(3) 27.1(5) 
C6 9151.9(8) -1123(3) 13213(3) 21.6(5) 
C7 8892.9(7) 127(2) 12459(3) 15.0(4) 
C8 9056.5(6) 1867(2) 12148(3) 14.5(4) 
09 8719.8(5) 2935(2) 13079(2) 14.8(3) 
C10 8260.7(6) 2667(2) 12664(3) 13.8(4) 
C11 8479.5(7) 2044(2) 9600(3) 14.2(4) 
C12 9002.5(6) 2270(3) 10193(3) 17.0(4) 
C1" 7657.0(7) 1167(3) 10894(3) 19.5(4) 
C11' 8572.4(8) 4729(3) 7264(3) 23.7(5) 
C11 II 7954.5(8) 677(3) 6649(3) 25.4(5) 
C1' 9543.5(6) 2235(2) 12870(3) 17.3(4) 
C2' 9938.1 (8) 1656(3) 11987(3) 28.5(5) 
C3' 10390.3(8) 1921 (4) 12657(4) 35.3(6) 
C4' 10449.8(8) 2750(3) 14217(4) 31.8(6) 
C5' 10060.6(8) 3340(3) 15087(4) 33.9(6) 
C6' 9607.08 30753 144263 26.65 
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Table A.1.2: Selected bond lengths (A) for 42 
Atoms Bond length Atoms Bond length 
S11-C11 1.839(2) S11-C11' 1.802(2) 
S11 '-C11 1.830(2) S11 '-C11" 1.807(2) 
010-C10 1.202(2) C1-C2 1.526(3) 
C1-C10 1.534(3) C1-C11 1.583(3) 
C1-C1 " 1.524(3) C2-C3 1.388(3) 
C2-C7 1.399(3) C3-C4 1.395(3) 
C4-C5 1.384(3) C5-C6 1.398(3) 
C6-C7 1.385(3) C7-C8 1.518(3) 
C8-09 1.477(2) C8-C12 1.536(3) 
C8-C1' 1.517(3) 09-C10 1.357(2) 
C11-C12 1.561 (2) C1'-C2' 1.390(3) 
C1 '-C6' 1.385(3) C2'-C3' 1.397(3) 
C3'-C4' 1.382(4) C4'-C5' 1.375(4) 
C5'-C6' 1.398(3) 
Table A.1.3: Selected bond angles (0) for 42 
Atoms Bond angle Atoms Bond angle 
C11-S11-C11' 102.74(10) C11-S11'-C11" 1 06.99(1 0) 
C2-C1-C10 103.89(16) C2-C1-C11 107.97(15) 
C2-C1-C1 " 113.50(17) C10-C1-C11 104.94(15) 
C1 0-C1-C1" 109.82(16) C11-C1-C1" 115.74(17) 
C1-C2-C3 125.82(19) C1-C2-C7 113.98(16) 
C3-C2-C7 120.11 (18) C2-C3-C4 119.24(20) 
C3-C4-C5 120.47(20) C4-C5-C6 120.61 (20) 
C5-C6-C7 118.85(20) C2-C7-C6 120.71(18) 
C2-C7-C8 112.57(16) C6-C7-C8 126.71 (18) 
C7-C8-09 106.47(15) C7-C8-C12 108.87(17) 
C7-C8-C1' 114.06(16) 09-C8-C12 106.00(15) 
09-C8-C1' 107.20(16) C12-C8-C1' 113.65(17) 
C8-09-C10 114.31(15) 010-C10-C1 125.85(17) 
C1-C10-09 114.47(16) 010-C10-09 119.67(19) 
S 11-C 11-S 11' 113.92(11 ) S11-C11-C1 104.75(13) 
S 11 -C 11-C 12 111.56(14) S11'-C11-C1 114.03(13) 
S11 '-C11-C12 104.15(13) C1-C11-C12 108.48(16) 
C8-C12-C11 110.54(16) C8-C1 '-C2' 119.24(21 ) 
C8-C1 '-C6' 121.92(19) C2'-C1'-C6' 118.78(19) 
C1'-C2'-C3' 120.50(24) C2'-C3'-C4' 120.29(23) 
C3'-C4'-C5' 119.42(21 ) C4'-C5'-C6' 120.58(24) 
C1 '-C6'-C5' 120.42(22) 
Symmetry transformations used to generate equivalent atoms 
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Table A.1.4: Anisotropic displacement parameters (A2 x 103) for 42. 
The anisotropic displacement factor exponent takes the form: 
2 .. 2 " .. 
-2n [(ha) U11 + ... + 2hka b U12] 
Atom U11 U22 U33 U23 U13 U12 
811 17.2(2) 17.1(2) 20.2(2) 4.3(2) 1.0(2) 2.2(2) 
811' 20.4(2) 23.0(2) 17.6(2) -4.0(2) 0.1 (2) 3.0(2) 
010 15.5(6) 18.0(7) 20.8(7) 0.0(6) 2.8(6) 3.3(5) 
C1 13.6(9) 14.6(9) 16.3(10) 0.1 (8) 2.0(8) -1.2(7) 
C2 19.7(9) 13.1 (9) 13.0(10) -0.3(8) 1.8(8) 0.7(7) 
C3 26.5(11 ) 16.4(9) 23.5(11 ) -3.0(9) 2.7(9) -4.2(8) 
C4 40.9(12) 12.4(9) 28.6(12) 1.2(10) 6.2(11 ) -2.9(9) 
C5 38.9(12) 16.2(10) 26.3(10) 6.7(9) 3.3(10) 8.4(9) 
C6 22.7(10) 21.1(10) 21.0(11) 2.4(9) 0.0(8) 4.8(8) 
C7 19.7(9) 11.4(8) 13.9(10) -0.3(7) 3.1 (7) 0.7(7) 
C8 12.3(8) 12.4(8) 18.8(10) 0.1 (8) -0.3(8) 1.6(7) 
09 11.9(6) 14.8(6) 17.7(7) -2.7(6) -0.3(5) 0.7(5) 
C10 14.7(8) 10.7(8) 16.0(9) 4.1 (8) -1.5(8) -1.6(7) 
C11 13.1 (8) 13.1 (9) 16.4(9) 0.8(7) 0.7(7) -0.1 (7) 
C12 11.8(8) 19.9(10) 19.4(10) 3.0(8) 1 .1 (8) -2.6(7) 
C1" 13.1 (9) 24.8(10) 20.1 (11 ) -0.3(9) 0.1 (8) -4.8(8) 
C11' 25.2(11 ) 23.8(10) 22.0(11 ) 8.1 (9) -0.4(9) -5.0(9) 
C11" 24.2(11) 33.1(12) 19.0(11) -1.1(10) -4.0(9) -7.6(9) 
C1' 13.4(8) 16.9(9) 21.5(10) 4.9(9) -3.3(9) -1.4(7) 
C2' 18.6(10) 44.3(13) 22.5(11 ) -0.7(11) 1.0(9) 4.8(10) 
C3' 14.8(9) 58.3(16) 32.8(13) 8.1(14) 1.8(10) 4.0(10) 
C4' 16.6(10) 45.4(14) 33.4(13) 14.6(13) -10.4(10) -6.4(9) 
C5' 26.7(12) 39.2(14) 35.9(14) -6.5(12) -11.9(11) -2.5(10) 
C6' 17.2 10 31.6 11 31.1 13 -5.6 10 -4.1 9 1.79 
Table A.1.S: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 103) 
for 42 
Atom x y z U{eq) 
H3 7904.4(8) -1835(3) 11753(3) 26.5 
H4 8340.1 (8) -3956(3) 13038(4) 32.7 
H5 9114.6(9) -3520(3) 13931 (3) 32.5 
H6 9467.7(8) -944(3) 13583(3) 25.9 
H12A 9209.0(6) 1544(3) 9495(3) 20.4 
H12B 9101.9(6) 3411 (3) 9979(3) 20.4 
H1"A 7524.2(13) 2174(7) 10041 (20) 29.2 
H1"B 7499.6(11) 910(20) 12003(4) 29.2 
H1"C 7608.8(7) 271 (13) 10060(20) 29.2 
H11'A 8465(4) 5813(9) 6895(15) 35.5 
H11 'B 8552(5) 3972{11 ) 6273(9) 35.5 
H11'C 8900.3(12) 4796(20) 7665(7) 35.5 
H11"A 7988(2) 190(20) 5483(9) 38.1 
H11"B 7853(3) 1815(3) 6530(20) 38.1 
H11"C 7719(2) 70(20) 7322(12) 38.1 
H2' 9900.2(8) 1076(3) 10918(3) 34.2 
H3' 10658.0(8) 1528(4) 12038(4) 42.4 
H4' 10756.9(8) 2912(3) 14685(4) 38.1 
H5' 10100.3(8) 3933(3) 16147(4) 40.7 
H6' 9340.68 34733 150493 31.9 
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A.2. X-ray crystal structure of 11-endo-ethoxy-1-methyl-9-
oxa-8-phenyltricyclo[6.2.2.02,7]dodec-2,4,6-trien-1 O-one 
(44b) 
Figure A.2.1 : 
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Table A.2.1: Atomic coordinates (x 104) and equivalent isotropic displacement parameters (A2 
x 103) for 44b. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
Atom x y z U(eq) 
010 2558(3) 5663(3) .8181(1) 94(1 ) 
C1 986(3) 7923(3) 8373(1 ) 49(1 ) 
C2 1778(3) 9240(3) 8726(1) 45(1 ) 
C3 2225(3) 10655(3) 8501 (1) 57(1 ) 
C4 2961 (3) 11735(3) 8883(1 ) 68(1 ) 
C5 3261 (3) 11418(3) 9481 (1) 65(1 ) 
C6 2820(3) 10002(3) 9717(1 ) 50(1 ) 
C7 2067(2) 8925(2) 9336(1 ) 41 (1) 
C8 1476(3) 7345(2) 9506(1 ) 41 (1) 
09 2221 (2) 6215(2) 9122(1 ) 55(1 ) 
C10 1982(3) 6506(3) 8529(1 ) 60(1 ) 
C11 -593(3) 7611 (3) 8649(1 ) 52(1 ) 
C12 -283(3) 7252(3) 9321 (1) 50(1 ) 
C1" 766(4) 8168(4) 7698(1 ) 71 (1) 
C1' 1921 (3) 6874(3) 10148(1) 43(1 ) 
C2' 1088(4) 7423(3) 10604(1 ) 65(1 ) 
C3' 1538(4) 7058(4) 11194(1 ) 75(1) 
C4' 2817(4) 6146(3) 11336(1) 67(1 ) 
C5' 3655(3) 5587(3) 10889(1 ) 65(1 ) 
C6 1 3211 (3) 5943(3) 10297(1 ) 55(1 ) 
011 -1537(2) 8950(2) 8543(1 ) 70(1 ) 
C11' -3193(4) 8751 (5) 8537(2) 105(1 ) 
C11" -4002(11 ) 9037(23) 8029(7) 210(10) 
C11A -385615 819014 79975 1094 
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Table A.2.2: Selected bond lengths (A) for 44b 
Atoms Bond length Atoms Bond length 
010-C10 1.193(3) C1-C2 1.502(3) 
C1-C10 1.505(4) C1-C1 " 1.513(3) 
C1-C11 1.545(3) C2-C3 1.376(3) 
C2-C7 1.386(3) C3-C4 1.372(4) 
C4-C5 1.362(4) C5-C6 1.385(3) 
C6-C7 1.374(3) C7-C8 1.503(3) 
C8-09 1.468(3) C8-C1' 1.501 (3) 
C8-C12 1.522(3) 09-C10 1.342(3) 
C11-011 1.408(3) C11-C12 1.528(3) 
C1'-C2' 1.368(3) C1'-C6' 1.376(3) 
C2'-C3' 1.374(3) C3'-C4' 1.356(4) 
C4'-C5' 1.358(4) C5'-C6' 1.373(3) 
011-C11' 1.418(4) C11 '-C11" 1.298(12) 
C11'-C11A 1.372(10) 
Table A.2.3: Selected bond angles (0) for 44b 
Atoms Bond angle Atoms Bond angle 
C2-C1-C10 105.3(2} C2-C1-C1 " 115.4(2) 
C10-C1-C1" 111.3(2) C2-C1-C11 106.8(2) 
C10-C1-C11 105.1(2) C1 "-C1-C11 112.2(2) 
C3-C2-C7 119.7(2) C3-C2-C1 126.6(2) 
C7-C2-C1 113.7(2) C4-C3-C2 119.6(2) 
C5-C4-C3 120.7(2) C4-C5-C6 120.6(3) 
C7-C6-CS 118.8(2) C6-C7-C2 120.6(2) 
C6-C7-C8 126.7(2) C2-C7-C8 112.7(2) 
09-C8-C1' 106.8(2) 09-C8-C7 106.1(2) 
C1 '-C8-C7 114.7(2) 09-C8-C12 105.7(2) 
C1 '-C8-C12 114.2(2) C7-C8-C12 108.7(2) 
C10-09-C8 114.3(2) 010-C10-09 119.2(3) 
010-C10-C1 126.3(2) 09-C10-C1 114.5(2) 
011-C11-C12 112.1 (2) 011-C11-C1 107.2(2) 
C12-C11-C1 109.7(2) C8-C12-C11 110.0(2) 
C2'-C1 '-C6' 118.1(2) C2'-C1'-C8 120.S(2) 
C6'-C1'-C8 121.3(2) C1 '-C2'-C3' 120.7(3) 
C4'-C3'-C2' 120.6(3) C3'-C4'-CS' 119.5(2) 
C4'-CS'-C6' 120.3(3) CS'-C6'-C1 ' 120.8(2) 
C11-011-C11' 117.2(3) C11"-C11'-011 116.2(6) 
C11 A-C11 '-011 112.8(6) 
Symmetry transformations used to generate equivalent atoms 
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Table A.2.4: Anisotropic displacement parameters (A2 x 103) for 44b. 
The anisotropic displacement factor exponent takes the form: 
-2n2 [(ha*)2U11 + ... + 2hka*b*U12J 
Atom U11 U22 U33 U23 U13 U12 
010 144(2) 78(1 ) 61 (1) -13(1 ) 24(1) 33(1) 
C1 60(2) 47(1 ) 40(1) 2(1 ) 3(1 ) -4(1 ) 
C2 41 (1) 45(1 ) 49(1 ) 6(1 ) 7(1 ) -1 (1 ) 
C3 58(2) 56(2) 58(2) 14(1 ) 6(1 ) -8(1 ) 
C4 73(2) 53(2) 78(2) 13(1 ) 8(2) -18(1) 
C5 66(2) 51 (2) 78(2) -5(1 ) 2(1 ) -20(1 ) 
C6 46(1) 50(1 ) 54(1 ) -2(1 ) -1 (1 ) -5(1 ) 
C7 36(1 ) 40(1 ) 46(1 ) 2(1 ) 4(1 ) 1 (1 ) 
C8 45(1) 37(1 ) 43(1 ) -1 (1 ) 6(1 ) 2(1 ) 
09 72(1) 44(1 ) 49(1 ) -2(1 ) 7(1 ) 13(1 ) 
C10 80(2) 52(2) 47(2) -5(1 ) 11 (1 ) 2(1 ) 
C11 55(2) 48(1 ) 51 (1) 4(1 ) -8(1 ) -11 (1) 
C12 47(1) 52(1 ) 50(1 ) 3(1 ) 0(1 ) -11 (1) 
C1" 93(2) 72(2) 46(2) 2(1 ) 2(1 ) -7(2) 
C1' 45(1) 37(1 ) 45(1 ) 3(1 ) 0(1 ) -4(1 ) 
C2' 78(2) 70(2) 46(2) 3(1 ) 2(1 ) 23(2) 
C3' 97(2) 81 (2) 46(2) 0(2) 3(2) 16(2) 
C4' 81 (2) 66(2) 49(2) 12(1 ) -18( 1) -16(2) 
C5' 48(2) 71 (2) 72(2) 22(2) -11 (1) -2(1 ) 
C6' 42(1 ) 62(2) 61 (2) 14(1 ) 4(1 ) 0(1 ) 
011 48(1) 77(1 ) 84(1 ) 21 (1) -7(1 ) -1 (1 ) 
C11' 60(2) 138(3) 113(3) 23(3) -6(2) -11 (2) 
C11" 29(4) 413(30) 178(13) 125(16) -46(5) 7(9) 
C11A 145 10 1177 666 -266 106 -186 
Table A.2.5: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 103) 
for 44b 
Atom x y z U(eq) 
H3 2028(3) 10878(3) 8092(1) 74 
H4 3258(3) 12693(3) 8731 (1) 88 
H5 3766(3) 12160(3) 9734(1 ) 85 
H6 3031 (3) 9783(3) 10125(1 ) 65 
H11 -1117(3) 6715(3) 8445(1) 68 
H12A -843(3) 7995(3) 9553(1 ) 65 
H12B -668(3) 6214(3) 9404(1 ) 65 
H1"1 253(4) 7272(4) 7511(1) 92 
Hi "2 1776(4) 8309(4) 7543(1 ) 92 
H1"3 129(4) 9078(4) 7611(1) 92 
H2' 208(4) 8050(3) 10514(1) 84 
H3' 961 (4) 7440(4) 11500(1) 97 
H4' 3119(4) 5904(3) 11737(1) 86 
H5' 4534(3) 4961 (3) 10983(1 ) 84 
H6' 3790(3) 5550(3) 9994(1 ) 71 
H11A -3400(4) 7682(5) 8652(2) 136 
H11B -3576(4) 9426(5) 8843(2) 136 
H11C -5103(11) 8874(23) 8075(7) 272 
H11 D -3669(11 ) 8348(23) 7724(7) 272 
H11E -3835(11 ) 10100(23) 7913(7) 272 
H11 F -4973(15) 8076(14) 8017(5) 142 
H11G -3402(15) 7194(14) 7915(5) 142 
H11H -3658 15 890914 7681 5 142 
A.3. X-ray crystal structure of 4-hydroxy-3-methylthio-
4-phenyl-4H-naphthalen-1-one (111) 
Figure A.3.1: 
Table A.3.1: Atomic coordinates (x 104) and equivalent isotropic displacement parameters (A2 
x 103) for 111. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
Atom x y z U(eq) 
C1 -2560(6) 5100(2) 5207(5) 23(1 ) 
C2 -1837(7) 5661 (2) 5865(6) 26(1 ) 
C3 -1222(7) 6077(2) 4967(6) 24(1 ) 
C4 -1449(7) 6014(2) 3142(5) 24(1 ) 
C4A -2074(7) 5398(2) 2537(5) 23(1 ) 
C5 -2076(7) 5251 (2) 945(6) 28(1 ) 
C6 -2726(8) 4704(2) 317(6) 35(1 ) 
C7 -3404(7) 4300(2) 1246(6) 35(1 ) 
C8 -3370(7) 4436(2) 2818(6) 30(1 ) 
C8A -2721 (6) 4980(2) 3475(5) 23(1 ) 
01 -2951 (5) 4712(1 ) 6102(4) 29(1 ) 
83 -114(2) 6735(1) 5719(2) 35(1 ) 
C3" -495(9) 6773(2) 7718(6) 44(1 ) 
04 287(5) 6178(1) 2767(4) 29(1 ) 
C1' -3002(7) 6452(2) 2290(6) 23(1 ) 
C2' -4801 (7) 6460(2) 2593(6) 24(1 ) 
C3' -6168(7) 6853(2) 1824(6) 28(1 ) 
C4' -5783(7) 7252(2) 690(6) 32(1 ) 
C5' -4020(8) 7237(2) 362(7) 36(1 ) 
C6' -26057 68462 1151 6 28 1 
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Table A.3.2: Selected bond lengths (A) for 111 
Atoms Bond length Atoms Bond length 
C1-01 1.244(5) C1-C2 1.438(6) 
C1-C8A 1.481 (6) C2-C3 1.360(6) 
C3-C4 1.533(6) C3-S3 1.739(5) 
C4-04 1.418(5) C4-C4A 1.519(6) 
C4-C1' 1.539(6) C4A-C8A 1.396(6) 
C4A-C5 1.401 (6) C5-C6 1.388(7) 
C6-C7 1.379(7) C7-C8 1.373(7) 
C8-C8A 1.389(7) S3-C3" 1.798(5) 
C1 '-C2' 1.386(6) C1'-C6' 1.403(6) 
C2'-C3' 1.370(7) C3'-C4' 1.404(7) 
C4'-C5' 1.370(7) C5'-C6' 1.393(7) 
Table A.3.3: Selected bond angles (0) for 111 
Atoms Bond angle Atoms Bond angle 
01-C1-C2 120.3(4) 01-C1-C8A 120.8(4) 
C2-C1-C8A 118.9(4) C3-C2-C1 122.2(4) 
C2-C3-C4 122.8(4) C2-C3-S3 125.0(4) 
C4-C3-S3 112.3(3) 04-C4-C4A 111.7(4) 
04-C4-C3 109.2(4) C4A-C4-C3 112.3(4) 
04-C4-C1' 107.6(4) C4A-C4-C1' 108.4(4) 
C3-C4-C1' 107.4(4) C8A-C4A-C5 118.4(4) 
C8A-C4A-C4 122.9(4) C5-C4A-C4 118.6(4) 
C6-C5-C4A 120.5(4) C7-C6-C5 120.4(5) 
C8-C7-C6 119.5(5) C7-C8-C8A 121.1(5) 
C8-C8A-C4A 120.0(4) C8-C8A-C1 120.0(4) 
C4A-C8A-C1 119.7(4) C3-S3-C3" 1 03.1 (3) 
C2'-C l'-C6' 119.0(4) C2'-C1'-C4 121.7(4) 
C6'-C1'-C4 119.3(4) C3'-C2'-C1' 120.9(4) 
C2'-C3'-C4' 120.5(5) C5'-C4'-C3' 118.7(5) 
C4'-C5'-C6' 121.5(5) C5'-C6'-C1 ' 119.3(4) 
Symmetry transformations used to generate equivalent atoms 
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Table A.3.4: Anisotropic displacement parameters (A2 x 103) for 111. 
The anisotropic displacement factor exponent takes the form: 
2 • 2 * • -2~ [(ha) U11 + ... + 2hka b U12] 
Atom U11 U22 U33 U23 U13 U12 
C1 22(2) 25(2) 27(3) 3(2) 14(2) 0(2) 
C2 29(3) 30(3) 24(3) 1 (2) 13(2) 2(2) 
C3 24(3) 21 (2) 26(3) 1 (2) 6(2) 0(2) 
C4 26(2) 24(2) 23(3) 0(2) 8(2) -4(2) 
C4A 27(3) 22(2) 22(2) 2(2) 9(2) 4(2) 
C5 35(3) 27(3) 27(3) 3(2) 15(2) 7(2) 
C6 48(3) 36(3) 27(3) -3(2) 18(3) 13(3) 
C7 39(3) 27(3) 36(3) -6(2) 7(3) 2(2) 
C8 32(3) 28(3) 32(3) 1 (2) 13(2) 0(2) 
C8A 25(2) 22(2) 23(2) 1 (2) 10(2) 0(2) 
01 34(2) 28(2) 30(2) 9(2) 16(2) 0(2) 
S3 42(1) 27(1 ) 34(1 ) -2(1 ) 7(1 ) -5(1 ) 
C3" 61 (4) 39(3) 25(3) -10(3) 3(3) 2(3) 
04 27(2) 28(2) 38(2) 8(2) 18(2) 1 (2) 
C1' 31 (3) 18(2) 20(2) -3(2) 5(2) -1 (2) 
C2' 27(3) 23(2) 25(2) -2(2) 11 (2) -3(2) 
C3' 25(3) 30(3) 30(3) -7(2) 11 (2) -1 (2) 
C4' 35(3) 20(2) 39(3) 0(2) 9(2) 2(2) 
C5' 36(3) 33(3) 38(3) 11 (2) 8(2) -3(2) 
C6' 293 293 323 72 172 -32 
Table A.3.S: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 103) 
for 111 
Atom x y z U(eq) 
H2 -1786(7) 5744(2) 6965(6) 32 
H5 -1628(7) 5527(2) 290(6) 34 
H6 -2705(8) 4606(2) -760(6) 42 
H7 -3890(7) 3932(2) 801 (6) 41 
H8 -3797(7) 4153(2) 3469(6) 36 
H3"A -102(51 ) 7161 (6) 8186(19) 65 
H3"8 265(43) 6467(11 ) 8398(14) 65 
H3"C -1855(12) 6711 (17) 7659(8) 65 
H4 1189(80) 5931 (25) 3178(66) 40 
H2' -5090(7) 6188(2) 3344(6) 29 
H31 -7386(7) 6856(2) 2060(6) 33 
H41 
-6726(7) 7527(2) 161 (6) 38 
H5' -3756(8) 7500(2) -420(7) 43 
H6' -13847 68452 9196 34 
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A.4. X-ray crystal structure of 
5-methyl 2-(benzoyl)thiobenzoate (112) 
Figure A.4.1: 
Table A.4.1: Atomic coordinates (x 104) and equivalent isotropic displacement parameters (A2 
xi 03) for 112. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
Atom x y z U(eq) 
S1 1986(1 ) 8647(1 ) 4062(1) 56(1) 
01 1352(2) 6202(2) 5924(1) 47(1) 
02 1665(2) 6401 (2) 8629(1) 48(1) 
C1 4086(2) 6626(3) 6247(2) 28(1 ) 
C2 4296(2) 5707(2) 7525(2) 27(1) 
C3 5916(3) 5270(3) 8184(2) 34(1 ) 
C4 7306(3) 5744(3) 7596(2) 39(1) 
C5 7102(3) 6658(3) 6338(2) 42(1) 
C6 5508(3) 7090(3) 5673(2) 38(1) 
C11 2390(3) 6982(3) 5529(2) 32(1 ) 
C12 -71 (3) 8568(4) 3510(2) 67(1) 
C20 2811 (3) 5227(3) 8253(2) 29(1 ) 
C21 2898(2) 3291 (3) 8602(2) 26(1) 
C22 4038(3) 2034(3) 8036(2) 33(1) 
C23 4070(3) 254(3) 8345(2) 41 (1) 
C24 2991 (3) -294(3) 9245(2) 45(1 ) 
C25 1872(3) 936(3) 9837(2) 42(1} 
C26 1807(3} 2732~3} 9514{2) 31 {1} 
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Table A.4.2: Selected bond lengths (A) for 112. 
Atoms Bond length Atoms Bond length 
S1-C11 1.766(2) S1-C12 1.790(2) 
01-C11 1.206(2) 02-C20 1.224(2) 
C1-C6 1.393(3) C1-C2 1.398(2) 
C1-C11 1.488(3) C2-C3 1.387(3) 
C2-C20 1.510(3) C3-C4 1.380(3) 
C4-C5 1.378(3) C5-C6 1.374(3) 
C20-C21 1.483(3) C21-C22 1.386(3) 
C21-C26 1.396(3) C22-C23 1.376(3) 
C23-C24 1.378(3) C24-C25 1.384(3) 
C25-C26 1.380(3) 
Table A.4.3: Selected bond angles (0) for 112 
Atoms Bond angle Atoms Bond angle 
C11-S1-C12 100.69(11 ) C6-C1-C2 119.0(2) 
C6-C1-C11 122.0(2) C2-C1-C11 118.9(2) 
C3-C2-C1 119.2(2) C3-C2-C20 117.5(2) 
C1-C2-C20 123.3(2) C4-C3-C2 120.8(2) 
C5-C4-C3 120.2(2) C6-C5-C4 119.5(2) 
C5-C6-C1 121.2(2) 01-C11-C1 122.4(2) 
01-C11-S1 122.2(2) C1-C11-S1 115.4(2) 
02-C20-C21 121.8(2) 02-C20-C2 119.4(2) 
C21-C20-C2 118.5(2) C22-C21-C26 119.6(2) 
C22-C21-C20 121.1(2) C26-C21-C20 119.3(2) 
C23-C22-C21 120.5(2) C22-C23-C24 119.8(2) 
C23-C24-C25 120.4(2) C26-C25-C24 120.1(2) 
C25-C26-C21 119.6(2) 
Symmetry transformations used to generate equivalent atoms 
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Table A.4.4: Anisotropic displacement parameters (A2 x 103) for 112. 
The anisotropic displacement factor exponent takes the form: 
-2n:2 [(ha*)2U11 + ... + 2hka*b*U12l 
Atom U11 U22 U33 U23 U13 U12 
81 35(1) 87{1) 30(1) 2(1 ) 0(1 ) -16(1 ) 
01 29(1 ) 57(1 ) 54(1 ) -5(1 ) -3(1 ) -21(1) 
02 48(1 ) 37(1 ) 61 (1) -20(1 ) 29(1 ) -15( 1 ) 
C1 25(1 ) 32(1 ) 28(1 ) -9(1 ) 2(1 ) -11(1) 
C2 25(1 ) 28(1 ) 29(1 ) -11 (1) 5(1 ) -8(1 ) 
C3 30(1 ) 38(1 ) 31 (1) -9(1 ) 0(1 ) -7(1 ) 
C4 25(1 ) 48(2) 45(1 ) -15(1 ) -4(1 ) -11 (1) 
C5 27(1 ) 56(2) 48(1 ) -14(1 ) 10(1 ) -22(1 ) 
C6 31 (1) 52(2) 30(1 ) -7(1 ) 7(1 ) -17(1 ) 
C11 23(1) 40(1 ) 31 (1) -13(1 ) 5(1 ) -7(1 ) 
C12 39(1 ) 108(2) 40(1 ) -17(1) -10(1 ) -9(2) 
C20 28(1 ) 32(1 ) 26(1 ) -10(1) 4(1 ) -8(1 ) 
C21 23(1 ) 30(1 ) 25(1 ) -7(1 ) 1 (1) -10(1) 
C22 30(1 ) 36(1 ) 33(1 ) -11 (1) 2(1 ) -11 (1) 
C23 40(1) 34(1 ) 49(1) -18(1) -9(1 ) -5(1 ) 
C24 52(2) 30(1 ) 50(1) -1 (1 ) -18(1 ) -18(1 ) 
C25 43(1 ) 47(2) 37(1) 1 (1 ) -4(1 ) -26(1 ) 
C26 28 1 351 291 -6 1 1 1 -13 1 
Table A.4.S: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 103) 
for 112 
Atom x y z U(eq) 
H3 6070(3) 4635(3) 9051 (2) 41 
H4 8406(3) 5440(3) 8060(2) 47 
H5 8058(3) 6987(3) 5933(2) 50 
H6 5372(3) 7716(3) 4805(2) 45 
H12A -461 (3) 9448(4) 2682(2) 101 
H12B -994(3) 8884(4) 4098(2) 101 
H12C 11 6(3) 7330(4) 3447(2) 101 
H22 4804(3) 2404(3) 7431 (2) 39 
H23 4832(3) -594(3) 7939(2) 49 
H24 3015(3) -1524(3) 9461 (2) 54 
H25 1147(3) 543(3) 10467(2) 50 
H26 10243 35843 99092 37 
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A.S. The P3SS Anti-tumour Assay 
This in vitro anti-tumour assay uses the P388 cell line (murine leukemia cells) 
and is up to a hundred times more sensitive to cytotoxic effects than the anti-viral 
BSC-l cell line. The P388 assay is therefore a cytotoxic-based assay against a specific 
leukemia cell type. The 1Cso result obtained from this assay represents the 
concentration of the test compound at which the number of viable cells is reduced by 
50% relative to the control. 
A two-fold dilution series of the sample of interest is incubated with P388 cells 
and MTT, a yellow tetrazolium salt, in sma]] plastic wells. After seventy-two hours of 
incubation the concentration of the sample required to reduce the number of viable cells 
by 50% relative to a control (P388 cells, MTT, media and solvent) is calculated. The 
mitochondria of viable leukemia cells reduce the yellow dye MTT to a purple formazan 
derivative'. By measuring the light absorbance at 540 nm in each well, a direct 
quantification of formazan formation and therefore the number of viable cells is able to 
be determined. The absorbance is expressed as a percentage cell viability relative to the 
control, and is plotted against the logarithm of the sample concentration in the well to 
generate a sample concentration versus cell viability curve. The antilogarithm of the 
concentration producing a 50% reduction in the number of viable cells gives the 1Cso 
result, which is expressed in the units of ng/mL. 
The P388 cell line represents a rapidly dividing cell type, thus its efficacy in 
finding products with activity in the predominantly occurring slow growing solid 
tumours of humans such as lung, colon, breast, skin and kidney cancers is strictly 
limited2. However, it is important to consider that a P388-active compound may still 
display a selective activity against these types of tumours. 
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Table A.5.1: (continued) 
CXN 98 CH30H/CH2CI2 34376 ~ ~ SCH3 3:1 
H CH3 3.0 mg/mL 
0 
109 CH30H 196 
o:l 2.5 mg/mL /f. SCH3 
0 
0 
111 CH30H > 31 250 ~ I ~ I 2.5 mg/mL b SCH3 Pt1 OH 
CC;CH' 112 CH30H 8918 I '-'::: 0 5.0 mg/mL 
.& 0 
Ph 






117a CH30H 35986 
* 
5.0 mg/mL /f. /ON 
Ph OH 
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